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Zusammenfassung 
Die Durchführung strukturbiologischer und biochemischer Analysen erfordert große Mengen an 
hochreinen Zielproteinen. Dabei steigt die Nachfrage nach komplexen, schwer zu exprimierenden 
Proteinen stetig, deren Produktion jedoch einen entscheidenden Engpass darstellt. Die Optimierung 
von Expressionssystemen und Produktionsprozessen ist daher ein wichtiges Unterfangen. Die 
methylotrophe Hefe Komagataella phaffii (Pichia pastoris) ist ein verbreitetes Expressionssystem 
zur Herstellung rekombinanter Proteine. Sie vereint die kostengünstige und einfache Handhabung 
von Mikroorganismen mit der Fähigkeit eine Vielzahl der posttranslationalen Modifikationen 
höherer Eukaryoten durchzuführen. Dadurch stellt P. pastoris eine interessante Alternative zu 
kostenintensiven Zellkulturen dar. Jedoch ergeben sich bei der erforderlichen stabilen 
Transformation von P. pastoris über homologe Rekombination einige entscheidende Nachteile. 
Diese umfassen eine begrenzte Anzahl etablierter genomischer Loci zur Integration von Zielgenen 
und eine stark variierende Expressionsleistung transformierter Klone, wodurch in der Regel ein 
langwieriges Screening nach Hochproduzenten („Jackpot-Klonen“) notwendig ist. 
Der erste Teil dieser Arbeit behandelt die Etablierung eines Rekombinase vermittelten 
Kassettenaustauschsystems (recombinase mediated cassette exchange, RMCE) zur Optimierung 
des Expressionssytems P. pastoris. Die spezifische Integration von Zielgenen in eine definiert 
austauschbare genomische Kassette einer P. pastoris RMCE Master-Zelllinie durch das Enzym Flp 
Rekombinase stellt eine vielversprechende Option dar, das Screening nach Jackpot-Klonen durch 
vorhersagbare Produktionsraten zu verhindern und bisher ungenutzte genomische Loci zur stabilen 
Proteinexpression zu erschließen. In dieser Arbeit wird die Herstellung eines RMCE Modell-
Systems in P. pastoris gezeigt. Ein beobachteter kritischer Einfluss einer Erkennungssequenz der 
Flp Rekombinase (FRT F3) auf die Expression des Zielgens wurde und über Transkriptions- und 
Translationsanalysen evaluiert. Abschließend wurde die Funktionalität des RMCE anhand eines 
Kassettenaustauschs in einer optimierten P. pastoris RMCE Master-Zelllinie nachgewiesen.  
Im zweiten Teil dieser Arbeit wird die Entwicklung einer Methode zur sekretorischen Herstellung 
der Ektodomäne der schwer zu exprimierenden Maus-Transmembranserinprotease Tmprss2 für 
strukturelle und funktionelle Analysen beschrieben. Tmprss2 spielt eine Schlüsselrolle in der 
Influenza A Infektion durch die proteolytische Aktivierung von Hämagglutinin H1. Die erste, 
erfolgreiche Produktion der aktiven Form von Tmprss2 und einer Mutante (D343N) konnte in 
P. pastoris erreicht werden. Die Ausbeuten konnten durch Optimierungen der Kultivierung und des 
Reinigungsprozesses deutlich erhöht werden. Schließlich wurde die Aktivität des rekombinanten 
Tmprss2 durch die enzymatische Prozessierung von Hämagglutinin H1 in vitro nachgewiesen.
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Synopsis 
Structural and biochemical analyses usually require high amounts of highly pure target proteins. 
Therein, the production of the increasingly demanded complex, difficult to express target proteins 
often presents a major bottleneck. Hence, the optimization of expression hosts and process 
strategies is an indispensably important task to pave the way for further studies. The 
methylotrophic yeast Komagataella phaffii (commonly known as Pichia pastoris) is a widely used 
expression system for the production of recombinant proteins. It presents an intriguing alternative 
to the costly mammalian or insect cell culture, as it unites the cost-efficient and simple handling of 
microorganisms with many of the sophisticated posttranslational processing capabilities of higher 
eukaryotes. However, the commonly required stable transformation of P. pastoris via homologous 
recombination results in several drawbacks. These include a limited number of established genomic 
loci for the integration of genes of interest (GOI). Moreoever, due to the strongly varying 
expression results of the transformants, extensive expression screens to identify high-producer 
(“jackpot”) clones are usually required.  
The first part of this work revolves around the establishment of a recombinase mediated cassette 
exchange (RMCE) system to optimize the expression system P. pastoris. The specific integration 
of GOI into a definedly exchangeable genomic cassette of a P. pastoris RMCE master cell line 
through the enzyme Flp recombinase presents a promising approach to eliminate the expression 
screening due to comparable productivities of exchanged producer clones. Furthermore, yet 
uncharacterized genomic loci can be made available for stable protein expression by this system. In 
this work, the generation of a P. pastoris RMCE master cell line is shown. An observed, critical 
influence of a recognition site of Flp recombinase (FRT F3) on the expression of the GOI was 
evaluated through transcriptional and translational analyses. Finally, a proof of concept is presented 
through a positive RMCE reaction in an optimized P. pastoris RMCE master cell line.  
The second part of this work deals with the establishment of a method for the secretory production 
of the ectodomain of the difficult to express transmembrane serine protease mouse Tmprss2 for 
structural and functional analyses. Tmprss2 plays a key role in influenza A virus infection through 
proteolytic activation of hemagglutinin H1. The first successful production of both the active form 
and a mutant form (D343N) of Tmprss2 was achieved in P. pastoris. The expression yields could 
be significantly improved through several optimizations of the cultivation and purification process. 
Lastly, the activity of recombinant Tmprss2 was proven through its ability to enzymatically process 
hemagglutinin H1 in vitro.  
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1 Introduction 
1.1 The relevance of recombinant protein expression 
Proteins are a highly diverse class of complex biological molecules. They are usually built from 
one or more polymerized chains consisting of the 23 proteinogenic amino acids. Comprising more 
than 50% of the dry weight of cells, proteins make up the main component of living cells. They 
participate in many essential functions of living cells taking part in signaling and regulation, for 
example as transcription factors, enzymes or membrane transporters. (Alberts et al. 2002) 
The research of the function of proteins and their regulatory mechanisms is indispensable in order 
to understand biological processes as a whole, including the research of diseases and infections. For 
instance, a number of diseases are caused by aberrant behavior of proteins, such as type II diabetes 
(Pillay and Govender 2013) or Alzheimer’s disease (Reitz and Mayeux 2014). Moreover, even 
normally functioning proteins of a host organism can be exploited by invading pathogens to 
mediate their infectivity, for example C-X-C chemokine receptor type 4 (CXCR4), which was 
identified as an essential host co-factor mediating the entry of human immunodeficiency virus into 
CD4+ T cells (Feng et al. 1996, Arnolds and Spencer 2014). The determination of three-
dimensional protein structures at atomic resolution plays a key role in gaining a detailed 
understanding of protein function. Particularly, the identification of binding partners and functional 
sites of proteins involved in pathogenesis is a substantial task to facilitate structure based drug 
design and to develop novel treatment strategies (Buchanan 2002, Zhang and Kim 2003).  
One major bottleneck for the determination of protein structures is the generation of sufficient 
amounts of highly pure, homogenous and soluble protein. However, meeting these requirements is 
often virtually impossible by protein extraction from natural sources, especially for challenging and 
complex proteins. For that matter, recombinant protein production is essential to generate the 
needed target proteins in the desired quality. Another important advantage of recombinant protein 
expression is the possibility to modify the desired target protein in ways that do not exist in nature.  
 The fusion of small peptide tags or whole proteins to the target protein is a widely used 
approach, for example to simplify its purification by affinity chromatography or to enhance its 
solubility (Arnau et al. 2006, Esposito and Chatterjee 2006).  
 Whole or partial fluorescent marker proteins can also be fused to the target protein to enable 
direct visual and quantifiable detection of the expression in vitro or in vivo (Walter et al. 2004, 
Cabantous et al. 2005).  
INTRODUCTION 
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 Completely or partially customized proteins can be designed, such as alternative antibody 
fragments such as the single chain variable fragments (scFv) (Carter 2006, Kontermann 2010). 
Furthermore, it is possible to insert specific mutations into proteins to fit to the desired 
application, for example to knock out the active site of an enzyme or to mimic the status of a 
phosphorylation site (Craik et al. 1987, Dissmeyer and Schnittger 2011).  
 Finally, in case of difficult-to-express target proteins, the production of partial, truncated 
protein constructs can significantly enhance the yield of the target protein, which can be a 
crucial factor for further experiments such as crystallization (Bleckmann et al. 2016a). 
The advent of recombinant DNA technology in the 1970s also marked the start for the heterologous 
expression of recombinant proteins (Cohen et al. 1973), leading to the recombinant production of 
human insulin in Escherichia coli (E. coli) as the first biotechnologically produced pharmaceutical 
(Goeddel et al. 1979). From there on, an increasing number of recombinant proteins have been 
produced for several biotechnological and pharmaceutical uses, such as enzymes for biocatalytical 
applications or vaccines for medical treatment (Makrides 1996, Kumar and Singh 2013).  
1.2 Prokaryotic and eukaryotic expression hosts 
Since the beginnings of recombinant protein expression, the need for high amounts of new, 
complex recombinant proteins in high purity increases constantly. Hence, the array of 
biotechnological expression hosts has since then been extended beyond the popular prokaryotic 
host E. coli. These alternative expression hosts feature several inherent advantages and drawbacks 
and show significant differences in regard of the expression strategy as well as in protein quality 
and yield (Hunt 2005).  
The gram-negative bacterium E. coli is the most abundantly exploited expression host up to now, 
which is used for the production of high amounts of proteins for pharmaceutical treatments or for 
structural biology (Nettleship et al. 2010, Kyriakopoulos and Kontoravdi 2013). E. coli offers 
several advantages. As a prokaryotic microorganism, E. coli is simple in handling and offers 
cultivation in inexpensive defined media. It features high growth rates and grows in high cell 
densities. Moreover, E. coli is genetically well characterized. Numerous straightforward and highly 
optimized protocols have become available over the years. These traits make E. coli a very cost- 
and work-efficient high-throughput system for recombinant protein expression. However, 
concomitantly with its simplicity, E. coli does not possess an endoplasmic reticulum (ER), which is 
necessary to perform distinct eukaryotic post-translational modifications (Berger et al. 2012). 
Moreover, E. coli is not able to efficiently secrete target proteins into the culture supernatant 
(Berger et al. 2012). For these reasons, E. coli is incapable to facilitate proper folding of many 
higher eukaryotic proteins (e. g. glycoproteins or membrane proteins), which often results in the 
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accumulation of misfolded target protein in inclusion bodies (Baneyx and Mujacic 2004, Aricescu 
et al. 2006, Byrne 2015).  
Over 50% of the human proteins are expected to be glycosylated (Apweiler et al. 1999). In these 
cases the application of eukaryotic cells for heterologous protein production, such as different 
vertebrate and invertebrate cell lines, can be largely beneficial for protein quality and yield (Wurm 
2004). However, cell culture is a significantly more cost- and work-intensive approach in 
comparison to E. coli. Mammalian cell lines are usually applied as expression hosts if human-like 
glycosylation patterns are desired to ensure full functionality of human target proteins. They offer 
posttranslational modifications and an array of chaperones, which can be critical to facilitate 
correct protein folding in order to generate high amounts of soluble target protein. In comparison to 
E. coli, they are characterized by slow growth kinetics in low cell densities. Moreover, they are 
highly susceptible to mechanical stress and require very specific culture media (Sandig et al. 2005). 
Two of the most popular mammalian cell lines are Chinese Hamster Ovary (CHO) cells and 
Human Embryonic Kidney (HEK) cells. HEK cells comprise one of the most elaborate expression 
hosts for human proteins. One variant, the HEK293-6E cell line, is particularly suitable for fast 
transient protein production in suspension cultures. HEK293-6E cells stably express the Epstein 
Barr virus nuclear antigen 1 (EBNA1), which binds to a replication origin (oriP) within an 
expression vector, allowing for it to be propagated by replication alongside the chromosomal DNA 
during mitosis (Van Craenenbroeck et al. 2000, Durocher et al. 2002). By that, the expression 
vector is retained in the nucleus of the host cells, which allows for a semi-stable protein production 
over time and concomitantly, higher expression yields. While the EBNA1 system is also available 
in CHO cell lines (Daramola et al. 2014), these cells are more frequently used for stable protein 
expression. The gene of interest (GOI) is stably integrated into the genome. This can be performed 
either randomly or by enzymatic insertion into specific cassette in genetically engineered master 
cell lines (Wilke et al. 2011, Baser et al. 2016). On the one hand, the generation of stable CHO 
producer cell lines is a significantly more time-consuming task in comparison to the plasmid based 
transient expression in HEK cells. On the other hand, the target protein can henceforth be produced 
continuously. Thus, the scale-up is independent of the addition of expensive plasmid DNA, which 
can be a critical cost factor.  
Alternatively to mammalian cells, several insect cell lines are frequently used as eukaryotic 
expression systems. Like mammalian systems, insect cells feature an advanced protein folding and 
secretion system. Hence, they offer full posttranslational modification capabilities, including 
glycosylation. However, the N-glycosylation pattern that the insect cells produce differs 
significantly to human cell lines, which presents a major limitation for the pharmaceutical 
applicability and may influence the full biological activity of the proteins. Insect cells apply a 
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truncated N-glycosylation pattern compared to mammalian cell lines, most prominently of the 
paucimannosidic type (Altmann et al. 1999). Unlike the complex type N-glycosylation present in 
human cells, these glycosylation patterns are less flexible and more homogeneous due to their 
simpler and shorter structure. This trait makes insect cells a particularly advantageous expression 
system for protein crystallization, because the proteins usually do not require extensive 
deglycosylation in order to form protein crystals. For this reason, it is not surprising that insect cells 
comprise the mostly used eukaryotic expression system for structural biology (PDB January 2017). 
The most popular insect cell lines used in structural biology are Spodoptera frugiperda SF21 
(IPLB-Sf21-AE), its clonal daughter cell line SF9 and Trichoplusia ni BTI 5B1-4 (High Five™, 
Hi5) (Vaughn et al. 1977, Granados et al. 2007, Durocher and Butler 2009). Compared to 
mammalian cells, SF21 and Hi5 offer simpler handling and cultivation parameters. They do not 
require additional support with CO2 and feature a higher tolerance to both osmolality and by-
product concentration (Ikonomou et al. 2003).  
The Baculovirus Expression Vector System (BEVS) is frequently used for the expression of 
recombinant proteins in SF21 and Hi5 cell lines. The BEVS allows for high expression levels 
through the infection with a recombinant baculovirus harboring an expression cassette for the GOI 
(Ikonomou et al. 2003). However, the necessary generation of recombinant baculovirus is usually a 
laborious task compared to the fast transient transfection of HEK cells (Meyer et al. 2013, Dalton 
and Barton 2014). Furthermore, the baculoviral infection induces proteolysis and cell death, which 
is unfavorable for continuous or extended expression processes and reliable expression results from 
batch to batch (Rhee et al. 1999, Dalton and Barton 2014). In addition to that, it is often necessary 
to work with both SF21 and Hi5 cells for efficient protein production in BEVS. Among these two 
cell lines, only SF21 cells are capable of producing high amounts of infective baculovirus particles 
and are hence used for baculovirus amplification (Wilde et al. 2014). Hi5 cells on the other hand 
exhibit only a low capacity of releasing infective baculovirus, but comprise the superior expression 
host to produce high amounts of target protein (Wickham et al. 1992, Davis et al. 1993). This can 
be a critical factor in terms of time consumption and cost efficiency, as it requires the use of 
different complex media and the handling of both cell lines. Still, the often obtained high protein 
yields and the homogenous glycosylation pattern usually outweigh these drawbacks making the 
BEVS a preferred system for high level protein production. 
Yeasts like Pichia pastoris present a compromise between bacteria and eukaryotic cell lines as 
expression hosts, displaying a number of advantageous traits of both worlds. They belong to the 
simplest available eukaryotic expression hosts. As such, they offer full post-translational 
modification capabilities, while being more comparable to E. coli in terms of handling as well as 
time consumption and cost effectivity. This PhD thesis mainly focuses on the yeast expression host 
P. pastoris, which will be discussed in detail in the following section (§ 1.3). In the end, each of the 
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eukaryotic and prokaryotic expression systems features several inherent advantages and drawbacks. 
The choice of the expression host is therefore always dependent on the properties of the desired 
target protein and the envisioned application.  
1.3 The eukaryotic yeast expression system Pichia pastoris 
The methylotrophic yeast Pichia pastoris (Komagataella phaffii) is a widely used expression 
system for the production of recombinant proteins (Ahmad et al. 2014, Bill 2015, Byrne 2015). 
Apart from that, P. pastoris serves as a model organism in cell biology in several studies, including 
autophagy, peroxisome biogenesis and Golgi function (Subramani et al. 2000, Farre and Subramani 
2004, Soderholm et al. 2004). The discovery of the ability of certain yeast species to metabolize 
methanol as a sole carbon and energy source ranges back to as early as 1969 (Ogata et al. 1969). 
Methanol presented an interesting carbon source, as it was inexpensive to synthesize from the 
naturally occurring gas methane. Consequently, the Phillips Petroleum Company (Barthlesville, 
Oklahoma, USA) made use of this metabolic trait to produce high protein animal feed from yeast 
biomass (single-cell protein, SCP). They patented the yeast Pichia pastoris and established a 
process protocol to grow it on methanol at high cell densities of greater than 130 g/L dry cell 
weight. Their progress was halted by the oil crisis in 1973 leading to dramatically increased 
methane costs. Hence, the SCP protocol never became competitive against another economically 
more feasible regeneratable protein source (soy beans) (Wegner 1990, Higgins and Cregg 1998). 
During the 1980s, the biotechnology company Salk Institute Biotechnology/Industrial Associates, 
Inc. (SIBIA) (La Jolla, Canada) started to develop P. pastoris as a heterologous gene expression 
system instead, in contract with Phillips Petroleum. At this time, major advancements for the 
genetic manipulation of P. pastoris were achieved at SIBIA, including the establishment of 
protocols and DNA vectors (Higgins and Cregg 1998). Furthermore, the strictly regulated alcohol 
oxidase I (AOX1) promoter was isolated, which offers strong expression during methanol feed. The 
AOX1 promoter in particular synergized well with the media and protocols that Phillips Petroleum 
had originally developed for the SCP process, resulting in a high yield expression system for 
heterologous proteins (Higgins and Cregg 1998). The principal system is still essentially in use up 
to now, with Research Corporation Technologies (Tucson, Arizona, USA) being the present patent 
holder and Thermo Fisher Scientific (Waltham, Massachusetts, USA) as the licensed reseller.  
 Pichia pastoris as a eukaryotic expression host 
As a single celled microbial eukaryote, P. pastoris offers several advantages. As a microorganism, 
P. pastoris shares many properties of bacterial expression hosts. It features a high growth rate and 
the handling of the cells is likewise uncomplicated compared to E. coli. P. pastoris requires only 
simple, inexpensive media and grows at moderate temperatures of ca. 28 to 30 °C, similar to the 
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popular model yeast Saccharomyces cerevisiae (S. cerevisiae). Additional support of the culture 
through CO2 or humidity is not required. These traits present a significant advantage over the cost-
intensive and laborious cell culture. Furthermore, P. pastoris is easy to genetically manipulate. The 
commonly applied methods are straightforward with a large and steadily growing array of 
protocols being available (Lin-Cereghino et al. 2005, Sunga et al. 2008, Looke et al. 2011, Aw and 
Polizzi 2016). Although it can be forced into mating and diploidy, P. pastoris is usually cultivated 
in its vegetative haploid state (Cregg 1987). Combined with the fact that its genome is completely 
sequenced (De Schutter et al. 2009, Küberl et al. 2011, Sturmberger et al. 2016), this allows for 
relatively simple, specific genetic engineering.  
While being similar to bacteria in terms of use and handling, P. pastoris displays several key 
advantages over prokaryotic expression systems like E. coli. Being a eukaryote, P. pastoris offers 
subcellular compartmentation including an ER. This enables the yeast to natively carry out many 
posttranslational modifications of higher eukaryotes, such as glycosylation or disulfide bond 
formation, which can be essential for protein quality and function (Wurm 2004, Byrne 2015). 
Another contrast to bacterial hosts is presented by the higher capabilities of P. pastoris in terms of 
protein processing and folding (Higgins and Cregg 1998). This includes an unfolded protein 
response (UPR) system in the ER, which leads to the expression of several stress chaperones to aid 
protein folding (Guerfal et al. 2010). The UPR system can also be triggered artificially to support 
the production of soluble, correctly folded recombinant target proteins (Guerfal et al. 2010). 
Moreover, P. pastoris offers powerful secretion capabilities, which allow directing natively 
secreted heterologous proteins into the culture medium. Notably, P. pastoris secretes only few 
native proteins by itself. This results in the target protein presenting virtually the only protein in the 
supernatant, simplifying any subsequent purification processes. Since the native secretion 
sequences of foreign target proteins may not work properly in yeasts like P. pastoris, a typical 
approach is the replacement of the original secretion signal with one compatible to P. pastoris. A 
popular example is the alpha mating factor pre pro secretion signal (MF-α ss) from the baker’s 
yeast Saccharomyces cerevisiae. Beneficially, the MF-α ss is cleaved off during secretion by the 
endogenous Kex and Ste13 proteases of P. pastoris. This results in a virtually native N-terminus of 
the heterologous target protein, although a short sequence of amino acid residues of the MF-α ss 
can remain at the N-terminus of the protein even after cleavage (Vedvick et al. 1991).  
P. pastoris holds two particularly important advantages as an expression host over many other 
types of yeast including S. cerevisiae. First, P. pastoris does not tend to perform 
hyperglycosylation during posttranslational modification, a condition that can even lead in a loss of 
activity (Eckart and Bussineau 1996, Bretthauer and Castellino 1999). Secondly, P. pastoris strictly 
prefers respiratory growth. Hence, P. pastoris does not generate significant amounts of ethanol as a 
cytotoxic by-product and can therefore be cultivated in very high cell densities (e. g. an OD600 of 
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400 units/mL) (Cregg 2007). This trait presents a considerable advantage over cell culture, as it 
enables high volumetric product yields. In this regard, P. pastoris for example has been reported to 
outperform CHO cell lines for the production of Fab antibody fragments, although the CHO cells 
displayed higher “per cell” productivities (Maccani et al. 2014).  
All in all, P. pastoris combines many of the advantages of the expensive and laborious cell culture 
and the simple, yet limited bacterial systems for the production of recombinant proteins. As such, 
P. pastoris comprises a highly interesting eukaryotic expression host. 
 Conventional cell line development in Pichia pastoris  
For the generation of P. pastoris clones expressing the GOI, the principal transformation and 
selection methods are comparable to those applied in E. coli or S. cerevisiae. However, the 
heterologous protein expression in P. pastoris commonly relies on stable transformation by 
homologous recombination (HR), as P. pastoris usually does not maintain episomal DNA vectors. 
Through this, a number of key differences arise for the development of the recombinant clones. 
1.3.2.1 P. pastoris strains for recombinant protein production 
Several genetically engineered P. pastoris strains for transformation and recombinant protein 
expression have been generated over the years, which are all genetically modified derivatives of the 
wildtype strain Y-11430 from the Northern Regional Research Laboratories (Peoria, Illinois, USA). 
Apart from antibiotic selection markers, auxotrophic selection based on amino acid biosynthesis is 
commonly used in P. pastoris. For example, the popular strain GS115 (his4) was originally 
generated through random mutagenesis from Y-11430 by Phillips Patroleum. It displays a 
knockout of the histidine biosynthesis pathway and is not able to grow on minimal medium without 
the supplementation of histidine (Cregg et al. 1985). Further strains exhibiting different amino acid 
biosynthesis gene knockouts have been developed likewise. Interestingly, even the commercially 
offered wildtype strain X-33 (Thermo Fisher Scientific) is principally an engineered strain. X-33 is 
based on the auxotrophic strain GS115 (his4), which was again transformed with the wildtype His4 
gene from P. pastoris to restore its prototrophy (Cregg 2007). In addition to auxotrophic mutant 
strains, several other engineered P. pastoris strains have been generated, for example offering 
deficiencies for endogenous proteases like PEP4. These strains generally allow for enhanced 
product quality, as these proteases could potentially cleave the target protein (Cereghino and Cregg 
2000). Still, the protease knockout strains also display slower growth rates and are more susceptible 
to stress, for example caused by the transition of the culture to methanol as a sole carbon source 
(Cereghino and Cregg 2000). This can in turn hamper the expression yield of the target protein 
(Cereghino and Cregg 2000).  
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1.3.2.2 Selection of DNA vectors and promoters to drive the target gene expression 
In addition to a suitable P. pastoris strain, it is important to select an optimal expression vector for 
protein production. Apart from the selection marker, the choice is primarily dependent on the 
promoter with the desired properties to drive the expression of the foreign GOI in P. pastoris. 
Common transformation methods in P. pastoris are based on stable integration of the expression 
vector. Consequently, the copy number of the GOI, which can eventually be expected, is several 
orders of magnitude lower than in transient systems (e.g. in HEK cell lines or in E. coli). Thus, the 
presence of a strong promoter leading to sufficiently high expression results is particularly 
important. Over the years, several novel promoters have been characterized in P. pastoris and 
numerous attempts have been made to further improve the array of known promoters through 
genetic engineering (Hartner et al. 2008, Qin et al. 2011, Liang et al. 2013, Periyasamy et al. 
2013b, Prielhofer et al. 2013, Zhang et al. 2013). Even the applicability of heterologous promoters, 
for example from the bacteriophage T7, has been addressed by researchers (Liang et al. 2012). The 
most prominently used promoters to date in P. pastoris for recombinant protein expression are the 
alcohol oxidase I (AOX1) promoter and the glyceraldehyde-3-phosphate dehydrogenase (GAP) 
promoter. Both promoters are part of many commercially available expression vectors, such as the 
pPICZ and pGAPZ vector families (Thermo Fisher Scientific).  
The methanol induced AOX1 promoter is frequently applied for protein expression in P. pastoris by 
inserting an “AOX1 promoter – GOI” expression cassette into the genomic AOX1 locus. P. pastoris 
harbors two native copies of the AOX gene designated (AOX1 and AOX2). The AOX1 promoter is 
the strongest available native promoter in regard of transcription activity. It is driving 85% of the 
AOX production, with the AOX2 promoter being only responsible for the remaining 15% (Cregg et 
al. 1989). Consequently, the knockout of the AOX1 gene results in a phenotype that is characterized 
by slow growth on methanol (methanol utilization slow, mutS). For example the strain KM71 (his4 
arg4 AOX1::ScARG4) or its prototroph variant KM71H (arg4 AOX1::ScARG4) (Lin-Cereghino 
and Lin-Cereghino 2007) display this phenotype. In contrast, the unmodified AOX1 wild type 
which is present for example in the strain X-33, is referred to as mut+ (methanol utilization plus). 
Double knockout strains for AOX1 and AOX2 are unable to grow on methanol (mut-). A particular 
benefit of using mutS strains is the significantly lower amount of methanol required to initiate and 
to maintain the induced expression, which is especially advantageous for scale-up (Cregg 2007).  
One key advantage of the AOX1 promoter for heterologous protein expression is its tight regulation 
(Cregg 1988, Hartner and Glieder 2006). At non-limiting growth conditions, the transcription of 
both AOX1 and AOX2 is virtually completely repressed in the presence glucose, glycerol and 
ethanol (Ellis et al. 1985, Cregg et al. 1989, Koutz et al. 1989). By that, the production process can 
usually be divided into two phases: An initial growth phase using glycerol as a carbon source to 
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accumulate high cell densities and a discrete production phase by completely switching the carbon 
source to methanol. This trait can be critically valuable for the production of toxic proteins. 
Furthermore, the two phase production synergizes well with mutS strains, often leading to higher 
productivities (Ascacio-Martinez and Barrera-Saldana 2004, Pla et al. 2006). The fact that mutS 
strains grow at slower rates than mut+ strains under methanol is beneficial in this case, because the 
cells are directing more resources into protein production instead of cell growth and division.  
The major disadvantage of using the AOX1 promoter is the required use of the highly inflammable 
and cytotoxic methanol as a substrate, which can be a critical factor for handling and scale-up. The 
amount of methanol added to the culture for the induction must be tightly regulated, since methanol 
is converted to formaldehyde as an intermediate product of the methanol utilization pathway. 
Unlike methanol however, formaldehyde is a cytotoxic substance for P. pastoris. If too much 
methanol is added to the culture, high levels of formaldehyde are produced and subsequently 
accumulated, because the formaldehyde dehydrogenase is not able to keep up with its further 
conversion. This eventually causes cell death and is usually detrimental for protein production. To 
prevent this problem, methanol is only added and maintained at low concentrations of 
0.1 to 0.5 % (v/v) to the culture. This particularly complicates small-scale high-throughput 
expression screenings in comparison to the use of constitutive promoters.  
Accordingly, several constitutive promoters have been characterized in P. pastoris as alternatives 
to the methanol dependent AOX1 promoter (Liang et al. 2013, Periyasamy et al. 2013a, Prielhofer 
et al. 2013). The most prominent constitutive promoter in P. pastoris is the GAP promoter, which is 
commonly applied to drive the expression of recombinant target proteins (Lee et al. 2005, Wen and 
Wang 2005, Hong et al. 2007). The GAP promoter provides a strong transcription rate. The 
transcriptional activity during feed with glucose is higher than during feed with glycerol or 
methanol. The main advantage of the GAP promoter is that its transcriptional activity is not 
dependent on the presence of cytotoxic methanol. This is particularly beneficial for large culture 
volumes and for high-throughput expression screening. In comparison to the AOX1 promoter, the 
GAP promoter performs about 6-8x weaker for the expression of eGFP (Liang et al. 2013). 
However, the GAP promoter can also outperform the AOX1 promoter depending on the target 
protein, as it was reported for the production of alkaline phosphatase (Yang et al. 2015).  
In summary, the selection of a promoter and an expression strain greatly depends on the desired 
application. It influences the cultivation strategy as well as the expected product yield and it can 
comprise a critical key point for the successful production of the target proteins in high quality.  
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1.3.2.3 Generation of stable P. pastoris producer cell lines by homologous recombination 
Method-wise, the generation of P. pastoris producer cell is in principal comparable to the protocols 
usually applied for E. coli. First, an expression vector is generated, which is then transformed into 
P. pastoris. Subsequently, positive clones are selected on appropriately selective agar plates. Since 
the transformation of P. pastoris relies on stable integration by HR, at least one homologous region 
must be present on the expression vector. Commonly, the promoter that drives the expression of the 
GOI fulfills this role. In contrast to E. coli vectors, a P. pastoris expression vector has to be 
linearized inside the homologous region prior to transformation of the cells for the HR to occur at 
efficient rates. The linearized vector is then transported to the nucleus, where the HR can occur 
between the homologous region on the vector and the respective genomic locus. The vector is then 
inserted into the genome and the recombinant cells can be selected for the introduced marker gene. 
A principal scheme of the generation of recombinant P. pastoris clones is depicted in Figure 1.1.  
 
Figure 1.1. Basic principle of the stable transformation of P. pastoris by homologous recombination.  
The expression vector (pPICZ-GOI) harbors the GOI, the AOX1 promoter (PAOX1) as a homologous region and 
a Zeocin resistance (ZeoR). The vector is linearized inside the PAOX1 through a uniquely cutting restriction 
enzyme (displayed by the pair of scissors) and subsequently transformed into P. pastoris. Inside the nucleus of 
the yeast, the homologous recombination (HR) can occur and the vector is stably inserted into the genomic 
locus homologous to the targeting sequence on vector (the AOX1 locus). A recombinant producer cell line is 
generated, which features an expression cassette for the GOI and can be selected for its Zeocin resistance. 
In addition to a single vector insertion, the HR can also occur multiple times. Thereby, tandem 
copies of the vector are inserted into the genomic locus, resulting in multi copy clones. The 
additional copies of the expression vector can be beneficial for target protein yields. However, this 
relation is not straightly linear and the expression will decrease again in the presence of too many 
vector copies (Liu et al. 2014). Even more so, it has been reported that higher expression yields 
could be achieved in clones displaying lower gene copy numbers for the production of some target 
proteins, e. g. alkaline phytase (Yang et al. 2012). If two different homologous regions are present 
at the 5’ and 3’ ends of the linearized vector, a gene replacement (Ω insertion) can occur at the 
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genomic region, which is also commonly used not only to introduce a GOI, but also to generate 
P. pastoris knockout strains (Higgins and Cregg 1998). The stable transformation via HR grants 
several advantages. Once isolated and characterized the recombinant producer clones can be stored 
and maintained for a virtually indefinite number of production processes with predictable 
expression results. Additional transformations are not required for later production runs. 
Furthermore, the expression cultures do not require the permanent addition of selective agents (e. g. 
antibiotics). This greatly simplifies subsequent handling and scale-up.  
However, the use of HR to generate recombinant P. pastoris clones also holds a number of 
drawbacks. While the workflow is initially straightforward in terms of transformation and selection 
(Figure 1.2), the transformed clones show significant differences in the expression of the gene of 
interest (GOI). Moreover, the HR machinery of P. pastoris is less efficient compared to 
S. cerevisiae, which leads to the risk of off-target integration events through non-homologous end-
joining (NHEJ) with unpredictable expression results (Näätsaari et al. 2012). This makes the 
generation of specifically modified P. pastoris strains considerably more complicated (Näätsaari et 
al. 2012). Interestingly, the expression yield of a target protein is also not solely affected by the 
inserted copy number of the recombinant expression cassette. Instead, the random insertion of a 
vector into a favorable genomic locus for the expression of the GOI can also result in significantly 
higher product yields. Due to the consequently strongly varying expression patterns, extensive 
screening is usually required to identify a high-producer (“jackpot”) clone. This is particularly 
critical for difficult to express target proteins (Higgins and Cregg 1998). Hence, the generation of a 
producer clone with suitable expression yields can result in a time-consuming and work-intensive 
process (Brooks et al. 2013).  
With every transformation, the expression vector is stably integrated into the genome, thereby 
permanently reserving its inherent selection marker gene from further use. This heavily 
complicates the process of introducing multiple genetic modifications to the yeast, because the 
range of antibiotic selection markers in P. pastoris is limited (Wan et al. 2004, Papakonstantinou et 
al. 2009). Hence, recycling of an antibiotic selection gene after a transformation is of great interest 
especially for genomic engineering applications. However, marker gene recycling usually presents 
a complicated and laborious procedure in itself, requiring site specific recombinases (Flp) or HR to 
loop out the selective cassette and remove it from the genome (Cregg and Madden 1989). 
The use of additional genetic elements such as negative selection markers is largely beneficial to 
efficiently select the resulting clones, yet this further complicates the process (Yang et al. 2009). 
Several attempts have been made to solve these various shortcomings of the stable cell line 
generation by HR in P. pastoris, for example by increasing HR efficiencies through the deletion of 
the gene encoding the KU70 homolog of P. pastoris. KU70 is a known key-player in the non-
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homologous-endjoining repair system (NHEJ) in S. cerevisiae. Its deletion indeed led to a 
significant increase of the HR targeting efficiencies in P. pastoris, but it also resulted in vastly 
decreased transformation efficiencies, reduced growth rates and higher susceptibility to random 
mutations of the genome (Näätsaari et al. 2012). 
 
Figure 1.2. Schematic overview of the principal work flow for protein expression in P. pastoris. 
An expression vector harboring the GOI (pPICZ-GOI) is linearized and transformed into P. pastoris. Following 
primary selection (e.g. for Zeocin resistance, ZeoR) (~3 days), grown colonies are singly streaked out for clone 
purification /single clone isolation (~3 days). To isolate multi copy clones, the single clone isolation step 
includes screening for growth on an increasing concentration gradient of the selective agent (e. g. Zeocin). The 
isolated clones are tested for their expression levels, which can take up several days or weeks, depending on 
the target protein. The identified high producer clones can then be used for scaled-up production processes. 
1.3.2.4 Episomal vector propagation by PARS sequences 
Vectors containing a Pichia Autonomous Replicating Sequences (PARS) comprise an alternative to 
the commonly applied stable integration of expression vectors, as they allow for a limited, episomal 
propagation of plasmids in P. pastoris (Cregg et al. 1985). Originally, ARS sequences were first 
discovered for S. cerevisiae (Szabo et al. 2003), where they are believed to play a role as DNA 
origins of replication (ori) during mitosis (Huberman et al. 1988).  
In contrast to the stable transformation via HR in P. pastoris, a vector containing a PARS sequence 
can be efficiently transformed as a circular plasmid without the need for linearization, thereby 
simplifying the procedure (Cregg et al. 1985, Lee et al. 2005). Furthermore, PARS vectors like 
pBGP1 are only kept at very low copy numbers inside the cells, averaging around one copy per 
cell. For these reasons, they have been applied for fast transient expression screenings as a time-
saving alternative to stable cell line generation (Aoki et al. 2003, Lee et al. 2005). However, the 
low copy number usually results in consequently low expression levels. Moreover, the presence of 
homologous sequences such as promoters or terminators on PARS plasmids can cause their 
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uncontrolled integration into the genome of P. pastoris after a random period of time (Higgins and 
Cregg 1998). By that, an originally isolated, homogeneous clone may diverge into a heterogeneous 
mixture of different clones, which can significantly compromise the expression levels. Therefore, it 
is not surprising that the majority of expression screens rely on stable transformation (Macauley-
Patrick et al. 2005), as only stably transformed clones offer long-term stability and constant product 
yields from an identified “jackpot” clone.  
1.4 The multi-host expression system 
The multi host expression system (mHost-XS) is a versatile system for protein expression 
screening and production in an array of different expression hosts. The basis of the mHost-XS is 
the unique single donor vector pFlpBtM (Meyer et al. 2013). It offers all the elements needed for 
fast transient expression in HEK293-6E cells, baculoviral-driven expression in insect cells as well 
as stable expression in CHO master cell lines via recombinase-mediated cassette exchange 
(RMCE). A basic scheme of the vector is depicted in Figure 1.3. 
 
Figure 1.3. Overview on the versatile multi-host vector pFlpBtM. 
The vector pFlpBtM contains all necessary elements for fast plasmid-based expression in HEK293-6E cells. The 
promoter region includes the strong CMV promoter and the EBV oriP mediates the replication of the plasmid 
in the host cells during mitosis. Furthermore, pFlpBtM can be used to generate recombinant bacmids for the 
BEVS via Tn7 transposition. Lastly, pFlpBtM can serve as a donor vector for a Flp recombinase based RMCE, 
due to the presence of a pair of heterospecific FRT sites (FRT F3 and FWT). This system is applied to generate 
stable CHO producer cell lines. A human PGK promoter (hPGK) and an ATG start codon (atg) are present 
inside the RMCE cassette to complement a selection trap in these cell lines.  
The expression of both intracellular and secretory proteins is possible with pFlpBtM. The secretion 
is realized by an N-terminal IgG secretion signal. Furthermore, pFlpBtM features C-terminal tags 
for protein purification and a TEV protease cleavage site to cleave them off. For the transient 
expression in HEK293-6E cells, the pFlpBtM comprises the strong cytomegalovirus (CMV) 
promoter. Furthermore, HEK293-6E cells constitutively express the Epstein-Barr nuclear antigen 1 
(EBNA1). EBNA1 mediates the replication of pFlpBtM and its propagation to the daughter cells 
during mitosis through an Epstein-Barr virus (EBV) oriP, which is present on the vector backbone.  
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The pFlpBtM plasmid further harbors all necessary elements for the Bac-to-Bac® baculovirus 
expression vector system (BEVS) (Thermo Fisher Scientific). The promoter region of pFlpBtM 
harbors baculoviral promoters for the expression of the GOI. For the generation of the recombinant 
bacmid, a specific E. coli strain is necessary, designated as DH10Bac. It carries a recombinant 
bacmid (EmBacY) and a helper plasmid coding for the enzyme transposase (Trowitzsch et al. 
2010). When DH10Bac is transformed with pFlpBtM, the transposase mediates the defined 
integration of the vector region between the two Tn7 sites (Tn7 L and Tn7 R) present on pFlpBtM 
into the mini-attTn7 site on the EmBacY. The mini-attTn7 site is embedded into the coding 
sequence of a lacZ gene in EmBacY. Through the transposition, the lacZ gene is disrupted, 
enabling visual selection for positive integration events by blue-white screening. Once the bacmid 
is purified, it is transfected into Sf21 insect cells where it causes the production of recombinant 
baculovirus particles. The transfection with the bacmid as well as any subsequent infection with the 
recombinant virus can be monitored through the expression of YFP, which is present on the bacmid 
backbone. A schematic overview of the workflow is shown in Figure 1.4.  
 
Figure 1.4. Schematic workflow of the generation of baculovirus for BEVS using the mHost-XS. 
The vector pFlpBtM, which harbors the GOI, is transformed into E. coli DH10Bac carrying the EmBacY 
bacmid. The transposase coded by a helper plasmid mediates the transposition of the vector region of 
pFlpBtM between the Tn7 sites into the corresponding mini-attTn7 site on the bacmid. The mini-attTn7 site is 
embedded within a lacZ gene, which is consequently disrupted, enabling blue-white screening. After 
purification, the recombinant bacmid can be used for the generation of baculoviruses and for the infection of 
insect cells. A YFP that is coded from the bacmid backbone of EmBacY aids monitoring the viral infection.  
In addition to this, insect cells can be brought to recombinant protein expression in a process called 
transactivation. This is performed by transiently transfecting of the insect cells with pFlpBtM 
(containing the GOI) and infecting them with “empty” baculovirus, which produces the necessary 
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proteins and transcription factors to induce protein expression directly from the plasmid 
(Bleckmann et al. 2016b).  
Finally, pFlpBtM serves as a donor vector for the stable transformation of specific CHO RMCE 
master cell lines via a recombinase-mediated cassette exchange (RMCE). These cell lines are stably 
transformed (“tagged”) with an exchangeable RMCE cassette. The expression of the exchangeable 
GOI is driven by an upstream residing “endogenous” EF promoter that is supplied by the 
transformed tagging vector. Upon co-transfection with pFlpBtM and a helper vector for the 
expression of Flp recombinase, the genomic RMCE cassette is exchanged for its counterpart on 
pFlpBtM. Thereby, the GOI and additional elements for selection of positive integration events are 
inserted into the genome. An overview of the RMCE method is presented in the following section. 
1.5 The recombinase mediated cassette exchange (RMCE) 
The RMCE system was originally established by Schlake and Bode in 1994 (Schlake and Bode 
1994). It is a convenient method for the highly specific and robust stable insertion of DNA 
cassettes into a predefined genomic locus of a host cell using the Flp recombinase (flippase, Flp), a 
member of the tyrosine family of site-specific recombinases (Ma et al. 2007). The RMCE is based 
on the generation of stable master cell lines (MCL) in a process called tagging, in which an 
exchangeable RMCE cassette is stably integrated into the genome of the desired expression host. It 
comprises a number of different elements, for example a fluorescent marker and/or an antibiotic 
resistance gene for robust primary selection. The promoter to drive the expression of the 
fluorescent marker (or a GOI after a cassette exchange) can either reside stably upstream of the 
tagging cassette inside the genome or it can be part of the exchangeable RMCE cassette. The 
borders of the exchangeable RMCE cassette are defined by a pair of heterospecific FRT (Flp 
recombinase targeting) sites in parallel orientation, for example FRT F3 and FRT FWT. FRT sites 
comprise short repeating 13 bp DNA sequences comprising two direct repeats and an inverted 
repeat separated by a variable 8 bp spacer (Schlake and Bode 1994). They form secondary 
structures, which are recognized by the Flp recombinase. The RMCE is based on the fact that the 
Flp is highly specific and only allows for recombination between identical FRT sites. Thus, the 
different FRT site variants that were obtained by mutating the spacer region do not display cross-
reactivity and are only recombined with an identical counterpart (Schlake and Bode 1994).  
The principle of the RMCE reaction is shown in Figure 1.5. To perform the RMCE, an identified 
stable RMCE MCL, a suitable donor vector and a helper vector delivering the Flp recombinase are 
needed. The donor vector (e. g. pFlpBtM) has to harbor an exchange cassette flanked by the same 
pair of FRT sites that is also flanking the genomic tagging cassette. When the donor vector and the 
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helper vector are transformed into the RMCE MCL, the RMCE reaction can occur following the 
expression of Flp recombinase.  
 
Figure 1.5. Schematic depiction of the RMCE reaction using the mHost-XS vector pFlpBtM. 
In the presence of Flp recombinase, the RMCE cassette of the donor vector (pFlpBtM) flanked by FRT F3 and 
FWT is exchanged with a parallel genomic tagging cassette, featuring an identical pair of FRT sites. Thereby, 
the GOI is stably inserted into the genome. The promoter to drive its expression is for example present 
“endogenously” in the genomic tagging locus (“Prom.”). The promoter region of pFlpBtM is irrelevant to the 
reaction, as it is not inserted into the genome (greyed out). Next to the GOI, a human PGK promoter (hPGK) 
and an ATG start codon are delivered to complement an otherwise inactive selection gene (selection trap, 
ΔSelection). The exchanged clones are screened for the selectivity conveyed by the complemented selection 
trap. This vastly improves screening for positively exchanged producer clones, as the excision of the donor 
cassette is generally thermodynamically favored over its insertion.  
Flp recombinase uses a type IB topoisomerase like mechanism to carry out the cassette exchange in 
a repeated two-step reaction process (Ma et al. 2007). It comprises first the creation of a Holliday 
junction intermediate and secondly the recombination of two complementary DNA strands 
presented by a pair of identical FRT sites (Ma et al. 2007). Therein, the cleavage of the DNA 
strands is performed by a highly conserved tyrosine nucleophile (Ma et al. 2007). Through the 
recombination of both FRT sites flanking the RMCE tagging cassette with their respective 
counterparts on the donor vector, the exchangeable donor cassette is inserted into the genome. 
Consequently, the elements of the tagging cassette are removed from the genomic locus. The Flp 
mediated cassette exchange is a dynamically reversible reaction process, with the excision reaction 
being thermodynamically favored over the insertion reaction (O'Gorman et al. 1991, Schübeler et 
al. 1998, Francastel et al. 1999). Hence, the application of selection markers for a successful 
integration of the donor vector into the genome is greatly beneficial to identify successfully 
exchanged clones. One particularly useful approach is to place a so-called selection trap directly 
downstream of the RMCE cassette. The selection trap presents an inactive selection marker gene, 
which lacks its ATG start codon and a promoter to induce its expression. Both of these elements 
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are delivered by the donor vector during a RMCE, thereby complementing the selection trap gene. 
The cells can subsequently be screened for the newly acquired selectivity. In contrast to the 
delivery of a full selection marker cassette, the selection trap method only provides the selectivity 
upon the defined vector integration via RMCE, avoiding false positive clones from random vector 
insertions into the genome. By that, the selection trap provides an efficient method to robustly 
select for positive RMCE events (Verhoeyen et al. 2001, Wilke et al. 2011, Baser et al. 2016).  
Anticipated benefits of establishing the RMCE system in P. pastoris 
The application of the RMCE system in P. pastoris displays several anticipated advantages over 
the current system based on HR. First, the RMCE should result in a highly specific and robust 
exchange of a GOI into a defined genomic locus, circumventing the problems arising from the use 
of HR.  
Secondly, the tagging with the RMCE cassette could be intentionally performed randomly to 
identify yet uncharacterized genomic loci for stable recombinant protein expression. Thereby, the 
established loci (AOX1 and GAP) could be left untouched for further potential applications.  
Thirdly, antibiotic selection markers can be placed inside the tagging RMCE cassette for robust 
primary selection during the generation of the MCL. The RMCE reaction would directly recycle 
these selection markers without any additional procedures.  
Lastly, the expression for the production of the target protein would only have to be screened once 
through the expression of a fluorescent marker protein from the RMCE tagging cassette of the 
MCL clones (as a model GOI). After the RMCE, the expression level of the integrated GOI should 
scale with that of the exchanged fluorescent marker. In other words, the RMCE is expected to 
result in clones with uniform expression results. This would eliminate the usually required 
extensive expression screens.  
1.6 Fluorescent proteins as visual expression markers  
Fluorescent proteins such as the green fluorescent protein (GFP) from Aequorea victoria 
(Shimomura et al. 1962) are commonly applied as marker proteins in many studies including gene 
expression and protein-protein interaction, as they allow for highly sensitive, straightforward and 
quantifiable measurements (Chalfie et al. 1994, Walter et al. 2004, Cabantous et al. 2005). GFP and 
other GFP-like fluorophores are usually simple proteins. This enables their heterologous production 
even in bacterial expression hosts like E. coli (Prasher et al. 1992). Moreover, the chromophore is 
formed intrinsically through an extended π-electron system by conserved amino acid residues of 
the protein (e.g. Ser65-Tyr66-Gly67 for GFP) (Ormö et al. 1996). Hence, the measurements of the 
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respective fluorescence do not require the addition costly substrates (Chalfie et al. 1994, Chalfie 
1995, Rodrigues et al. 2001).  
For these reasons, fluorescent proteins were selected as marker proteins to establish the RMCE 
system in P. pastoris in this PhD study. It should be noted that yeasts like P. pastoris intrinsically 
display a weak auto fluorescence, which particularly interferes with GFP measurements (Cormack 
et al. 1997, Hitchcock et al. 2006). In contrast, the measurement of red fluorescent proteins (RFP), 
which is performed at longer wavelengths, greatly reduces the influence of both light scattering and 
the intrinsic auto fluorescence of yeast cells (Hitchcock et al. 2006). An additional advantage of 
using RFPs as markers for gene expression is the fact that the expression is already visible at 
ambient light. Therefore, two RFP were selected as fluorescent markers to track the tagging of the 
yeast cells with the RMCE cassette: The monomeric RFP mCherry from Discosoma sp., which 
offers a particularly high photostability (Shaner et al. 2004), and the RFP from 
Corynactis californica, which is available as “RudolphRFP” in a codon optimized form for high 
level expression in P. pastoris (ATUM, Newark, California, USA). 
It had been shown in prior studies with CHO RMCE master cell lines that the excitation and 
emission wavelengths of green and red fluorescent proteins differ sufficiently to enable separate 
measurements of both chromophores from the same cell (Baser et al. 2016). Hence, GFP was 
chosen as a model GOI to monitor the cassette exchange reaction in P. pastoris. As mentioned 
before, the auto fluorescence of P. pastoris interferes with GFP measurements. For this reason, a 
suitable variant of GFP was selected to counter said interference and to generate a sufficiently 
strong signal in P. pastoris. This variant is based on enhanced GFP (eGFP), which is a mutant form 
with significantly higher illumination levels (Cormack et al. 1996). For high level expression in 
yeast cells specifically, the eGFP gene was further codon optimized (yeast enhanced GFP; y-eGFP) 
(Cormack et al. 1997). A synthetic clone of y-eGFP generated by Christian Kambach (HZI, 
Braunschweig) is used in this work. The parameters of the fluorochromes used in this PhD study 
are listed in Table 1.1. 
Table 1.1. Properties of the fluorescent marker proteins used in this work. 
Name Excitation [nm] Emission [nm] MW [kDa] Length [aa] Reference 
 
mCherry 
 
587 610 26.7 236 Shaner et al. 2004 
 
RudolphRFP 
 
553 570 25.3 226 ATUM (Newark, CF, USA) 
 
y-eGFP 
 
484 510 26.9 238 
Christian Kambach, HZI 
based on Cormack et al. 1997 
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1.7 The type II transmembrane serine protease Tmprss2  
The major portion of the proteases in the respiratory tract consists of serine proteases (Meyer and 
Jaspers 2015). Among these is the family of the type II transmembrane serine proteases (TTSP), 
which display a number of common structural traits. They comprise an N-terminal intercellular tail, 
followed by the transmembrane domain and an ectodomain containing a variable stem region and 
the C-terminal serine protease domain (SPD) (Bugge et al. 2009). TTSPs are initially expressed as 
single-chain proenzymes, which require auto-catalytic activation by cleavage of a conserved 
zymogenic site downstream of a basic arginine or lysine (Bugge et al. 2009). The zymogenic 
activation results in molecular rearrangement of the ectodomain, while the cleaved parts of the 
protein are covalently kept together by a conserved disulfide bond (Bugge et al. 2009).  
TTSPs are divided in four subfamilies based on phylogenetic analyses of their SPD and their 
domain structure (Figure 1.6). These are the Matriptase subfamily, the HAT / DESC (human 
airway trypsin-like protease / differentially expressed in squamous cell carcinoma) subfamily, the 
Hepsin / Tmprss (transmembrane protease serine) and finally the Corin subfamily (Netzel-Arnett et 
al. 2003, Szabo et al. 2003, Szabo and Bugge 2008, Antalis et al. 2010).  
Tmprss2 is a member of the Hepsin/Tmprss subfamily. Similar to other TTSPs such as Matriptase 
or HAT, Tmprss2 is widely expressed in epithelial tissues, including the prostate epithelium, the 
ovaries as well as the upper airway epithelium and the alveoli (Lin et al. 1999, Bugge et al. 2009). 
Depending on its localization and tissue site, Tmprss2 can exist as either a full length protein or in 
a variety of truncated forms (Afar et al. 2001, Chen et al. 2010). Apart from the membrane-bound 
state, the ectodomain can also be released into the pericellular environment (Yasuoka et al. 1997, 
Afar et al. 2001). Tmprss2 was shown to reduce epithelial sodium channel activity, which led to the 
proposition that Tmprss2 might be responsible for regulating ion transport and sodium currents in 
the airway epithelium (Donaldson et al. 2002). Moreover, Tmprss2 reportedly takes part in 
inflammatory responses in the prostate by proteolytic activation of protease-activated receptor 2 
(Wilson et al. 2005). Yet, the exact physiological function of Tmprss2 is still unclear, since 
Tmprss2 knockout mice were healthy and showed neither a discernible phenotype nor any 
compensatory up-regulation of other TTSPs (Kim et al. 2006).  
According to different reports, Tmprss2 is speculated to play a key role in the activation and 
subsequent replication of respiratory viruses, such as the H1N1 influenza A virus, the human 
metapneumovirus or the SARS coronavirus (Böttcher et al. 2006, Shirogane et al. 2008, Böttcher et 
al. 2009, Bertram et al. 2012).  
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Figure 1.6. Simplified schematic overview of the TTSP subfamilies. 
TTSPs are divided into four subfamilies: The HAT/DESC subfamily, the Hepsin/Tmprss subfamily, the 
Matriptase subfamily and the Corin subfamily. A schematic view of the domain structures is depicted on the 
left-hand side. The names of the respective members are depicted on the right-hand side. Tmprss2 (bold) is a 
member of the Hepsin/Tmprss subfamily. For simplification, the emphasis was laid on the basic domain 
structures. Differences in the exact lengths of the N- and C-terminal tails are not depicted. All TTSPs are 
zymogens, which require autocatalytic activation through cleavage upstream of the respective serine protease 
domain. Abbreviations: HAT: human airway trypsin-like protease; DESC: differentially expressed in 
squamous cell carcinoma; Tmprss: transmembrane protease serine; MSLP: mosaic serine protease large-form. 
TM: transmembrane domain; SEA: sea urchin sperm protein/enteropeptidase/agrin domain; SPD: serine 
protease domain; SRCR: scavenger receptor cysteine-rich domain; LDLA: low density lipoprotein receptor 
class A; CUB: Cls/Clr, urchin embryonic growth factor bone morphogenetic protein-1 domain; MAM: 
meprin/A5 antigen/receptor protein phosphatase mu domain; Frizzled: Frizzled domain.  
 The role of Tmprss2 during influenza A pathogenesis 
Seasonally occurring influenza epidemics as well as unpredictable pandemics are a grave threat to 
public health. This is exemplified by the 1918 flu pandemic caused by the H1N1 influenza A virus 
(IAV). It infected over 500 million people world-wide, resulting in approximately 50 million 
deaths (Taubenberger and Morens 2006). Current therapy approaches rely on targeting the viral 
proteins neuraminidase and M2. However, the development of resistance to these anti-viral drugs is 
frequently observed, because of the high mutation rate of the virus (Hurt et al. 2012). For this 
reason, the identification of new drug targets for the treatment of influenza A infection is an 
essential task. Therein, invariable host cell factors, which are critically essential for viral 
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pathogenesis but not for cellular survival, comprise highly interesting targets to develop novel 
strategies for antiviral therapy (Hatesuer et al. 2013). 
The activation of the viral surface protein hemagglutinin (HA) by proteolytic cleavage of its 
precursor form (HA0) into its disulfide-linked subunits HA1 and HA2 presents an essential step for 
IAV infectivity (Klenk and Rott 1988, Steinhauer 1999). The majority of the IAV subtypes harbor 
HAs with monobasic cleavage sites, which are only cleaved in a limited number of tissues such as 
the respiratory tract (Klenk and Rott 1988, Steinhauer 1999). The TTSPs Tmprss2 and HAT, which 
are present on airway epithelial cells, were identified as possible candidates to catalyze this 
reaction and subsequently shown to be able to proteolytically activate the monobasic HAs H1, H2 
and H3 in MDCK cell culture, resulting in enhanced viral replication (Böttcher et al. 2006, 
Böttcher et al. 2009). Consistently with these results, Tmprss2 was later found to be critically 
essential for the activation of H1N1 and - to a lesser extent - H3N2 IAV in living mice, as  
Tmprss2-/- knockout mice were significantly less susceptible to H1N1 infection compared to 
wildtype mice (Hatesuer et al. 2013). Interestingly, Tmprss2 deficient mice were in contrast not 
protected from infection by a multi-basic H7N7 IAV (Hatesuer et al. 2013). These results were 
further supported by different reports, which also showed that Tmprss2 deficient mice were 
protected from H1N1 infection (Sakai et al. 2014, Tarnow et al. 2014).  
As mentioned before, Tmprss2 knockout mice do not show any phenotypic alterations (Kim et al. 
2006). This makes Tmprss2 an interesting drug target to develop novel treatment strategies against 
IAV infection by structure-based drug design (SBDD). Solving the crystal structure of mouse 
Tmprss2, especially of the enzyme-substrate interaction surface in combination with HA H1, 
presents an important step on the path to gain a deeper understanding the proteolytic activation of 
HA by Tmprss2. This PhD thesis deals with the establishment of a method to generate the required 
amounts of mouse Tmprss2 for crystallization experiments. 
 Mouse Tmprss2 as a recombinant target protein 
Mouse Tmprss2 (NCBI reference number NP_056590) is a 490 aa long protein with a molecular 
weight of ~70 kD. Its extracellular domain comprises a low density lipoprotein receptor class A 
domain (LDLA), a scavenger receptor cysteine-rich domain (SRCR) and the catalytic serine 
protease domain (SPD). The total extracellular domain spans over 384 aa with a molecular weight 
of ~45 kD, with the C-terminal serine protease domain taking up 236 aa (~30 kD). A schematic 
overview of the protein domain structure of mouse Tmprss2 is depicted in Figure 1.7.  
The selection of a suitable construct and an expression host is essential to gain the required 
amounts of mouse Tmprss2 for structural analyses. The SPD carries out the primary proteolytic 
activity of Tmprss2 and thus comprises an essential part of the recombinant construct for SBDD. 
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The LDLA and SRCR domains are speculated to play an important role for the activity of Tmprss2, 
as the proteolytic activity was significantly reduced for soluble truncated fractions comprising only 
the C-terminal SPD (Afar et al. 2001, Böttcher-Friebertshauser et al. 2010). Similar observations 
were made for another TTSP, Matriptase-2. Matriptase-2 harbors a SEA domain and four LDLA 
domains (LDLA1-4) upstream of its SPD (Figure 1.6). Blocking LDLA3 or mutating either 
LDLA2 or SEA reportedly hindered zymogenic activation and resulted in a loss of function (Lee et 
al. 2007, Ramsay et al. 2009, Silvestri et al. 2009). Furthermore, despite the homologies to other 
TTSPs, only Tmprss2 can cleave HA H1 efficiently in vivo, as evident by the previously mentioned 
experiments carried out in living mice (Hatesuer et al. 2013). Hence, the LDLA and SRCR 
domains of Tmprss2 might play an important role in the activation and substrate binding 
capabilities of Tmprss2. Consequently, the full length ectodomain of Tmprss2 was selected to serve 
as the recombinant target protein for SBDD. 
 
Figure 1.7. Schematic overview of mouse Tmprss2. 
Mouse Tmprss2 comprises 490 amino acids. The N-terminal, cytoplasmic domain is followed by a 
transmembrane domain (TM) and the ectodomain, which comprises a LDLA (low density lipoprotein receptor 
class A), a SRCR (scavenger receptor cysteine-rich) and a serine protease domain. The conserved residues of 
the catalytic triad were identified as histidine 294 (H294), aspartate 343 (D343) and serine 439 (S439) (Vaarala 
et al. 2001). The zymogenic cleavage site is located between the SRCR and the serine protease domains. A 
covalent disulfide bond (S – S) keeps the protein attached following autocatalytic activation.  
Comparable to other TTSPs, Tmprss2 is a multi-domain glycoprotein. Tmprss2 harbors two 
cysteine-rich domains (LDLA and SRCR) with multiple disulfide bonds. It is conceivable that the 
folding machinery of eukaryotic cells and their ability to perform posttranslational modifications in 
the ER is largely beneficial for the production of the ectodomain of Tmprss2. In accordance to this, 
several groups reportedly relied on P. pastoris for the secretory production of the full ectodomains 
of other TTSPs (Hepsin, DESC1 and Matriptase-1), as well as the SPD of Matriptase-2 (Friedrich 
et al. 2002, Somoza et al. 2003, Yuan et al. 2011, Zhao et al. 2013). Moreover, the ectodomains of 
Matriptase-2, Hepsin and DESC1 were also expressed in Drosophila S2 insect cells (Beliveau et al. 
2009). It should be noted that the same research group only reported the production of the SPD of 
Matriptase-1 in E. coli (Désilets et al. 2006, Beliveau et al. 2009). Taken together, the reports 
indicate that eukaryotic cells likely present the most suitable expression system for the whole 
ectodomain of a TTSP. For this reason, P. pastoris was selected as the initial expression host to test 
the production of the ectodomain of mouse Tmprss2 in this PhD thesis.  
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1.8 Aim of this work 
As described in the introduction, Pichia pastoris is a powerful eukaryotic expression host for the 
cost-efficient production of recombinant proteins. Still, P. pastoris displays some drawbacks. The 
number of established genomic loci for stable protein expression is still limited. And even after 
targeting an expression vector into an established locus (AOX1 or GAP) by homologous 
recombination, extensive screening is required to identify high producer (“jackpot”) clones. The 
expression levels are not solely based on gene copy number, but also on random integration events. 
Within the context of protein expression, two general aims exist. On the one hand, the time-
efficient generation of a jackpot clone is desired for any gene of interest. Hence, the efficiency of 
this process has to be improved. On the other hand, it is also of interest to optimize an expression 
system to enhance the production of a specific target protein. 
For the first aim, this PhD thesis deals with the improvement of the expression system P. pastoris 
through the establishment of a recombinase mediated cassette exchange (RMCE) system to 
specifically integrate a GOI into any genomic locus harboring a stable RMCE cassette. This should 
result in the fast generation of producer clones with uniform product yields. The exchange of a GOI 
into a jackpot clone should likewise result in a high producer clone for the GOI. In this work, an 
initial pilot for a P. pastoris RMCE system should be established, using the genomic GAP locus to 
ensure comparability of different tested variants of the RMCE cassette. The RMCE cassettes 
should be designed to meet the specific demands of P. pastoris, including an appropriate selection 
trap to select for exchanged clones. A set of DNA vectors should be cloned to stably insert this 
RMCE cassette into the genome of P. pastoris (“tagging”). Following clone evaluation, a proof of 
concept should be provided through a RMCE reaction in P. pastoris. 
For the second aim, this PhD thesis focuses on the secretory production of the full ectodomain of 
the transmembrane serine protease mouse Tmprss2. Tmprss2 is a highly interesting drug target 
playing a crucial role for influenza A infectivity. Hence, the recombinant production of Tmprss2 
for structural and functional analyses is an important step on the path structure based drug design. 
The expression of mouse Tmprss2 should be tested in a number of expression hosts, starting with 
P. pastoris. Using the most suitable host, the production and the downstream processes should be 
improved for the optimal production of Tmprss2. Finally, a preliminary enzymatic activity test 
should be performed to evaluate the ability of recombinant Tmprss2 to specifically cleave its 
putative viral substrate hemagglutinin H1.  
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2 Material and methods 
2.1 Chemicals, kits and reagents 
Unless stated otherwise, all chemicals used were purchased as “pro analysis” grade from Bayer, 
Becton Dickinson (BD), Carl Roth, GE Healthcare, Lonza, Macherey-Nagel, Merck KGaA 
(Merck), New England Biolabs (NEB), Qiagen, Roche, Sigma-Aldrich (Merck KGaA) and Thermo 
Fisher Scientific.  
 Water quality 
The purified water used in this work was filtered by a 0.22 μm Milli-Q dispense system (Merck 
KGaA) and will be referred to as “MQ-H2O”. Sterile, purified water was obtained by autoclaving 
MQ-H2O for 20 min at 121 °C. This water was treated as a substitute for bi-destilled water 
(ddH2O). Unless stated otherwise all buffers and solutions were prepared with MQ-H2O. 
 Enzymes and molecular weight standards 
An overview of commonly used enzymes and molecular weight standards in this work is presented 
in Table 2.1 and Table 2.2. 
Table 2.1. Enzymes. 
Name Supplier 
Restriction Endonucleases NEB 
T4 Ligase Roche 
Antarctic Phosphatase NEB 
Phusion® Hot Start II DNA Polymerase NEB 
KOD Hot Start DNA Polymerase Merck 
RNase A Qiagen 
DNase I SFPR, HZI 
Table 2.2. Molecular weight standards. 
Name Application Supplier 
Smart Ladder DNA agarose gel electrophoresis Eurogentech 
PageRuler Plus prestained SDS-PAGE, Western Blot Thermo Fisher Scientific 
PageRuler unstained SDS-PAGE Thermo Fisher Scientific 
Precision Plus AllBlue SDS-PAGE, Western Blot Bio-Rad 
Precision Plus unstained SDS-PAGE Bio-Rad 
Amersham HMW standard Native PAGE GE Healthcare 
Amersham LMW standard Native PAGE GE Healthcare 
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 Culture media & supplements  
The media for yeast and bacterial cultures were autoclaved 20 min at 121 °C. Heat instable 
components such as glucose and antibiotics were added after sterile filtration (0.2 µm) to the 
autoclaved medium. 
The cultivation of E. coli was performed in LB medium (Table 2.3). For LB agar plates, the LB 
medium was supplemented with 16 g/L of Bacto-Agar (BD) prior to sterilization. The regenerative 
cultivation phase of transformed E. coli was done in SOC medium (super optimal broth for 
catabolite repression) was used (Table 2.4). Unless noted otherwise, the appropriate antibiotics or 
reagents for blue-white selection were applied at the concentrations listed in Table 2.5. 
Table 2.3. LB medium. 
Component Final concentration 
Bacto Tryptone 10 g/L 
Bacto Yeast Extract 5 g/L 
NaCl 5 g/L 
in MQ-H2O to 1 L 
Table 2.4. SOC medium. 
Component Final concentration 
Bacto Tryptone 20 g/L 
Bacto Yeast Extract 5 g/L 
KCl 186 mg/L 
NaCl 50 mg/L 
in MQ-H2O to 1 L 
Supplements to add after autoclaving: 
MgCl2 (1 M Stock) 10 mM 
Glucose (20 % v/v Stock) 10 mM 
Table 2.5. Antibiotics and supplements for bacterial cultures. 
Name Applied final concentration 
Ampicillin (Amp) 100 µg/mL 
Chloramphenicol (Cm) 25 µg/mL 
Gentamicin (Gm) 7 μg/mL µ  
Kanamycin (Kan) 50 µg/mL 
Tetracyclin (Tet) 10 µg/mL 
Zeocin (Zeo) 50 µg/mL 
Bluo Gal 100 µg/mL 
IPTG 40 µg/mL 
 
Applied antibiotics and their concentrations as well as commonly used stock solutions are listed in 
Table 2.6 and Table 2.7. The cultivation of P. pastoris in suspension cultures was conducted in 
YPD, BMGY, BMMY, BMD or BMM media. The recipes are listed in Table 2.8 and Table 2.9. 
All optional supplements for different media variants are marked in italics. For agar plates 20 g/L 
of Bacto-Agar (BD) were added to the media prior to sterilization. Auxotrophic selection of 
P. pastoris GS115 was conducted on MD agar plates; MDH agar plates (MD supplemented with 
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histidine) served as comparative control plates (Table 2.10). An autoclaved solution of  
1 M D-Sorbitol in MQ-H2O was used for the cultivation phase of transformed P. pastoris. 
Cultivation in the bioreactor was performed with the media described in Table 2.11 - Table 2.15.  
Table 2.6. Antibiotics for yeast cultures. 
Name Applied final concentration 
Geneticin G418 (G418) 300 µg/mL 
Zeocin (Zeo) 100 µg/mL 
Table 2.7. Common P. pastoris stock solutions. 
10x YNB Final concentration 
Yeast Nitrogen Base (YNB) 
(with ammonium sulfate, without amino acids) 
134 g 
in MQ-H2O to 1 L 
 Heated if necessary to dissolve 
 Filter sterilized and stored at 4 °C 
 
500x B Final concentration 
Biotin 20 mg 
in MQ-H2O to 100 mL 
 Filter sterilized and stored at 4 °C  
100x H Final concentration 
L-Histidine 400 mg 
in MQ-H2O to 100 mL 
 Filter sterilized and stored at 4 °C  
10x D Final concentration 
D-Glucose (Dextrose) 200 mg 
in MQ-H2O to 1 L 
 Filter sterilized and stored at 4 °C  
500x GY Final concentration 
Glycerol p.a. 100 mL 
in MQ-H2O to 1 L 
 Sterilized by autoclaving and stored at 4 °C  
10x M Final concentration 
Methanol 5 mL 
in MQ-H2O to 100 mL 
 Filter sterilized and stored at 4 °C  
1 M Potassium Phosphate Buffer pH 6.0 Final concentration 
K2HPO4 (1 M Stock) 132 mL 
KH2PO4 (1 M Stock) 868 mL 
 Adjusted pH if necessary with phosphoric acid or KOH 
 Filter sterilized and stored at room temperature 
 
Antifoam Struktol® J 673 A Stock Final concentration 
Struktol® J 673 A 5 % (v/v) 
in methanol to 500 mL 
 Filter sterilized and stored at room temperature  
Table 2.8. YPD(S) medium. 
Component Final concentration 
Bacto Peptone 2 % (w/v) 
Bacto Yeast Extract 1 % (w/v) 
Only for YPDS: D-Sorbitol 1 M 
in MQ-H2O to 900 mL 
Supplements to add after autoclaving: 
10xD Stock 100 mL 
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Table 2.9. BMD/BMG/BMM and BMDY/BMGY/BMMY media. 
Component Final concentration 
Only for BMDY/BMGY/BMMY: Bacto Yeast Extract 1 % (w/v) 
in MQ-H2O to 700 mL 
Supplements to add after autoclaving: 
1 M Potassium Phosphate Buffer pH 6.0 Stock 100 mL 
10x YNB Stock 100 mL 
500x B Stock 2 mL 
Only for BMD(Y): 10x D Stock (Glucose) 100 mL 
Only for BMG(Y): 10x GY Stock (Glycerol) 100 mL 
Only for BMM(Y): 10x M Stock (Methanol) 100 mL 
Table 2.10. Solid MD and MDH medium. 
Component Final concentration 
Bacto Agar 7.5 g 
in MQ-H2O to 400 mL 
Supplements to add after autoclaving: 
10x YNB Stock 50 mL 
500x B Stock 1 mL 
Glucose (Dextrose) 50 mL 
Only for MDH: 100 x H Stock 5 mL 
Table 2.11. Bioreactor growth medium (for 2 L scale fermentation). 
Component Final concentration 
Glycerol p.a.  72 g 
K2SO4 32.8 g 
MgSO4x7 H2O 26.8 g 
CaSO4x2 H2O 1.67 g 
in MQ-H2O  
 Direct autoclaving in the reactor vessel 
in 1.4 L 
Supplements to add after autoclaving: 
Hexametaphosphate medium 400 mL 
PTM1 Trace Salt Stock 7.83 mL 
500x B 7.83 mL 
Table 2.12. Hexametaphosphate medium pH 5.6 (for 2 L scale fermentation). 
Component Final concentration 
Sodium Hexametaphosphate 45 g 
(NH4)2SO4 16.2 g 
in MQ-H2O 
 Adjusted pH to 5.6 if necessary with H2SO4  
 Filter sterilized and stored at 4 °C 
to 400 mL 
Table 2.13. PTM1 trace salts stock (for 2 L scale fermentation). 
Component Final concentration 
CuSO4x5 H2O 6.00 g 
NaI 0.08 g 
MnSO4xH2O 3.00 g 
Na2MoO4x2 H2O 0.20 g 
CoCl2 0.50 g 
ZnCl2 20.0 g 
Fe(II)SO4*7 H2O 65.0 g 
HBO3 0.02 g 
H2SO4 5.0 mL 
in MQ-H2O 
 Filter sterilized and stored at 4 °C 
to 1 L 
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Table 2.14. Bioreactor glycerol feed stock (for 2 L scale fermentation). 
Component Final concentration 
Glycerol p.a. 397 mL (50 % w/v) 
in MQ-H2O to 1 L 
Supplements to add after autoclaving: 
PTM1 Trace Salt Stock 3.6 mL 
500x B 3.6 mL 
Table 2.15. Bioreactor methanol feed stock (for 2 L scale fermentation). 
Component Final concentration 
Methanol 500 mL  
Supplements to add after autoclaving: 
PTM1 Trace Salt Stock 6 mL 
500x B 6 mL 
 
The cell culture media used for the cultivation of insect cell lines and mammalian cell lines were 
purchased as ready-to-use solutions (Table 2.16). F-17 medium was supplemented with additives 
prior to use according to Table 2.17. An overview of all supplements is presented in Table 2.18. All 
required supplements were only added after filtration at 0.2 µm. 
Table 2.16. Cell culture media. 
Cell Culture Medium Cell Line Supplier 
EX-CELL™ 405 Hi5 SAFC 
EX-CELL™ 420 SF21 SAFC 
F17 HEK293-6E Thermo Fisher Scientific 
Table 2.17. Supplements used in F17 medium. 
Name Final concentration 
G418 25 µg/L 
Pluronic F68 1 g/L 
L-Glutamine 7.5 mM 
Table 2.18. Cell culture supplements. 
Name Supplier 
Fetal Calf Serum (FCS) Thermo Fisher Scientific 
G418 Thermo Fisher Scientific 
Gentamicin Thermo Fisher Scientific 
Pluronic F68 Thermo Fisher Scientific 
L-Glutamine Thermo Fisher Scientific 
 
 Transfection reagents 
Delivery of recombinant DNA to cells was performed using cationic lipofection techniques. The 
reagents used for each cell line and DNA construct as listed in Table 2.19. 
Table 2.19. Transfection reagents. 
Reagent Application Supplier 
SuperFect Bacmid Transfection Qiagen 
Polyethylenimine (linear, MW ~25 kDa) HEK293-6E Polysciences 
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2.2 Oligonucleotides and plasmids 
Oligonucleotides were used for sequencing, cDNA synthesis and PCR (including fusion PCR and 
RT-PCR). All oligonucleotides in this work have either been obtained from specific kits or were 
ordered at Eurofins Genomics (Ebersberg, Germany) in HPSF or HPLC purified quality. For 
simplification, DNA oligonucleotides that were used for PCR or for DNA sequencing will be 
referred to as “primers” further on, unless specifically stated otherwise. Thereby, the primer 
binding to the defined 5’ region of the template DNA will be designated as the forward primer, 
while the primer binding complementary to the respective 3’ region will be referred to as the 
reverse primer. A complete list of all used primers can be found in Appendix I. The principal 
plasmids used in this work are listed and explained in Table 2.20. An overview of the vectors that 
were generated in this work is listed below (§ 2.3). 
Table 2.20. Plasmids. 
P. pastoris Expression vectors 
pPICZ(α) / pGAPZ(α) (Thermo Fisher Scientific) 
Vector family for protein expression using the AOX1 promoter (pPICZ) or the GAP promoter (pGAPZ). The letter “α” 
indicates the presence of a S. cerevisiae α-mating factor secretion signal (MF-α ss) on the vector for secretory 
expression. The plasmids harbor a Zeocin resistance cassette for dual selection in E. coli and in P. pastoris. Therein, the 
Zeocin resistance gene Sh ble is flanked by a TEF1/EM7 fusion promoter and a CYC1 terminator. 
 
pPIC9K (Thermo Fisher Scientific) 
Expression vector which harbors the AOX1 promoter. It also includes the 3’AOX1 genomic region to mediate gene 
replacement upon transformation. This vector is usually applied for the generation of mutS strains by replacing the 
AOX1 gene with the GOI and the remaining vector sequence. Selection in E. coli is performed with ampicillin. For 
auxotrophic selection in P. pastoris, pPIC9k harbors a his4 gene. Furthermore, a bacterial Tn903 kanamycin resistance 
gene is present on the vector, which is used to screen for P. pastoris multi copy insertion clones against an increasing 
gradient of G418.  
pBGP1 (Courtesy of David Resina, Bioingenium S.L., reference Lee et al. (2005)) 
Episomal expression vector is based on pGAPZα-A (Thermo Fisher Scientific). A PARS1 sequence was added to the 
backbone of pGAPZα-A in order to facilitate episomal replication of the plasmid in P. pastoris. Furthermore, the pUC 
origin of replication (ori) was replaced by a combination of the pBR322 ori and a bacterial ampicillin resistance 
cassette to allow for a more cost-efficient bacterial selection. 
 
E. coli Vectors 
pJET1.2 (Thermo Fisher Scientific) 
Intermediate vector for blunt cloning of PCR products. The vector was obtained as part of the CloneJET PCR Cloning 
Kit. 
 
pET22B(+) (Merck) 
Expression vector for E. coli, which harbors a pelB signal for periplasmic localization of the recombinant target protein. 
 
Vectors used in cell culture 
pFlpBtM‐III (Steffen Meyer, HZI) 
Third version of the versatile multi‐host expression. It is applicable for transient expression in HEK293-6E cells and for 
the creation of bacmids using TN7 based transposition. Furthermore, it serves as a RMCE donor vector for CHO Lec 
3.2.8.1 cell lines employing FRT F3 and FWT sites. For secretory expression, pFlpBtM-III offers an IgG secretion signal. 
 
pTTo/GFPq (NRC, BRI, Montreal, Canada) 
A control vector that is used to monitor the transfection efficiency in HEK293-6E cells. It harbors a GFPq gene (red 
shifted green fluorescent protein) for detection via flow cytometry. 
 
 
 
MATERIAL AND METHODS 
 
 32  
Parental Construction Vectors 
FPB-31-902-RudolphRFP (ATUM) 
Commercially obtained vector carrying the gene for the red fluorescent marker RudolphRFP.  
 
pBGP1 (Courtesy of David Resina, Bioingenium S.L., reference Lee et al. (2005)) 
The fragment comprising the ampicillin resistance cassette and the pBR322 ori was taken from this vector to create 
the vector pGAPZAΔ8 from pGAPZα-A in this work. Furthermore, it served as a basis to generate the Flp recombinase 
expressing RMCE helper plasmid for P. pastoris. 
 
pFlpBtM-III-mCherry (Steffen Meyer, HZI) 
The gene of the fluorescent marker mCherry was cloned from this vector. Furthermore, the human PGK (hPGK) 
promoter was cloned from this vector for the selection trap analysis in P. pastoris.  
 
pGAPZα-A (Thermo Fisher scientific) and pGAPZAΔ8 
This vector was used to clone the vector pGAPZAΔ8, which served as a basis to generate the P. pastoris RMCE vector 
pYTA and its variants as well as the exchange vector pYEX. In comparison to pGAPZα-A, pGAPZAΔ8 harbors the 
ampicillin resistance cassette and the pBR322 ori of pBGP1 (see above). The MF-α ss was removed from this vector. 
The vector product pGAPZAΔ8 misses 8 bp at the original position of the MFα-ss compared to the commercially 
available pGAPZ-A. This is reflected in the suffix “Δ8”. 
 
pPIC9K (Thermo Fisher scientific)  
This vector was used as a source to clone the genomic 3’AOX1 region and the his4 gene into respective P. pastoris 
RMCE tagging vectors. 
 
pOG44 (Thermo Fisher Scientific) 
Flp recombinase expression vector of the Flp-InTM system (Thermo Fisher Scientific). The flp gene was amplified from 
this plasmid to generate the RMCE helper plasmid for P. pastoris. 
 
pOpIE1-eGFP-HA (Maren Bleckmann, HZI) 
The OpIE1 promoter was taken from this vector to be tested as a possible alternative to the hPGK promoter on 
pFlpBtM for the multi-host compatible induction of the selection trap upon RMCE. 
 
pUC57-A1:hsABCB6-SyntheticSegments (Christian Kambach, HZI) 
The y-eGFP gene was amplified from this plasmid to be used as model GOI in P. pastoris. 
 
 
 
pUC57-SplGFP (Synthesis by GenScript, Hong Kong, China) 
Commercially obtained vector that harbors two synthetic fragments used to generate the P. pastoris RMCE tagging 
vector. The first fragment comprises “BstBI – FRT F3 – MCS – NotI”, which includes a modified multi cloning site (MCS). 
The second fragment consists of PciI – ATG – FRT FWT – HindIII – NcoI”. “ATG” denotes a start codon to complement 
the RMCE selection trap.  
 
pUC57-mTMPRSS2-D343N-FLAG-8xHis (Synthesis by GenScript, Hong Kong, China) 
Commercially obtained vector carrying the gene of the P. pastoris optimized ectodomain of mouse Tmprss2-D343N 
with a C-terminal combination of TEV protease site, 1xFlag tag and 8xHis tag. 
 
 
2.3 Generated DNA vectors in this work 
A number of DNA plasmids was designed and cloned for the projects of this PhD thesis. In this 
section, the generation of these vectors, including the cloning strategy, is described in detail. 
pGAPZAΔ8, pYEXs and pYTA 
The RMCE tagging vector for P. pastoris was cloned from the plasmid pGAPZα-A (Thermo Fisher 
Scientific). First, the MF-α ss sequence was deleted through digestion with BstBI and EcoRI. The 
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sticky ends were filled in and the vector was blunt ligated using the CloneJET PCR Cloning Kit. 
Furthermore, a fragment comprising an ampicillin resistance cassette and a pBR322 origin of 
replication (ori) from the vector pBGP1 (§ 2.2) was cloned into the plasmid, replacing the pUC ori, 
through digestion with PciI and BglII. The vector product was designated as pGAPZAΔ8. The term 
“Δ8” indicates that the vector is missing 8 bp between the BstBI and EcoRI restriction sites 
compared to the commercially available pGAPZ-A (Thermo Fisher Scientific).  
The FRT sites (F3, FWT) and the Δhis4 gene were cloned into pGAPZAΔ8 using two synthetic 
DNA modules (GenScript). The first synthetic module comprised a 5’-BstBI site, FRT F3, a 
modified MCS and a 3’-NotI site (Synth-A). The second module comprised a 5’-PciI site, a PstI 
site, an ATG codon, an NdeI site, FRT Fwt, a HindIII site and a 3’NcoI site (Synth-B). The his4 
gene was PCR amplified in two parts from pPIC9k (Thermo Fisher Scientific) without its ATG 
start codon (Δhis4). The parts were defined by its native NcoI site at 880 bp of the gene. The 5’-
fragment of Δhis4 (Δhis4-A; 4-880 bp) was amplified with the primers HindIII-dHis4-F and dHis4-
880NcoI-R. Hence, the product displayed 5’-HindIII and 3’-NcoI sites. The 3’-fragment (Δhis4-B; 
880 bp-2532 bp), including the downstream transcriptional terminator sequence, was amplified 
with the primers 880NcoI-dHis4-F and dHis4T-ScaI-R, adding a 3’-ScaI site to it in addition to the 
native 5’-NcoI. The vector Δhis4-B was digested with NcoI and ScaI and cloned into pGAPZAΔ8, 
which was digested with NcoI and EcoRV. Thereby, Δhis4-B was placed downstream of the 
TEF1/EM7 promoter, replacing the Zeocin resistance gene (Sh ble) and part of its CYC1 
terminator. The validated vector product was digested between the TEF1/EM7 promoter and Δhis4-
B by NcoI. Synth-B was inserted at this site after digestion with PciI and NcoI. Δhis4-A was 
inserted downstream of FRT FWT via HindIII and NcoI, completing the Δhis4 CDS. The vector 
product was designated as pGAPZAΔ8-Fwt-his4+, as it featured a complemented Δhis4 gene under 
the control of the TEF1/EM7 promoter. Next, Synth-A was inserted into pGAPZAΔ8-Fwt-his4+ 
via BstBI and NotI, replacing its original MCS with the “FRT F3 – modified MCS” combination. 
The resulting vector was named pYEXs (“yeast exchange simulation”).  
The y-eGFP gene was cloned into pYEXs as a model GOI. For this, the gene was PCR amplified 
from pUC57-A1:hsABCB6-SyntheticSegments (Christian Kambach, HZI) with the primers EcoRI-
yeGFP-F and SacII-yeGFP-R and cloned into the MCS of pYEXs using EcoRI and SacII. The 
vector product was named pYEXs-yeGFP. The human PGK1 (hPGK) promoter from pFlpBtM-III 
(Steffen Meyer, HZI) and the OpIE1 promoter from Orgyia pseudotsugata from pOpIE1-eGFP-HA 
(Maren Bleckmann, HZI) were respectively cloned into pYEXs-yeGFP, replacing the TEF1/EM7 
promoter upstream of Δhis4. For this, the hPGK promoter was PCR amplified with the primers 
BamHI-PGK-F and PGK-PstI-R. The OpIE1 promoter was PCR amplified with the primers 
BamHI-OpIE1-F and PstI-OpIE1-R. The PCR products were cloned into pYEXs-yeGFP through 
BamHI and PstI. The resulting plasmids were named pYEXsPGK-yeGFP and pYEXsOpi-yeGFP.  
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The tagging vector named pYTA (“yeast tagging”) was generated from pYEXs. The Zeocin 
resistance cassette (“TEF1/EM7 promoter – Sh ble – CYC1 terminator”) was amplified by PCR 
from pGAPZAΔ8 with the primers BamHI-TEF1-F and Cyc1T-NdeI-R, adding a 5’-BamHI and a 
3’-NdeI site. The PCR product was cloned into pYEXs through BamHI and NdeI, replacing the 
“TEF1-EM7 promoter – ATG start codon” combination. The RudolphRFP gene was incorporated 
into pYTA by cloning it directly from the plasmid FPB-31-902-RudolphRFP (ATUM) into the 
MCS of pYTA via EcoRI and NotI. The resulting vector was designated as pYTA-RudolphRFP.  
Fluorochrome test vectors (pPICZ / pGAPZAΔ8 - RudolphRFP / mCherry / y-eGFP) 
To generate the GAP and AOX1 test cell lines based on pGAPZAΔ8 and pPICZ-A (Thermo Fisher 
Scientific), the genes of RudolphRFP, y-eGFP and mCherry were cloned into the MCS of the two 
vectors through EcoRI and NotI. RudolphRFP and y-eGFP were directly cloned from pYTA-
RudolphRFP and pYEXs-yeGFP. The mCherry gene was PCR amplified from the vector pFlpBtM-
II-mCherry (Steffen Meyer, HZI) with the primers EcoRI-mCherry-F and NotI-mCh(woTAG)-R 
for cloning. The six vector products were named: pPICZ-RudolphRFP, pPICZ-yeGFP, pPICZ-
mCherry, pGAPZAΔ8-RudolphRFP, pGAPZAΔ8-y-eGFP and pGAPZAΔ8-mCherry. 
pYTAaox-mCherry and pYTAaox-GAP-mCherry  
For the generation of the AOX1 tagging vector pYTAaox-mCherry, the vector pYTA-RudolphRFP 
was modified. The AOX1 promoter was cloned directly into pYTA from pPICZ-A (Thermo Fisher 
Scientific) using BglII and BstBI. The 3’-AOX1 region was cloned into the vector via PciI, 
following its PCR amplification from pPIC9k (Thermo Fisher Scientific) with the primers PciI-
3'AOX-f and PciI-3'AOX-r. The resulting vector was designated as pYTAaox. The mCherry gene 
was cloned into pYTAaox through EcoRI and NotI following PCR amplification from the vector 
pFlpBtM-II-mCherry (Steffen Meyer, HZI) with the primers EcoRI-mCherry-F and NotI-
mCh(woTAG)-R. The resulting tagging vector was named pYTAaox-mCherry. The GAP promoter 
was inserted into the RMCE cassette of pYTAaox-mCherry downstream of FRT F3 in an additional 
cloning step. The GAP promoter was PCR amplified from pGAPZAΔ8 with the primers BsaI-
MfeI-GAP-F and EcoRI-GAP-R, thereby adding a 5’-BsaI (MfeI) site and a 3’-EcoRI site to the 
fragment. The PCR product was digested with BsaI and EcoRI and ligated into pYTAaox-mCherry 
(digested with EcoRI). The vector product was named pYTAaox-GAP-mCherry. 
Variants of the RMCE tagging vector pYTA to relocate FRT F3 
In total, four additional variants were generated from the first version of the tagging vector pYTA-
RudolphRFP (V1). For variant V2 (pYTAΔF3-RudolphRFP), a fragment comprising FRT F3 and 
RudolphRFP was isolated from pYTA-RudolphRFP digested with BstBI and NotI and replaced by 
the corresponding region of the vector pGAPZAΔ8-RudolphRFP. The vector product was named 
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pYTAΔF3-RudolphRFP, since this cloning step effectively resulted in the deletion of F3 from the 
tagging vector (ΔF3). 
In variant V3 (pYTAF3PR-RudolphRFP), FRT F3 was moved into the promoter region (PR) of the 
GAP promoter, upstream of its TATA box. FRT F3 was inserted into the GAP promoter by fusion 
PCR (see chapter 2.6.1). Two fragments comprising vector regions upstream and downstream of 
the TATA box of the GAP promoter were amplified by PCR from pYTA-RudolphRFP (V1). The 
5’-fragment (fragment A) comprised the GAP promoter region upstream of the TATA box, the 
TATA box itself and a partial sequence of FRT F3. The 3’-fragment (fragment B) consisted of the 
remaining sequence of FRT F3 (overlapping with the sequence on fragment A), the TATA box, the 
continuing GAP promoter region and the gene encoding RudolphRFP. The fusion PCR was 
conducted with FRT F3 serving as the overlapping fusion sequence. The final PCR product 
comprised the modified GAP promoter and RudolphRFP with 5’-SpeI and 3’NotI sites. The used 
primers are listed in Table 2.21. The PCR product was finally used to replace the GAP promoter of 
pYTA-RudolphRFP through cloning with SpeI and NotI.  
Table 2.21. Primers of the fusion PCR to insert FRT F3 into the GAP promoter.  
FRT F3 added in two parts in two rounds of PCR to a location upstream of the TATA box of the GAP 
promoter. The sequences of the oligonucleotides are listed in the appendix. Italics indicate the internal primers 
that were used to introduce the modification. 
Fragment Product Forward primer Reverse primer 
A SpeI-(5’PGAP)-F3-part1 SpeI-PGAP-F GAPintF3-R 
B F3-part2-(3’PGAP)-RudolphRFP-NotI GAPintF3-F NotI-Rudolph-R 
A+B (Fusion) SpeI-PGAP-F3PR-RudolphRFP-NotI SpeI-PGAP-F NotI-Rudolph-R 
 
To generate variant V4 (pYTAatgF3-RudolphRFP), the GAP promoter was amplified by PCR from 
pYTA-RudolphRFP with the oligonucleotide primers SpeI-PGAP-F and BstBI-PGAP-ATG-R, 
which added a 5’-SpeI site, the modified sequence and a 3’-BstBI to the PCR product. The PCR 
product was cloned into pYTA-RudolphRFP through SpeI and BstBI, replacing the original GAP 
promoter with the modified version. The vector product harbored the ATG codon upstream of F3. 
In variant V5 (pYTAUR-RudolphRFP), the GAP promoter was placed downstream of FRT F3 
inside the RMCE cassette of pYTA-RudolphRFP. To enable the integration in the GAP locus by 
homologous recombination, a 508 bp chromosomal upstream region of GAP (URG) from 
P. pastoris GS115 (Genbank #FN392320, position 809,079 – 809,598) was added to the vector 
upstream of FRT F3. The URG was amplified by PCR from isolated genomic DNA of P. pastoris 
GS115 (§ 2.6.1, 2.6.11) and a combination of “5’-XbaI – FRT F3 – SpeI – 3’-NotI” was added to its 
3’-end for cloning. This was done in three rounds of PCR with the XbaI-URG-F serving as the 
forward primer. The primers URG-F3-R1, SpeI-URG-F3-R2 and Not-Spe-F3_R served as the 
respective reverse primers. The resulting “URG – FRT F3” product was digested with XbaI and 
NotI and ligated into pYTA-RudolphRFP (digested with SpeI and NotI), removing the “GAP 
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promoter – F3 – RudolphRFP” sequence. The “GAP promoter –RudolphRFP” combination from 
pGAPZAΔ8-RudolphRFP was subsequently cloned into the vector via SpeI and NotI.  
pYEXsUR-yeGFP, pYEXUR-yeGFP and pBGP1KΔ8-FlpWT 
The P. pastoris exclusive RMCE donor vector was generated based on pYTAUR-RudolphRFP 
(V5). First, RudolphRFP and the Zeocin resistance cassette of pYTAUR-RudolphRFP were 
replaced with a fragment from pYEXs-yeGFP comprising the y-eGFP gene and the “TEF1 
promoter – ATG start codon” combination using EcoRI and NdeI. The resulting vector with the 
complemented selection trap Δhis4 was named pYEXsUR-yeGFP. To generate the RMCE donor 
vector pYEXUR-yeGFP, Δhis4 was deleted from this vector through digestion with HindIII and 
EcoRV. The sticky ends were filled in and vector was blunt ligated using the components of the 
CloneJET PCR Cloning Kit. 
The Flp recombinase delivering RMCE helper vector pBGP1KΔ8-FlpWT was designed based on 
the episomal PARS1 plasmid pBGP1 (Lee et al. 2005). The Sh ble gene on pBGP1 was exchanged 
for the Tn903 kanamycin resistance gene as a feasible alternative for direct selection on G418 (Lin-
Cereghino et al. 2008, Papakonstantinou et al. 2009). The Tn903 gene was amplified from pPIC9k 
(Thermo Fisher Scientific) in two rounds of PCR with the forward primer NcoI-kan_f and the 
respective reverse primers kan_r1 and ScaI-kan_r2. The PCR product comprised a 5’-NcoI site, the 
Tn903 gene, a PstI site, the first 27 bp of the CYC1 terminator and a 3’-ScaI site. It was digested 
with NcoI and ScaI and ligated into pBGP1 (digested with NcoI and EcoRV). The resulting vector 
was designated as pBGP1K. The GAP promoter, the MF-α ss and the MCS of pBGP1K were 
replaced by the corresponding fragment from pGAPZAΔ8 using SpeI and BamHI. Thereby, the 
MF-α ss was effectively deleted from pBGPK1. The vector product was designated as pBGP1KΔ8. 
The FLP gene was taken from pOG44 (Thermo Fisher Scientific) and amplified by PCR with the 
oligonucleotide primers Bsa-Flpwt-F and Not-Flpwt-R, adding a 5’-BsaI (EcoRI) site and a 3’-NotI 
site to its ends. BsaI was used to create an EcoRI overhang. The PCR product was cloned into the 
MCS of pBGP1KΔ8 using EcoRI and NotI, resulting in the vector pBGP1KΔ8-FlpWT. 
Tmprss2 expression vectors based on pPICZα-A and pFlpBtM-III / pFlpBtM-III-insect 
The Tmprss2 genes were amplified in two rounds of PCR with the forward primer BsaI-TMP-F and 
the reverse primers TMP-R1 and NotI-TMP-R2, respectively, to add the CDS of the C-terminal 
tags (“TEV site – 1xFlag tag – 8xHis tag”). Thereby, a 5’-BsaI (EcoRI) site and a 3’-NotI site were 
added for cloning. The PCR products were digested accordingly and cloned into pPICZα-A 
(digested with EcoRI and NotI). The resulting vectors were designated as pPICZα-Tmprss2-WT 
and pPICZα-Tmprss2-D343N. 
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The vectors to express the serine protease domain (SPD) of Tmprss2 (amino acids 254 – 490; gene 
positions 760 – 1470 bp of the native, full length protein) in P. pastoris were generated based on 
pPICZα-A. The SPD of Tmprss2-WT and Tmprss2-D343N including the tags was respectively 
amplified by PCR from pPICZα-Tmprss2-WT and pPICZα-Tmprss2-D343N with the primers 
BsaI-TMPSPD-F and NotI-TMP-R2, which added 5’-BsaI (to create an EcoRI overhang) and 3’-
NotI sites. The PCR products were subsequently cloned into pPICZα-A with BsaI / EcoRI and 
NotI. The vectors were designated as pPICZα-Tmprss2-SPD-WT and pPICZα-Tmprss2-SPD-
D343N. 
The generation of expression vectors for P. pastoris with codon optimized constructs was also 
based on pPICZα-A. The Tmprss2-D343N gene was codon optimized for P. pastoris by GenScript 
(Tmprss2-D343Nopt), including the tags (“TEV site – 1xFlag tag – 8xHis tag”). The native EcoRI 
of Tmprss2 was removed during the gene optimization. The synthetic fragment was flanked by a 
5’-EcoRI site and a 3’-NotI site. The wildtype gene Tmprss2-WTopt was obtained by fusion PCR 
from Tmprss2-D343Nopt as described in chapter 2.6.1. An overview including the used primers is 
listed in Table 2.22. Tmprss2-WTopt and Tmprss2-D343Nopt were cloned into pPICZα-A via 
EcoRI and a NotI. The vectors were named pPICZα-A-Tmprss2-WTopt and pPICZα-A-Tmprss2-
D343Nopt. 
Table 2.22. Primers of the fusion PCR to generate Tmprss2-WTopt.  
The gene Tmprss2-WTopt was generated by fusion PCR to a location upstream of the TATA box of the GAP 
promoter. The sequences of the oligonucleotides are listed in the appendix. Italics indicate the internal primers 
that were used to introduce the modification.  
Fragment Product Forward primer Reverse primer 
A EcoRI-tmprss2-WToptpart1 EcoRI-Tmprss2-opt-F int-TMPopt-mut-R 
B tmprss2-WToptpart2-NotI int-TMPopt-mut-F NotI-Tmprss2-opt-R 
A+B (Fusion) EcoRI-tmprss2-WTopt-NotI EcoRI-Tmprss2-opt-F NotI-Tmprss2-opt-R 
 
The vector pPICZ-HSA was generated based on pPICZα-A (Thermo Fisher Scientific). The HSA 
gene was amplified by PCR from isolated genomic DNA of the P. pastoris GS115 HSA mutS 
control strain that is available as part of the Pichia Expression Kit (Thermo Fisher Scientific). The 
recombinant HSA gene in this strain comprises the natural CDS, except for a silent point mutation 
to remove a native SacI site. The PCR was conducted with the primers BstBI-HSA-FOR and XhoI-
HSA-MCS-REV to add 5’-BstBI and 3’-XhoI sites to the product for cloning as well as a slightly 
modified MCS fragment for the vector, which does not include the SfiI site anymore in comparison 
to the original MCS, as this enzyme cuts inside HSA. The “HSA-MCS” PCR construct was cloned 
into pPICZα-A via BstBI and XhoI. The vector was designated as pPICZ-HSA. The “HSA-MCS” 
sequence forms a common ORF with the inherent c-myc and 6xHis tags of the vector to also enable 
stand-alone expression of tagged HSA. The codon optimized gene Tmprss2-D343Nopt was cloned 
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directly into pPICZ-HSA from pPICZα-Tmprss2-D343Nopt by EcoRI and NotI. The resulting 
vector was designated as pPICZ-HSA-Tmprss2-D343Nopt.  
The multi-host vector pFlp-BtM-III (Steffen Meyer, HZI) was used for the expression of Tmprss2 
in HEK2936E cells. For the expression in SF21 and Hi5 insect cell lines, a newly developed 
derivative of pFlpBtM-III, pFlpBtM-III-insect (Maren Bleckmann, HZI), was used. The genes of 
Tmprss2-WT and Tmprss2-D343N including the tags were amplified by PCR from pPICZα-
Tmprss2-WT and pPICZα-Tmprss2-D343N with the primers NheI-TMP-F and NotI-TMP-R2. The 
PCR fragments were cloned in frame with the IgG ss into pFlpBtM-III and pFlpBtM-III-insect 
using NheI and NotI. The vector products were designated as pFlpBtM-III-Tmprss2-WT, pFlpBtM-
III-Tmprss2-D343N, pFlpBtM-III-insect-Tmprss2-WT and pFlpBtM-III-insect-Tmprss2-D343N. 
2.4 Strains and cell lines 
All cloning works were performed in E. coli Top10. The generation of recombinant bacmids was 
performed in E. coli DH10 strains harboring the EmBacY bacmid and a transposase expressing 
helper plasmid (DH10EmBacY). All E. coli strains are listed in Table 2.23. The RMCE system was 
established in P. pastoris strain GS115. The expression of Tmprss2 was performed in strain 
KM71H. The strains are listed in Table 2.24. Table 2.25 depicts the cell lines that were evaluated 
as expression hosts for Tmprss2.  
Table 2.23. Bacterial strains. 
E. coli strain Genotype   Supplier 
Top10 F‐ mcrA Δ(mrr‐hsdRMS‐mcrBC) φ80 (lacZ) ΔM15 ΔlacΧ74 recA1 
araD139 Δ(ara, leu) 7697 galU galK rpsL (StrR) endA1 nupG λ‐ 
  Thermo Fisher Scientific 
DH10(EmBacY) F- mcrA Δ(mrr-hsdRMS-mcrBC) Φ80(lacZ) ΔM15ΔlacX74 recA1 endA1 
araD139 Δ(ara, leu)7697 galU galK l- rpsL nupG /BacloxP/ pBADZ-
His6Cre/pMON7124 
  EMBL (Berger) 
Table 2.24. Yeast strains. 
E. coli strain Genotype  Methanol utilization Supplier 
GS115 his4 mut+ Thermo Fisher Scientific 
KM71H aox1::ARG4, arg4 mutS Thermo Fisher Scientific 
Table 2.25. Cell lines. 
Cell Line Organism of origin Reference 
HEK293-6E Human embryonic kidney epithelium Durocher et al. (2002) 
IPLB-SF-21 AE (Sf21) Ovaries of Spodoptera frugiperda Vaughn et al. (1977) 
BTI-Tn-5B1-4 (Hi5) Ovaries of Trichoplusia ni Wickham and Nemerow (1993) 
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2.5 Software 
Microsoft Word was used for text editing. Graphic design and image editing was performed with 
Microsoft PowerPoint, Adobe Photoshop and GIMP. Table-based batch calculations and generation 
of graphs were performed in Microsoft Excel. VectorNTI suite 8.0 (Thermo Fisher Scientific) was 
used for PCR primer design, the development of cloning strategies and to perform in silico 
restriction analyses and protein translation. For in silico genome browsing for cloning and analyses, 
the sequencing data of P. pastoris GS115, published by De Schutter et al. (2009) was used. The 
data was obtained from the NCBI/GenBank (Bethesda, Maryland, USA) with the accession 
numbers FN392319, FN392320, FN392321 and FN392322 for P. pastoris chromosomes 1-4, 
respectively. DNA and protein sequence alignments were conducted with MultAlin (Corpet 1988). 
To aid the design of truncated versions of Tmprss2, predictions were made with Phyre2 (Kelley et 
al. 2015). For RNA secondary structure predictions, the web-tool RNAFold of the Vienna RNA 
Websuite was used (Gruber et al. 2008).  
2.6 Molecular biological methods 
The protocols for the molecular biological methods in this work have been adapted from standard 
collections (Sambrook 2001). All prepared DNA plasmids were subjected to validation by 
restriction digestion (§ 2.6.3) and sequencing. Sequencing was performed at the at the Genome 
Analytics platform GMAK at the HZI Braunschweig (Germany). 
 Polymerase chain reaction (PCR) 
PCR was used to amplify target DNA from plasmid or genomic DNA templates either for 
cloning or for analysis. For cloning reactions, the PCR was conducted with the Phusion® Hot 
Start II DNA Polymerase (NEB). The standard mix and the default program are listed in Table 2.26 
and Table 2.27. For the amplification of genomic DNA, the standard PCR mix from Table 2.26 was 
slightly modified. Instead of the 5x HF-buffer the provided 5x GC-buffer was used and the PCR 
mix was additionally supplemented with 5 % (v/v) DMSO. The PCR program (Table 2.27) was 
also slightly modified by doubling the cycle times (C1: 1 min, C2: 1 min and C3: 1 min/1 kb). 
Table 2.26. Standard PCR mix with Phusion® Hot Start II DNA Polymerase. 
Component Concentration 
5x HF Reaction buffer 20 µL 
Forward primer (10 µM) 2.5 µL 
Reverse primer (10 µM) 2.5 µL 
dNTP mix (10 mM) 2 µL 
Template DNA ~15 ng 
Phusion Hot Start II High-Fidelity DNA Polymerase (2 U/µL) 1 µL 
MQ-H2O x 
Total volume 100 µL 
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Table 2.27. Default PCR Program with Phusion® Hot Start II DNA Polymerase. 
Step Temperature Time Cycle Repeats (C1-C3) 
Initial denaturation 98 °C 5:00 min  
C1: Denaturation 98 °C 0:30 min  
C2: Annealing  
(adjusted to fit PCR primer Tm) 
52-72 °C 0:30 min 30x 
C3: Extension 72 °C 0:30 min / 1 kb  
Final Extension 72 °C 10 min  
Pause 16 °C ∞  
 
Fusion PCR was performed to introduce internal mutation or new sequences to a template DNA. 
Briefly, two fragments are initially amplified from the desired template DNA. The first fragment 
(A) covers the 5’ region up to the position at which the mutation should be introduced. The second 
fragment (B) equally covers the 3’ region. Both fragments are designed to harbor overlapping ends 
of 15 bp – 20 bp with the respective other fragment. The fusion of both fragments is performed in 
another PCR comprising two phases that are performed in direct succession. In the first phase, both 
fragments are fused via their overlapping borders and the free 3’ overhangs are filled up by the 
polymerase. In the second phase, forward and reverse primers for the whole construct are added 
and the fused DNA is subsequently amplified. In this thesis, the fusion PCRs were carried out with 
the Phusion® Hot Start II DNA Polymerase (NEB). The PCR to amplify the fragments A and B 
was performed with the standard mix and the default program (Table 2.26, Table 2.27). The 
reaction mix and the PCR program for the fusion PCR, are listed in Table 2.28 and Table 2.29. 
Table 2.28. PCR mixes for fusion PCR with Phusion® Hot Start II DNA Polymerase. 
Mix I – Components: Concentration 
5x HF Reaction buffer 12 µL 
Forward primer (10 µM) 2.5 µL 
Reverse primer (10 µM) 2.5 µL 
dNTP mix (10 mM) 3 µL 
DNA Fragment A ~30 ng 
DNA Fragment B ~30 ng 
Phusion Hot Start II High-Fidelity DNA Polymerase (2 U/µL) 1.2 µL 
MQ-H2O x 
Total volume 60 µL (3 x 20 µL) 
Mix II – Components: Concentration 
5x HF Reaction buffer 5 µL 
Forward primer (10 µM) 2.5 µL 
Reverse primer (10 µM) 2.5 µL 
Phusion Hot Start II High-Fidelity DNA Polymerase (2 U/µL) 0.5 µL 
MQ-H2O 11.5 µL 
Total volume 20 µL 
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Table 2.29. PCR Program for fusion PCR with Phusion® Hot Start II DNA Polymerase. 
Phase I – Steps: Temperature Time Cycle Repeats (C1-C3) 
Initial denaturation 98 °C 10:00 min  
C1: Denaturation 98 °C 5:00 min  
C2: Annealing  
(adjusted to fit PCR primer Tm) 
52-72 °C 1:30 min 7x 
C3: Extension 72 °C 1:00 min / 1 kb  
Final Extension 72 °C ∞  
Addition of Mix II 
Add 5 µL of reaction mix II per 20 µL of reaction mix I 
Phase II – Steps: Temperature Time Cycle Repeats (C1-C3) 
Initial denaturation 98 °C 5:00 min  
C1: Denaturation 98 °C 0:30 min  
C2: Annealing  
(adjusted to fit PCR primer Tm) 
52-72 °C 0:30 min 30x 
C3: Extension 72 °C 0:30 min / 1 kb  
Final Extension 72 °C 10 min  
Pause 16 °C ∞  
 
For the analysis of bacmid DNA, the KOD Hot Start DNA Polymerase was used. The standard 
PCR mixture and the PCR program are listed below (Table 2.30, Table 2.31). All obtained PCR 
products were analyzed by agarose gel electrophoresis (see 2.6.2). If necessary, the PCR products 
were subsequently purified by gel extraction (§ 2.6.7.1).  
Table 2.30. Standard PCR mix with KOD Hot Start DNA Polymerase. 
Component Concentration 
10x KOD Reaction buffer 5 µL 
MgSO4 (25 mM) 2 µL 
Forward primer (10 µM) 1.5 µL 
Reverse primer (10 µM) 1.5 µL 
dNTP mix (10 mM) 1 µL 
Template DNA 1 µL 
KOD Hot Start DNA Polymerase (1 U/µL) 1 µL 
MQ-H2O 37 µL 
Total volume 50 µL 
Table 2.31. Default PCR Program with KOD Hot Start DNA Polymerase. 
Step Temperature Time Cycle Repeats (C1-C3) 
Initial denaturation 94 °C 2:00 min  
C1: Denaturation 94 °C 0:15 min  
C2: Annealing  
(adjusted to fit PCR primer Tm) 
60 °C 0:30 min 30x 
C3: Extension 72 °C 0:20 min / 1 kb  
Final Extension 72 °C 10 min  
Pause 16 °C ∞  
 
 Agarose gel electrophoresis 
DNA agarose gel electrophoresis was performed with gels comprising 1 % (w/v) agarose in 1x 
TAE buffer (Table 2.32). Prior to use, the agarose was completely dissolved by heating. After 
cooling to ~60 °C the mixture was cast on prepared gel trays and supplemented with 
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ethidium bromide (10 mg/mL stock solution) or Roti®-GelStain (Carl Roth) at a dilution 1.5 µL 
staining substance per 100 mL gel. For loading into the sample pockets, the DNA samples were 
mixed with a 6x DNA loading buffer (Table 2.32). Gels were run in 1x TAE buffer at 10 to 
15 V/cm for 30 min and documented under UV illumination at 254 nm. 1 kb SmartLadder 
(Eurogentec) was used as a molecular weight standard in all runs (Table 2.2). 
Table 2.32. Buffers for DNA electrophoresis. 
Buffer Composition 
TAE 35.4 mM Trizma® base 
0.1 % (v/v) glacial acetic acid 
1 mM EDTA 
pH 8.5 
6x DNA Loading Buffer 0.4 % (w/v) glycerol p.a. 
10 % (v/v) 100x bromphenol blue 
0.03 M EDTA 
 
 Restriction digestion of DNA  
All restriction digestions were performed with enzymes by NEB according to the manufacturer’s 
protocols with 0.5 U/µL of each restriction enzyme. If possible, the High Fidelity (HF) versions of 
the enzymes were used. Analytical restriction digests were conducted at 10 µL scale with 1.5 µg to 
3 µg of plasmid DNA and a reaction time of 60 min. Preparative restriction digests were performed 
at 100 µL scale with 5 µg to 10 µg of plasmid DNA and a reaction time of 120 min to 180 min. 
 Ligation of DNA fragments 
The integration of digested DNA fragments (inserts) into a compatibly digested vector backbone 
was performed by T4 ligation. All digested vector backbones were dephosphorylated for 15 min at 
37 °C with Antarctic phosphatase (NEB) according to the supplier’s protocol to avoid religation. 
The Antarctic phosphatase was inactivated by incubating the reaction mix at 70 °C for 15 min. The 
ligation reaction was conducted in 20 µL volume with 1 U T4 DNA ligase (Roche) according to the 
supplier’s manual. The smaller fragment, usually the insert, was applied in a 4:1 molar excess over 
the vector backbone. Two controls were set up for each reaction. In the first control, no insert was 
added to the mix (religation control). In the second control, neither insert nor T4 ligase were added 
(negative control). The ligation was performed for 60 min to 120 min at room temperature.  
The blunt ligation of PCR products or DNA fragments into the vector pJET1.2 for amplification 
and sequencing was performed with the CloneJET PCR Cloning Kit (Thermo Fisher Scientific) 
according to the manufacturer’s manual with the following modifications. All reactions were 
performed according to the “Sticky End Protocol”. About 3 - 5 µL of PCR product were used for 
the reaction. The blunting reaction was extended to 15 min at 70 °C. The ligation time was also 
extended to 30 min at room temperature. The components of the kit were also used to blunt and 
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religate digested DNA vector backbones following the same protocol. In this case the digested 
vector backbone was handled like a PCR insert and pJET1.2 was not added to the reaction mix. 
 Preparation of competent E. coli cells 
E. coli TOP10 cells were streaked out on non-selective LB agar plates and incubated overnight at 
37 °C. Chemically competent cells were generated by the Inoue method as described by Sambrook 
and Russell (2006). Electro-competent cells were prepared using a 40 mL pre-culture inoculated 
with a single colony and grown overnight at 37 °C and 130 rpm. The pre-culture was used to 
inoculate a 400 mL culture at an OD595 of 0.05. The cultures were grown at 37 °C and 130 rpm 
until an OD595 of 0.5 was reached and chilled in sterile centrifuge tubes on ice for 30 min with 
occasional mixing. The cells were centrifuged (4 °C; 10 min; 3,000 rpm) and washed with 200 mL 
sterile, ice-cold wash buffer (1 mM HEPES, 10 % (v/v) glycerol, pH 7.0). The centrifugation and 
washing step was repeated twice with sterile, ice-cold wash buffer (100 mL) and 10 % (v/v) 
glycerol solution (10 mL), respectively. After centrifugation, the cells were suspended 1 mL ice-
cold, sterile 10 % glycerol solution and aliquoted in sterile 1.5 mL reaction tubes. The aliquots 
were frozen in liquid nitrogen and stored at -80 °C.  
 Transformation of E. coli 
E. coli cells were typically transformed with 2 ng of intact plasmid DNA or ~10 ng of DNA from a 
ligation mix. For electroporation, the DNA was mixed with 50 - 60 µL of electro-competent cells 
in ice-cold 2 µm cuvettes and incubated on ice for 5 min. The transformation was performed with a 
Bio-Rad Gene PulseTM according to the manufacturer’s protocol. Immediately after the 
electroshock, 1 mL of SOC medium was added to the cells. Transformed cells were cultivated for 
60 min at 37 °C with mild shaking. For chemical transformation, the DNA-cell mix was incubated 
on ice for 30 min. A heat shock was conducted at 42 °C for 30 s. Afterwards, the cells were cooled 
on ice for 2 min and 1 mL SOC medium was added. Cultivation was performed for 60 min at 37 °C 
with mild shaking. For both transformation methods alike, 50 to 200 µL of the bacterial suspension 
were plated on selective LB agar plates and incubated overnight at 37 °C. 
 DNA preparation and purification  
2.6.7.1 DNA gel extraction and purification from reaction mixes 
To extract DNA fragments from agarose gels, the NucleoSpin® Gel and PCR Clean-up Kit 
(Macherey-Nagel) was used according to the manufacturer’s protocol. In addition, the kit was also 
used for direct purification of DNA from PCR and restriction digestion samples.  
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2.6.7.2 DNA plasmid mini and midi preparations 
For DNA plasmid preparations, overnight cultures (16 h) of single E. coli clones carrying the 
respective plasmid were grown at 37 °C and 130 rpm in LB medium with appropriate antibiotics. 
Mini preparations were performed with the cells of 4 mL cultures with the GenElute™ Plasmid 
Miniprep Kit (Sigma) according to the supplier’s manual with the following modifications. The 
elution was performed in 50 µL instead of 100 µL elution buffer. After the addition of the elution 
buffer, the columns were incubated for 1 min at room temperature prior to final the centrifugation 
step. Midi preparations were conducted with the cells of 200 mL overnight cultures using the 
PureYieldTM Plasmid Midi Prep System Kit (Promega) according to the supplier’s manual. 
 Generation and preparation of recombinant bacmids 
Bacmids were created according to the Tn7 transposition based method with the EMBacY bacmid 
(Trowitzsch et al. 2010). Blue-white screening was used to identify clones carrying the 
recombinant EmBacY with the GOI. In this work, the vectors pFlpBtM-III-insect-Tmprss2-WT 
and pFlpBtM-III-insect-Tmprss2-D343N (§ 2.3) were used as donor vectors for the Tn7 
transposition. The vectors were transformed into E. coli DH10(EmBacY) by electroporation 
(§ 2.6.6). The cells were selected on LB agar plates supplemented with tetracycline, gentamicin and 
kanamycin, bluo gal and IPTG. After growth, white colonies were picked and streaked out on fresh 
agar plates to avoid false positives. To prepare the recombinant bacmid, 20 mL of LB medium 
supplemented with kanamycin, gentamicin and tetracycline were inoculated from a single white 
colony. The culture was incubated at 37 °C and 130 rpm for up to 24 h. 1.5 mL of the culture were 
transferred to suitable reaction tubes and centrifuged for 2 min at 13,000 x g and 4 °C. The 
supernatant was completely removed by pipetting and the cells were resuspended in 300 µL of the 
resuspension solution P1. 300 µL of lysis solution P2 were added and mixed gently. The mix was 
incubated for 5 min at room temperature until it became translucent. 300 µL of the neutralization 
solution P3 were then added and the sample was incubated on ice for 10 min. The formed 
precipitate of protein and genomic DNA was pelleted by centrifugation for 10 min at 13,000 x g 
and 4 °C. The clear supernatant was transferred to a fresh reaction tube containing 800 µL of 
isopropanol to precipitate the bacmid DNA. The sample was mixed gently, incubated on ice for 
10 min and centrifuged for 15 min at 13,000 x g and 4 °C. The supernatant was removed, the DNA 
pellet was washed with 500 µL of 70% ethanol and the centrifugation step was repeated. The 
ethanol was completely removed and the pellet was air dried at room temperature. Finally, the 
DNA was resuspended in 40 µL of the buffer NE from the NucleoSpin® Gel and PCR Clean-up 
Kit (Macherey-Nagel) (5 mM TrisHCl, pH 8.5). The buffers P1-P3 are listed below in Table 2.33. 
The cells of the remaining 18.5 mL of the culture were used to generate 1 mL glycerol stocks in 
10 % (v/v) glycerol. The vials were frozen in liquid nitrogen and stored at -80 °C. 
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Table 2.33. Buffers for the bacmid preparation. 
Buffer Composition 
Solution P1 (Resuspension, Qiagen) 50 mM Tris-HCl (pH 8.0), 10 mM EDTA, 100 µg/mL RNAse A 
Solution P2 (Lysis, Qiagen) 0.2 M NaOH, 1 % (w/v) SDS 
Solution P3 (Neutralization, Qiagen) 3 M Potassium Acetate (pH 5.5) 
 
 Preparation of electro-competent P. pastoris  
Electro-competent P. pastoris cells were prepared and transformed according to the condensed 
protocol by Lin-Cereghino et al. (2005). The desired P. pastoris strain was streaked out on YPD 
agar plates without antibiotics (or appropriately selective media) and incubated at 30 °C for 48 h. A 
50 mL pre-culture was inoculated and grown overnight in YPD at 30 °C and 130 rpm. A 400 mL 
YPD main culture was inoculated from the overnight culture at a final OD595 of 0.1 – 0.15 in a flask 
large enough to provide aeration. The culture was incubated at 30 °C and 130 rpm until an OD595 of 
0.8 – 1.0 was reached. The cells were harvested for 5 min at 500 x g and the supernatant was 
removed. The cells were resuspended in 9 mL of ice-cold BEDS solution (10 mM bicine-NaOH, 
pH 8.3, 3 % (v/v) ethylene glycol, 5 % (v/v) dimethyl sulfoxide / DMSO) supplemented with 1 mL 
1 M DTT. The suspension was incubated for 5 min at 30 °C and 100 rpm. The culture was 
centrifuged for 5 min at 500 x g and the cells were resuspended in 2 mL of BEDS solution without 
DTT. The competent cells were either used directly or frozen slowly in a Mr. Frosty™ Freezing 
Container with isopropanol (Thermo Fisher Scientific) and stored at -80 °C. 
 Stable transformation of P. pastoris  
Prior to transformation into P. pastoris, the integrating vectors were linearized through unique 
digestion and subsequently purified (§ 2.6.3 and 2.6.7). The restriction enzymes used for 
linearization are listed in Table 2.34. Since the original CDS of Tmprss2 harbored a native SacI 
site, DraI was used to linearize the respective vectors. To generate single copy clones, 25 ng of 
linearized vector DNA were transformed. For multi copy clones, 100 ng of DNA were used. To 
perform the RMCE in P. pastoris, the vectors pBGP1Δ8K-FlpWT and pYEXUR-yeGFP were 
transformed in their circular states. The vectors were mixed prior to transformation with an excess 
of pBGP1Δ8K-FlpWT of 4:1 (80 ng : 20 ng). After the transformation, 1 mL 1 M D-Sorbitol 
solution was added to the cells. Following cultivation of the samples at 30 °C (mild shaking) for 
1 h, the cells were plated on YPDS Zeocin agar plates or MD plates for appropriate primary 
selection. The plates were incubated at 30 °C for 2-3 d. For single clone isolation, grown colonies 
were diluted in 1 mL of sterile 1 M Sorbitol solution and streaked out again on fresh selection 
plates. To select for multi copy clones, the clones were streaked out on multiple plates with an 
increasing gradient of Zeocin (100 µg/mL to 1 mg/mL). 
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Table 2.34. Restriction enzymes for vector linearization to stably transform P. pastoris. 
Homologous region Vectors Enzyme 
AOX1 Promoter  All pPICZ(α) derived plasmids SacI / DraI  
GAP Promoter  All pGAPZ(α)/pGAPZAΔ8 derived plasmids AvrII 
AOX1 Promoter and 3’AOX1 pPIC9K, pYTAaox-RudolphRFP BglII 
URG pYTAUR-RudolphRFP SphI 
 
 Genomic DNA extraction from P. pastoris and PCR analysis 
The stable insertion of the vector into the genome of P. pastoris was analyzed by genomic PCR. 
The isolation of genomic DNA was performed adapted from the publication by Looke et al. (2011). 
P. pastoris clones were grown overnight from single clones at 30 °C and 130 rpm in appropriate 
medium. 100 - 200 µL of the overnight cultures (OD595 of ~0.4) were transferred to suitable 
reaction tubes and centrifuged at 12,000 x g for 1 min. The cells were resuspended in 100 µL of 
P. pastoris LiOAc lysis buffer (200 mM Lithium acetate, 1 % SDS) and incubated for 15 min at 
90 °C. The lysate was briefly cooled on ice and 0.5 µL of RNase A (100 mg/mL stock, Qiagen) 
were added. The samples were incubated for 10 min at room temperature. 300 µL of ethanol p.a. or 
isopropanol were added and the sample was vortexed. Precipitation of the DNA could be extended 
to 30 min on ice or at -20 °C. The cell debris and the precipitated DNA were pelleted by 
centrifugation at 15,000 x g, 3 min. The pellet was washed with 1 mL 70 % ethanol (p.a.). After 
another centrifugation step (15,000 x g, 1min), the ethanol was carefully completely removed. The 
pellet was air dried and dissolved in 100 µL of elution buffer NE (NucleoSpin® Gel and PCR 
Clean-up Kit, Macherey Nagel). The dissolved DNA was separated from the cell debris by another 
centrifugation step at 15,000 x g, 30 s and transfer into a new reaction tube. The concentration was 
measured with the Nanodrop (§ 2.6.14). The PCR amplification of the genomic DNA was 
conducted as described in chapter 2.6.1. For each PCR, ~1 µL of the isolated genomic DNA were 
used. In order to exclude undesired background signal due to off-target binding of the PCR 
primers, the DNA of a respective control clone was used as a negative control template. The 
analysis of the P. pastoris RMCE master cell lines and the fluorochrome test cell lines was 
performed with two parallel PCRs. The first PCR (PCR1) was conducted to validate the integration 
of the vector into P. pastoris. The second PCR (PCR2) was conducted in parallel to distinguish 
single copy insertion clones from multi copy clones. A detailed overview of the PCR primers and 
the expected fragment sizes is described in Appendix II. 
 Functionality test of the selection trap Δhis4 by cell growth  
The selected clones were streaked out on YPD agar plates and grown for 48 h. One grown colony 
was dissolved in 1 mL of sterile 1 M Sorbitol solution. This “undiluted” mix was serially diluted to 
1:100 and 1:1000 in 1 M Sorbitol. From all dilutions, 2.5 µL were dropped on MD and MDH agar 
plates. The plates were incubated for 48 h at 30 °C and the cell growth was documented. 
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 Glycerol stocks of P. pastoris 
Glycerol stocks were made from purified single clones, which were grown overnight at 30 °C and 
130 rpm in 2 mL of suitable, selective medium. 800 µL of the culture were combined with 200 µL 
of sterile glycerol (p.a.) in 1 mL cryo vials and mixed by vortexing. The vials were frozen slowly in 
a Mr. Frosty™ Container with isopropanol (Thermo Fisher Scientific) and stored at -80 °C. 
 Quantification of DNA and protein concentrations 
The concentration of DNA and proteins was assessed photometrically using a NanoDrop  
ND-2000c (Thermo Fisher Scientific) as described in the manufacturer manual. Nucleic acids were 
quantified at 260 nm. The A260/280 ratio was used to track protein contaminations. A ratio of 
~1.8 was accepted as pure DNA. A ratio of ~2.0 was accepted as pure RNA. Protein quantifications 
were carried out with the absorbance at 280 nm. To relate the absorbance to the actual protein 
concentration, it had to be divided by the molar extinction coefficient of the protein according to 
the Beer-Lambert law. The molar extinction coefficients of target proteins were calculated by 
Vector NTI. For recombinant Tmprss2, a factor of 0.45 mg/mL per 1 A280 was applied. 
 Transcriptional analysis by RT-PCR 
2.6.15.1 Total RNA isolation from P. pastoris and cDNA synthesis 
The clones were cultivated in 500 µL BMD medium in 2 mL 96-deepwell plates for 24 h at 28 °C 
and 1200 rpm in a Titramax 1000 incubator (Heidolph Instruments GmbH, Schwabach, Germany). 
Total RNA was isolated using NucleoSpin® RNA kit (Macherey Nagel), according to the supplier’s 
manual. The cDNA was synthesized from the isolated total RNA using the peqGOLD M-MuLV H 
plus Reverse Transcriptase (VWR Life Science CC, Erlangen, Germany) according to the 
manufacturer’s instructions. Protector RNase inhibitor, dNTP mix (PCR grade) and anchored 
Oligo(dT)18 primer were taken from the Transcriptor First Strand cDNA Synthesis Kit (Roche 
Diagnostics, Mannheim, Germany). For each cDNA synthesis, a control was set up without reverse 
transcriptase (no reverse transcriptase, NRT) to exclude false positive signals during RT-PCR due 
to genomic DNA contamination. 
2.6.15.2 Quantitative RT-PCR 
The transcriptional analysis was conducted with four technical replicates of three independent 
biological clones of each tested cell line variant. The reverse transcription PCR (RT-PCR) was 
performed using the SsoFastTM EvaGreen® Supermix (Bio-Rad) according to the supplier’s manual. 
The PCR was conducted for 40 cycles in a CFX96 Touch™ Real-Time PCR Detection System 
(Bio-Rad). Melting curves were analyzed to display only one peak. To exclude false positive 
MATERIAL AND METHODS 
 
 48  
signals due to contamination of the PCR mixes, no template control (NTC) reactions were 
performed for each primer set. The RT-PCR was performed with three sets of primers. The names 
and expected PCR product sizes are depicted in Table 2.35. The sequences are listed in Appendix I.  
Table 2.35. Used RT-PCR primers. 
Name Codes for Function in Experiment Primers Fragment 
RudolphRFP RudolphRFP Tested transcript of the GOI 
rt_Rud-F 
rt_Rud-R 
138 bp 
PGK1 
Phosphoglycerate 
kinase 1 
Reference to normalize readouts of each sample 
rt_PGK1-F 
rt_PGK1-R 
137 bp 
ACT1 Beta Actin Reference, handled like GOI to evaluate comparability 
rt_ACT1-F 
rt_ACT1-R 
142 bpI 
 
2.6.15.3 RT-PCR data analysis 
Data analysis was performed using the comparative CT (cycle threshold) method adapted from 
Schmittgen and Livak (2008). The readouts of each set of technical replicates were averaged. If no 
CT readout was obtained during the experiment, the CT was set by definition to 40. The first step 
comprised the “internal” calibration of each sample by correlating the readout for a tested GOI 
(RudolphRFP or ACT1 as a control GOI) to the corresponding readout of reference gene (PGK1) 
by subtraction of the respective CT values, resulting in the so-called ΔCT value: 
 𝛥𝐶𝑇 = 𝐶𝑇(𝐺𝑂𝐼) − 𝐶𝑇(𝑅𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒/𝑃𝐺𝐾1) (Eq. 1) 
The ΔCT values of each biological triplicate were averaged. The averaged ΔCT values of all RMCE 
master cell line variants were put into relation by correlating them to the positive control (PC) as a 
selected reference sample by subtracting the respective ΔCT values (resulting in the ΔΔCT value). 
The relative fold change of the respective transcripts was calculated as 2-ΔΔCT for easier 
accessibility. For this, the PC was defined as 1 (= 100 %). 
 𝛥𝛥𝐶𝑇 = 𝛥𝐶𝑇(𝑎𝑛𝑦 𝑡𝑒𝑠𝑡𝑒𝑑 𝑐𝑒𝑙𝑙 𝑙𝑖𝑛𝑒) − 𝛥𝐶𝑇(𝑃𝐶) (Eq. 2) 
 𝐹𝑜𝑙𝑑 𝐶ℎ𝑎𝑛𝑔𝑒 = 2−𝛥𝛥𝐶𝑇  (Eq. 3) 
Student’s t-tests were performed to ensure significance of the data. Gaussian Error Propagation was 
calculated as described by Papula (2008). 
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2.7 Cell culture techniques 
 Determination of cell number and viability 
Cell numbers and viability (SF21, Hi5 and HEK293-6E) were assessed through the trypan blue dye 
exclusion method in a Neubauer hemocytometer. Trypan blue binds to proteins. As it is not able to 
permeate intact cell membranes, only dead cells are stained. To count the cells, 25 µL cell culture 
were diluted in 75 µL 0.5 % trypane blue solution. The stained and unstained cells of four big 
squares of the hemocytometer were counted. Cell density and viability were calculated as follows: 
𝐶𝑒𝑙𝑙 𝐷𝑒𝑛𝑠𝑖𝑡𝑦 (
𝐶𝑒𝑙𝑙𝑠
𝑚𝐿
) =
𝐶𝑒𝑙𝑙𝑠 ∙  104  ∙  𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟 (4)
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑐𝑜𝑢𝑛𝑡𝑒𝑑 𝑏𝑖𝑔 𝑠𝑞𝑢𝑎𝑟𝑒𝑠 (4)
= 𝐶𝑒𝑙𝑙𝑠 ∙  104 
𝑉𝑖𝑎𝑏𝑖𝑙𝑖𝑡𝑦 [%]  =
𝑉𝑖𝑎𝑏𝑙𝑒 𝐶𝑒𝑙𝑙𝑠 ∙  100
𝑇𝑜𝑡𝑎𝑙 𝐶𝑒𝑙𝑙𝑠
 
 Cell size determination 
The progress of baculoviral infection can be monitored through an increase in the diameter of 
infected insect cells. This was done with the CASY Cell Counter (Innovatis), which delivers 
simultaneous readouts for the number, the viability and the size of measured cells following a cell 
type specific calibration. The device was used according to the manufacturer’s guidelines after the 
samples were diluted in an isotonic, particle pure buffer to reach the measurement range of the 
device. The CASY counter works by electric current exclusion. The measured particles (cells) are 
diluted in an electrolyte and flow through a capillary passing an electrical field, which induces a 
resistance that is proportional to the size of the measured cells. This also allows measuring the 
viability of a sample, as the intact membrane of living cells exhibits a significantly higher 
resistance compared to dead cells.  
 Analytic flow cytometry with the Guava EasyCyte Mini 
In this work a Guava EasyCyte Mini System (Merck) was used to monitor the efficiencies of the 
transfections of HEK293-6E cells as well as the baculoviral infections of SF21 and Hi5 cells. 
Moreover, the expression analysis of the P. pastoris RMCE master cell line variants and exchanged 
producer cell lines was conducted by flow cytometry to quantify the expression of RudolphRFP 
and y-eGFP. The Guava EasyCyte Mini is equipped with a 488 nm argon laser for excitation. It 
offers three band-pass filters (525/30, 583/30 and 680/30) to detect the emission of green, yellow 
and red signals. In this work, the 525/30 filter was used to detect the expression of GFPq, y-eGFP 
and YFP. RudolphRFP was detected with the 583/30 band-pass filter. For the determination of 
fluorescence the cell suspensions were diluted 1:10 in PBS. For the expression analyses in 
P. pastoris, the mean red or green fluorescence was defined as the measurement value. 
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 Transient transfection of HEK293-6E with PEI 
Serum-free cultivated HEK293-6E cells were transfected using linear polyethylenimine (PEI) with 
an average molecular weight of 25 kDa (Polysciences). The cells were transfected in their 
exponential growth phase at a cell density of 1.5 – 2.0 x 106 cells/mL. The transfected DNA 
comprised a mix of 95 % expression vector (pFlp-BtM-III-Tmprss2-D343N or pFlpBtM-III-
Tmprss2-WT) and 5 % of pTTO/GFPq, which was used to monitor the transfection efficiency. Per 
30 mL culture (set up in fresh medium), the transfection mix was prepared with 30 μg of the DNA 
mix and 75 µg of PEI. The DNA and PEI were each separately added to 1.5 mL of F17 medium in 
sterile 15 mL polystyrene tubes and vortexed briefly. Afterwards, the DNA solution added to the 
PEI solution and the mix was vortexed briefly. After incubation at room temperature for 15 min, 
the now complexed transfection mix was added to cell culture.  
 Transfection of SF21 cells with bacmids and virus amplification 
The generation of baculoviruses to express Tmprss2-WT and Tmprss2-D343N was performed by 
transfecting adherent SF21 cells with the generated recombinant EMBacY bacmids (§ 2.6.8) using 
SuperFect (Qiagen). For the preparation of the first virus generation 0.4 x 106 SF21 cells from a 
culture supplemented with 5 % FCS were seeded on 6-well plates. For each transfection, 5 µL of 
the isolated recombinant bacmid and 10 µL of SuperFect were diluted in 150 µL serum free  
Ex-Cell 420 medium for pre-complexing. The mix was incubated for 10 min at room temperature 
and supplemented with 850 µL of Ex-Cell 420 with 5 % FCS. This final mixture was used to 
substitute the culture media covering the adherent cells in the 6-well plates. After 2 h of incubation 
at 27 °C, further 1.5 mL of Ex-Cell 420 with 5% FCS were added to each well. The initial virus V0 
was harvested with the supernatant after 3 - 5 d of incubation at 27 °C, depending on the YFP 
expression from EmBacY. The baculovirus-containing supernatant was used to perform one round 
of virus amplification (VA1). For this, serum-free suspension SF21 cells were seeded in a density 
of 0.5 × 106 cells/mL in 2 x 50 mL cultures and incubated at 27 °C and 100 rpm. The cultures were 
then infected through the addition of 2 % (v/v) of the harvested virus supernatant. The cell number, 
viability and cell diameter were determined every 24 h by manual counting and with the CASY 
Counter as described in chapters 2.7.1 and 2.7.2. Furthermore, the expression of YFP was 
monitored using the Guava Flow EasyCyte System (§ 2.7.3). The virus-containing supernatant was 
harvested 48 h after the cells had stopped proliferating. The supernatant was separated from the 
cells by centrifugation at 5,000 x g for 15 min and filtered with 0.45 µm diameter. The cleared 
VA1 was directly used to infect SF21 and Hi5 expression cultures. 
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2.8 Protein production and purification 
 Stable protein expression in P. pastoris  
The cultivation of the generated and purified P. pastoris producer clones were conducted at 
28 °C to 30 °C. Shake flask cultures were performed in baffled flasks at 130 rpm. High-throughput 
expression screenings using 2 mL 96-deepwell plates were conducted at 1000 to 1200 rpm in a 
Heidolph Titramax 1000 incubator (with at most 1.5 mL per well). For comparative expression 
experiments, the OD595 was tested to ensure the comparability of the results. In all experiments 
except for high throughput expression in 96-deepwell plates, 1 mL samples were taken every 24 h. 
The cells were spun down at 14,000 x g for 3 min. For secretory proteins (Tmprss2, HSA) the 
supernatant and the cells were stored separately at -20 °C after freezing in liquid nitrogen for later 
analyses. For intracellular proteins (fluorochromes) the supernatant was discarded and only the 
cells were stored. 
The GAP promoter based expression in GS115 was performed in YPD, BMD or BMDY medium. 
The expression was conducted for 48 h, unless stated differently. During comparative analyses, 
technical replicates of a single biological clone were inoculated from one common pre-culture. The 
expression was started at an inoculated OD595 of 0.1. For the AOX1 promoter based expression in 
GS115 (mut+), the cells were grown in BMGY for 24 h and resuspended in an equal volume of 
BMMY after centrifugation at 3,000 x g for 5 min to induce the expression. The expression was 
conducted for 48 hpi (hours post induction). The induction was maintained by the addition of 0.5 % 
(v/v) methanol every 24 hpi.  
For the AOX1 based expression in the mutS strain KM71H pre-cultures were grown in BMGY 
medium for 24 to 48 h or until an OD595 of ~10 was reached. The cells were harvested at 3,000 x g 
for 5 min. The supernatant was discarded. In shake flasks, cells were resuspended at 1/5 of the pre-
culture volume in BMMY medium. In 96-deepwell plates, 1/3 of the preculture volume was used 
instead for easier handling. The expression was conducted for 48 hpi, unless noted otherwise. The 
induction was maintained by the addition of 0.5 % (v/v) methanol every 24 hpi. In later 
experiments, the antifoam Struktol® J 673 A was added at 1 % (v/v) to the culture media. To 
harvest the supernatant after the expression phase, the cultures were centrifuged at 6,000 x g for 
10 min. The supernatant was subsequently fully cleared by to two more rounds of centrifugation at 
24,000 x g for 30 min and passage through a 0.2 µm filter.  
The AOX1 promoter based expression in KM71H was scaled up to 2 L or 5 L Labfors bioreactors 
(Infors HT, Bottmingen-Basel, Switzerland). The expression was conducted according to the 
protocol of the Helmholtz Protein Sample Production Facility (PSPF) at the HZI (Braunschweig, 
Germany) with the media described in Table 2.11 – Table 2.15 (§ 2.1.3). The cultivation was 
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conducted at 28 °C and ~pH 6.0. The pH was maintained with 12.5 % (v/v) ammonia solution. 
Stirring (6-bladed impeller) was started at 400 rpm and increased if necessary to ensure aerobic 
culture conditions (pO2 > 0). The process parameters were monitored during the run. To start a 
reactor run, a first pre-culture of 50 mL was grown in shake flasks with YPD medium, 
supplemented with Zeocin (100 µg/mL). From this culture, a 400 mL YPD pre-culture was 
inoculated. Once the culture reached an OD595 of 15 to 20, it was used to inoculate the installed and 
sterilized bioreactor at a final OD595 of 1. The cells were grown for ~24 h, until the glycerol of the 
bioreactor growth medium was used up, which was monitored through an increase of the pO2. The 
cultivation was then continued at carbon-source limiting conditions through the slow addition of 
the glycerol feed solution to the reactor. As soon as an OD595 of 180 to 250 was reached, the 
glycerol feed was stopped and the exhaust of glycerol in the medium was again tracked by the pO2. 
At this point, methanol feeding was started. The cells were slowly adapted to methanol by its step-
wise addition of 0.1 % – 0.5 %. A methanol sensor and an automatic pump (Raven Biotech Inc., 
Vancouver, Canada) were used to maintain 0.5 % (v/v) methanol in the bioreactor. The expression 
was conducted for 48 hpi. The culture supernatant was harvested by centrifugation at 6,000 x g for 
10 min, separated from the cells and fully cleared by to two more rounds of centrifugation at 
24,000 x g for 30 min followed by passaging through a 0.2 µm filter.  
 Plasmid based transient expression in HEK293-6E 
Transfections were carried out as described in chapter 2.7.4. The transformed cells were cultivated 
under standard conditions (37 °C, 100 rpm, 5 % CO2 in a humidified atmosphere). The cell count, 
the viability the green fluorescence of GFPq were analyzed every 24 h. Samples of the culture 
supernatant as well as aliquots of 1 x 106 cells were taken for analysis and stored at -20 °C until 
further use. The transfected cultures were expanded 48 h post transfection (hpt) with fresh medium 
to a total volume of 50 mL and supplemented with tryptone (TN1) at a final concentration of 0.5 %. 
After 72 hpt the cultures were additionally fed with 4.5 g/L glucose. The expression was terminated 
after 96 hpt and the total culture was harvested for further analysis. The cells were separated from 
the supernatant by centrifugation at 500 x g for 5 min.  
 Protein expression in SF21 and Hi5 insect cells using BEVS  
The virus amplification was carried out as described in chapter 2.7.5. For baculoviral protein 
production insect cells were seeded in 120 mL suspension cultures of each SF21 and Hi5 cells with 
an initial cell density of 1x 106 cells/mL. The cells were infected with 10 % (v/v) of VA1. The 
infection kinetics were tracked every 24 h through cell count, cell diameter and the percentage of 
the YFP fluorescent cells. Samples of the culture supernatant as well as aliquots of 1 x 106 cells 
were taken for analysis and stored at -20 °C until further use.  
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The cultivation was stopped at 72 h post infection for SF21 and at 96 h post infection for Hi5. The 
whole culture was harvested and the cells were separated from the supernatant by centrifugation at 
500 x g for 5 min. 
 Cell lysis of P. pastoris  
The cell lysis of P. pastoris was carried out with acid washed glass beads (size 0.5 mm) according 
to the Pichia Expression Kit manual (Thermo Fisher Scientific). The cell pellets of harvested 1 mL 
samples were thawed quickly and placed on ice. 100 μL of ice cold Breaking Buffer (BB, Table 
2.36) were used to resuspend each cell pellet. The volume was estimated and acid-washed glass 
beads were added roughly at the same volume. The cell-bead mixtures were subjected to eight 
cycles of rigorous vortexing and incubation on ice for respectively 30 s. The samples were 
centrifuged for 10 min at 16,000 x g and 4°C. The clear soluble lysate fraction was transferred to 
fresh 1.5 mL reaction tubes. To obtain the insoluble fraction, an equal amount of fresh lysis buffer 
was added to the remaining mix of glass beads and cell debris. To prepare SDS-PAGE samples, 
50 μL of lysate were mixed with an appropriate volume of SDS-loading buffer (§ 2.9.1,Table 2.43) 
and boiled for 5 min at 95 °C. 
Table 2.36. P. pastoris Breaking Buffer (BB). 
Component Final concentration 
Sodium phosphate buffer, pH 7.4 (1 M stock) 50 mM 
EDTA 1 mM 
Glycerol p.a. 5 % (v/v) 
in MQ-H2O  
To add before use 
DNAse (1 mg/mL) 2 - 5 µg per 50 mL of BB 
Protease Inhibitor (Roche cOmplete™, EDTA-free) 1 tablet per 50 mL of BB 
 
 Cell lysis of HEK293-6E, SF21 and Hi5 cells  
250 µL of lysis buffer (Table 2.37) were added to the cell pellet of harvested 1 mL samples. The 
cells were resuspended by vortexing. The mixture was kept on ice for 15 min and centrifuged at 
16,000 x g for 15 min to separate the soluble and insoluble fractions. For the lysis of the total 
cultures, 25 mL of lysis buffer were added to the frozen cells. The mixture was vortexed rigorously 
and the tube was then incubated on ice for approximately 30 min. The resuspended cells were 
disrupted by sonication in a Sonopuls sonifier (Bandelin) using 80 W in intervals of 1 s for 2 min. 
The samples were centrifuged at 30,000 x g for 30 min in order to separate soluble and insoluble 
fractions. The samples could be stored at -20 °C until the analysis was conducted. 
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Table 2.37. Mammalian and insect lysis buffer for protein extraction. 
Component Final concentration 
Sodium phosphate buffer, pH 8.0 50 mM 
Imidazole 5 mM 
NaCl 300 mM 
IGEPAL CA-630 0.5 % (v/v) 
Beta-mercaptoethanol  3 mM 
in MQ-H2O  
To add before use 
DNAse (1 mg/mL) 5 - 10 µg per 50 mL of lysis buffer 
Protease Inhibitor (Roche cOmplete™, EDTA-free) 1 tablet per 50 mL of lysis buffer 
 
 Trichloroacetic acid (TCA) precipitation of proteins 
TCA precipitation was used as a simple method to concentrate small samples for tests of protein 
expression by SDS-PAGE and Western blot. 1 mL of culture supernatant or total cell lysate was 
mixed with 100 µL of 100 % TCA. The mixture was incubated on ice for 30 min and centrifuged at 
15,000 x g and 4 °C for 15 min to pellet the precipitated protein. The protein pellet was washed in 
1 mL of ice-cold 70 % ethanol and centrifuged again for 5 min at 15,000 x g and 4 °C. Remaining 
ethanol was removed and the protein pellet was dissolved in 50 µL NE buffer (5 mM Tris-HCl, 
pH 8.5) from the NucleoSpin® Gel and PCR Clean-up Kit (Macherey-Nagel). 
 Dialysis and diafiltration 
Dialysis was performed to exchange the buffer of small volumes (< 50 mL per sample) using dry 
Spectra/Por® dialysis tubes (Spectrum Laboratories Inc., Rancho Dominguez, California, USA) 
with a MWCO of 10 kDa or less. Prior to use, the tubes were soaked in the desired exchange 
buffer. Dialysis was conducted in two repetitions at 4 °C with slow stirring of the buffer with at 
least volumes of exchange buffer compared to the volume of the original sample. Diafiltration of 
50 mL to 500 mL culture supernatant were conducted using the VIVAflow 200 system (Sartorius 
AG) with a 10 kDa MWCO membrane according to the supplier’s manual. Prior to use, the 10 % 
storage ethanol solution was completely removed from the cartridge. Thereafter, the cartridge was 
washed with least 500 mL of MQ-H2O to remove residual ethanol. The water was completely 
drained from the system. The supernatant was initially concentrated in the device. 200 mL of the 
supernatant were placed inside the concentrate reservoir. The remaining supernatant was connected 
to the reservoir from a separate bottle (feed reservoir). The sample was concentrated to ca. 50 mL 
to 100 mL by circulation through the system. The concentrated sample was dialyzed by connecting 
the desired exchange buffer to the feed reservoir and continued recirculation of through the system 
with least 10 volumes of buffer. After recovery of the concentrated and diafiltrated sample, the 
system was cleaned according to the supplier’s guidelines and stored in 10 % ethanol. Large-scale 
diafiltration (> 500 mL) was performed with a ProFlux® tangential flow system (Merck) equipped 
with two Pellicon 2 cassettes (Merck) with 10kDa MWCO according to the manufacturer’s 
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instructions. Samples were concentrated to ~500 mL and diafiltered with at least 10 volumes of 
buffer. The concentration and diafiltration of cleared and filtered P. pastoris culture supernatants in 
the ProFlux unit was done by Nadine Konisch (RPEX, HZI). 
 Concentration of protein samples with Vivaspin concentrators  
Vivaspin concentrators (Sartorius AG, Göttingen, Germany) with polyether sulfone (PES) 
membranes were used to concentrate smaller volumes. For this, protein solutions were centrifuged 
at < 5,000 x g (Vivaspin 20) or < 4,000 x g (Vivaspin 2 and Vivaspin 6) until the desired volume 
was reached. Buffer exchange could be performed by refilling the columns with the exchange 
buffer after concentration. This was done with at least 10 volumes (related to the original sample).  
 Small-scale protein capture with magnetic beads 
Small-scale His tag batch purifications were performed with MagneHisTM Ni‐Particles (Promega) 
according to the supplier’s manual with 30 µL of uniformly suspended magnetic beads per 1 mL of 
dialysed or diafiltered P. pastoris culture supernatant. All reactions were performed in 100 mM 
HEPES buffer pH 7.5, 500 mM NaCl. For the washing buffer, imidazole was added at a final 
concentration of 10 mM. The elution buffer was supplemented with 500 mM imidazole. For 
binding, the mix was gently inverted ten times and incubated for 5 min at room temperature while 
keeping the material suspended. Three washing steps were performed, before the protein was 
eluted into 100 µL elution buffer through 5 min of batch incubation. 
 Small-scale batch binding analysis with resin material 
The analysis was performed in 50 mL reaction tubes with 50 µL of equilibrated beads of either  
Ni-NTA His‐Bind® SuperflowTM Resin (Novagen) against a His tag or of ANTI-FLAG® M2 
Affinity Gel (Sigma) against a Flag tag. Both materials were used following the supplier’s 
protocols with 50 mM sodium phosphate buffer pH 7.4, 300 mM NaCl serving as the binding 
buffer. From a harvested and cleared, but not diafiltered, culture supernatant, four 20 mL samples 
were taken to test the two resin materials respectively under two conditions. In the first step, all 
samples were equally supplemented with a final concentration of 50 mM sodium phosphate buffer 
pH 7.4, 300 mM NaCl to adjust the pH for binding. The binding to Ni-NTA material was tested 
with or without the addition of 1 mM NiSO4. For the ANTI-FLAG material, the elution at low pH 
(pH 3.5) and using Flag peptide (SBAU, HZI) were compared. An overview is shown in Table 
2.38. After sample preparation and initial probing (SDS-PAGE samples), equilibrated resin 
materials were added. Binding was performed overnight at 4 °C with gentle shaking. The material 
was separated from the supernatant by centrifugation at 500 x g for 5 min. The supernatant was 
now treated as the “non-bound” fraction (= “flowthrough”). The beads were transferred to fresh 
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reaction tubes for easier handling, washed 3x by resuspension in 1 mL of the appropriate wash 
buffer followed by centrifugation at 500 x g for 1 min. Elution was performed under the conditions 
denoted in Table 2.38. For the low pH elution, the pH of the eluate was immediately neutralized by 
the addition of a final concentration of 25 mM Tris-HCl buffer, pH 8.0. SDS-PAGE samples were 
prepared from all liquid fractions (§ 2.9.1) and from the resin material. For this, the material was 
suspended in 2x concentrated SDS loading buffer after the elution and boiled at 95 °C for 5 min.  
Table 2.38. Overview of the tested conditions for direct capture of Tmprss2 by Ni-NTA or ANTI-FLAG. 
Sample Modified binding conditions Elution conditions 
Ni-NTA 1 - Competitive (500 mM imidazole)  
Ni-NTA 2 Presence of 1 mM NiSO4 Competitive (500 mM imidazole) 
α-Flag 1 - Acid (0.1 M glycine HCl, pH 3.5) 
α-Flag 2 - Competitive (100 µg/mL Flag peptide) 
 
 Large-scale protein capture by affinity chromatography 
The secretory Tmprss2 constructs expressed in this work were equipped with a C-terminal 8xHis 
tag that was mainly used for primary affinity capture on nickel or cobalt based resin material. The 
capture was performed with self-packed Mobicol columns (MoBiTec) or an ÄKTA-FLPC unit (GE 
Healthcare). The recipes of the buffers used in this work are listed in Table 2.39. The elution was 
performed competitively against imidazole. For this, two buffers (A and B) were prepared with 
different imidazole concentrations. Buffer A was prepared without imidazole (“0 mM”) and 
directly used as the binding/equilibration buffer. Buffer B was prepared with 1 M of imidazole. His 
wash buffer (10 mM of imidazole) and His elution buffer (150 - 500 mM imidazole, depending on 
the resin material) were prepared by mixing buffers A and B. Unless noted otherwise, all 
supernatants were diafiltered against binding buffer and concentrated to 500 mL prior to loading 
onto the column (§ 2.8.7). Buffer B could be added to the diafiltered supernatant at a final 
concentration of 10 mM imidazole to enhance the specificity of the Ni-NTA binding. 
For manual His capture with self-packed columns, Ni‐NTA His‐Bind® SuperflowTM Resin 
(Novagen) was used. The experiment was carried out according to the manufacturer’s instructions. 
A 20 mL syringe was screwed on top of the stacked column as a reservoir. Prior to use, the resin 
was washed with 10 column volumes (CV) each of 20 % ethanol and MQ-H2O. A third washing 
step was conducted with buffer A. The supernatant was loaded onto the resin at appropriate speed 
for the resin material and the size of the column using a peristaltic pump. After loading, the resin 
was washed with wash buffer, until no signal was obtained anymore from an attached and 
calibrated UV monitor (280 nm). The target protein was eluted with elution buffer in a series of 
500 µL to 1 mL fractions. The elution was also monitored by UV (280 nm). The affinity capture 
with an ÄKTA-FPLC (GE Healthcare) was performed with prepacked HisTrap FF or HiTrap 
TALON® columns of 1 mL or 5 mL size (GE Healthcare). The ÄKTA unit was operated according 
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to the manufacturer’s instructions. Buffers A and B were degassed by ultra-sonication prior to use. 
The eluent fraction was collected in a series of 1 mL samples using an automatic sampler.  
Capture by ion exchange was conducted with Q-Sepharose Fast Flow resin (GE Healthcare) 
according to the manufacturer’s instructions. The buffers are listed below in Table 2.39. The 
capture of Tmprss2 was performed at pH 9.0 with a gradient of 0 - 500 mM NaCl in an ÄKTApilot 
(GE Healthcare) that was operated as instructed by the manufacturer. A XK 50/30 column was 
packed with 25 mL of resin material and equilibrated prior to use. The cleared P. pastoris culture 
supernatant was diluted 1:10 in Q-Sepharose FF Buffer A before being added to the column. The 
eluent fraction was collected in a series of samples in accordance to the monitored UV 280 nm 
absorbance. The ion gradient was monitored through the conductivity. 
For every affinity capture, the different fractions of the prufication process were analyzed by SDS-
PAGE and Western blot (§ 2.9.1, 2.9.3).  
Table 2.39. Buffer recipes for protein Ni-NTA and Q-Sepharose capture. 
Buffer Composition 
His Buffer A (variant 1) 50 mM sodium phosphate, pH 7.4, 150 – 300 mM NaCl 
His Buffer B (variant 1) 50 mM sodium phosphate, pH 7.4, 150 – 300 mM NaCl, 1 M imidazole 
His Buffer A (variant 2) 50 mM Tris-HCl, pH 7.4 – 8.0, 150 – 300 mM NaCl 
His Buffer B (variant 2) 50 mM Tris-HCl, pH 7.4 – 8.0, 150 – 300 mM NaCl, 1 M imidazole 
Q-Sepharose FF Buffer A 25 mM Tris-Base, pH 9.0 (0 mM NaCl) 
Q-Sepharose FF Buffer B 25 mM Tris-Base, pH 9.0, 1 M NaCl 
 
 Deglycosylation by Endo Hf  
Endo Hf (NEB, Ipswich, Massachusetts, USA) (1 x 106 U/mL) was used according to the 
manufacturer’s guidelines. Both native and denaturing conditions were respectively tested with 
~1 µg of Tmprss2-D343N. For denaturing conditions, the protein was mixed with 1 µL 
10x Glycoprotein Denaturing buffer and MQ-H2O to a final volume of 10 µL. The sample was 
incubated for 10 min at 100 °C. Thereafter, 2 μL of 10x GlycoBuffer 3, 3 µL H2O and 5 μL of 
Endo Hf were added to make a final reaction volume of 20 µL. For native conditions, the first two 
steps were skipped and the 20 µL reaction mix was directly set up with the protein and 
consequently a higher volume of MQ-H2O. The deglycosylation reaction was conducted for 1 h at 
37 °C. The recipes of the reaction buffers are noted below. 
Table 2.40. 10x Deglycosylation buffers (Endo Hf). 
Buffer Composition 
10x Glycoprotein Denaturing Buffer 5 % (v/v) SDS; 40 mM DTT 
10x GlycoBuffer 3 50 mM sodium acetate; pH 6.0 
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2.9 Protein analytical methods 
 SDS-PAGE  
SDS-PAGE (sodium dodecyl sulphate polyacrylamide gel electrophoresis) was used to analyze 
protein quality and yields under denaturing conditions (Laemmli 1970). Self-made gels were used 
consisting of a lower resolving gel (10 % or 12 % acrylamide) and an upper stacking gel (5 % 
acrylamide) (Table 2.41; Table 2.42). Usually 15 µL to 30 µL of protein sample were mixed with 
an appropriate amount of 4 x SDS loading buffer (Table 2.43) and heated for 5 min at 95 °C for 
denaturation. To enhance resolution, the samples were collected in the stacking gel by an initial run 
at 120 V for 5 min. Thereafter, the gels were run at 160 V for ~1 h, until the bromphenol blue front 
reached the end of the gel. The SDS gel was washed 3x 5 min in MQ-H2O to remove excess SDS 
and subsequently stained with either InstantBlue (Expedeon, San Diego, USA) or Coomassie 
staining solution (Table 2.41). Alternatively to self-cast gels, Criterion™ precast gels (Bio-Rad) 
were used according to the supplier’s protocols. The electrophoresis was then performed at 150 V. 
The used molecular weight standards are listed in Table 2.2. 
Table 2.41. Buffers and reagents for SDS-PAGE. 
Buffer Composition 
4× Upper buffer 0.5 M Tris-HCl pH 6.8, 0.4 % SDS (v/v) 
4× Lower buffer 1.08 M Tris-base, 0.42 M Tris-HCl, pH 8.8 
SDS Running Buffer 3 g/L Tris-base, 14.4 g/L Glycin, 1 g/L SDS, pH 8.3 
Coomassie Staining 50 % Ethanol, 10 % acetic acid, 0.25 % Coomassie R-250 
Coomassie Destaining 50 % Ethanol, 10 % acetic acid 
Table 2.42. Compositions of SDS-PAGE gels (for eight gels). 
Component 12 % Resolving Gel 10 % Resolving Gel 5 % Stacking Gel 
Acrylamide/bisacrylamide 30 % (v/v) 12 mL 10 mL 1.5 mL 
4× Upper buffer ‐ ‐ 2.5 mL 
4× Lower buffer 7.5 mL 7.5 mL ‐ 
10 % SDS solution (in MQ-H2O) 0.3 mL 0.3 mL ‐ 
MQ-H2O 10.1 mL 12.4 mL 5.9 mL 
TEMED 40 µL 40 µL 30 µL 
40 % APS  60 µL 60 µL 30 µL 
Table 2.43. 4x SDS loading buffer. 
Component Final concentration 
SDS 7 % (v/v) 
Glycerol p.a. 0.22 % (v/v) 
Tris-HCl pH 6.8 9.6 mM 
Beta-mercaptoethanol 2.4 mM 
Bromphenol blue 0.22 mg/mL 
in MQ-H2O  
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 Native PAGE 
In a native PAGE, protein samples are separated without denaturation of secondary structures. 
Hence, the migration is influenced by the net charge on the protein surface and the hydrodynamic 
radius in addition to its mass. To ensure protein migration to the cathode in the absence of SDS, a 
slightly negative charge is applied through Coomassie G-250, which does not denature the proteins 
(Schägger and von Jagow 1991). The NativePAGETM Novex Bis-Tris Gel System (Thermo Fisher 
Scientific) was used (4-16% gels) in this work according to the manufacturer’s instructions. The 
HMW Native (66 - 669 kDa) and LMW Native (14.4 - 97 kDa) standards by GE Healthcare were 
used as molecular weight markers. 
 Western blotting 
The sensitive detection of specific proteins from culture supernatant was performed by Western 
blots and immunostaining. Either a Trans-Blot-SD device or a Trans-Blot Turbo Transfer System 
(both by Bio-Rad) were used to mediate the transfer of protein samples from a freshly run SDS 
polyacrylamide gel to a polyvinylidene difluoride (PVDF) membrane (Immobilon-P, Merck) in a 
semi dry blotting procedure. The SDS gel and two gel-sized pieces of Western blot filter paper 
were equilibrated for 10 min in Western blot transfer buffer (25 mM Tris-base, pH 8.0, 192 mM 
Glycine, 15 % (v/v) methanol). The PVDF membrane was briefly activated with methanol and 
subsequently equilibrated in transfer buffer for 5 min. The gel was directly placed on the 
membrane. Both were then allocated between two layers of the soaked filter paper and placed on 
the anode of the blotting apparatus. The blot was run at 14 V for 30 min (Trans-Blot-SD) or for 
7 min with mixed Mw program (Trans-Blot Turbo). Unspecific binding sites for antibodies on the 
PVDF membrane were saturated/blocked by incubating the membrane at room temperature for 
30 - 60 min in 10 mL of TBS-T (20 mM Tris-base, pH 8.0, 150 mM NaCl, 0.05 % (v/v) Tween) 
supplemented with 2.5% (w/v) of skim milk powder (blocking solution). The saturated membrane 
was washed 3x for 5 min in TBS-T and incubated at 4 °C overnight (mildly shaking) with 10 mL of 
TBS-T supplemented with an appropriate amount of primary antibody. If the primary antibody was 
compatible to blocking solution, the washing steps following the saturation of the membrane were 
skipped and the antibody was directly applied in 10 mL of fresh blocking solution. After antibody-
binding, the membrane was washed 3x for 5 min in TBS-T and incubated with an appropriate 
secondary antibody, conjugated either to AP (alkaline phosphatase) or HRP (horseradish 
peroxidase) in TBS-T. The binding was performed at room temperature for 2 h. The membrane was 
washed 3x 5 min in TBS-T to remove the unbound secondary antibodies. For AP staining, the 
membrane was equilibrated for 5 min shaking in AP buffer (100 mM Tris base pH 9.5, 100 mM 
NaCl, 5 mM MgCl2). Staining was performed by the BCIP/NBT Color Development Substrate 
(Promega) with 33 µL BCIP (50 mg/mL) and 66 µL NBT (50 mg/mL) in 10 mL AP buffer. After a 
MATERIAL AND METHODS 
 
 60  
maximum of 30 min the reaction was terminated in MQ-H2O. HRP staining was performed using 
the Lumi-Light Western Blotting Substrate (Sigma) according to the supplier’s manual. The protein 
was detected in a Fujifilm LAS-3000 Imager. 
The antibodies used in this work are listed in Table 2.44. If not stated otherwise, the detection of 
Tmprss2 constructs was performed in this work with a mouse-produced ANTI-FLAG M2 primary 
IgG monoclonal antibody (Sigma) and an AP-conjugated goat anti-mouse secondary IgG 
polyclonal antibody (Promega).  
Table 2.44. Antibodies used for Western blots. 
Antibody Type Working Concentration Supplier 
Mouse α-Flag  
monoclonal 
primary 
1:4000 in blocking solution or TBS-T Sigma (F3165) 
Mouse IgG1 α-His-Tag  
monoclonal 
primary 
1:2000 in TBS-T Merck (#70796) 
Goat α-mouse IgG (H+L)-AP 
polyclonal 
secondary  
1:7500 in TBS-T Promega (S3721) 
Goat α-mouse IgG(H+L)/IgM-HRP 
polyclonal 
secondary 
1:3000 in TBS-T Dianova (115-035-062) 
Rabbit α-PR8HA (H1) 
polyclonal 
primary 
1:4000 in blocking solution or TBS-T Sino Biological (11684) 
Goat Anti-Rabbit IgG (H+L)-AP  
polyclonal 
secondary 
1:5000 in TBS-T Bio-Rad (#1706518) 
 
 Slot blotting  
Slot blots allow loading liquid samples containing the target protein directly onto a nitrocellulose or 
PVDF membrane for immunostaining. In contrast to Western blotting, the slot blot allows to 
quickly use the sensitivity of immunostaining without the need to perform SDS-PAGE first. Since 
the transfer is usually realized by pulling the sample liquid through the membrane with applied 
vacuum, it is possible to load greater amounts of the sample into one concentrated spot on the 
membrane compared to SDS-PAGE and Western blot. However, the samples are not separated by 
size on a slot blot. Also, staining due to cross-reactivity of the applied antibody (background/noise) 
cannot be separated from the true signal. Hence, slot blotting only comprises a preliminary 
expression screening to compare different clones and select the most promising ones for further 
analyses. In this work, slot blots were performed with a Minifold® II Slot-Blot Manifold System 
(Cole-Parmer, Vernon Hills, Illinois, USA) for high throughput expression screenings of Tmprss2. 
The apparatus was prepared according to the manufacturer’s guidelines with a PVDF membrane 
(Immobilon-P, Merck). The preparation of the membrane followed the same method (including 
buffers and solutions) described in chapter 2.9.3. 150 to 300 µL of P. pastoris culture supernatant 
were loaded per slot. Vacuum was only applied as briefly as possible, until the samples had been 
completely pulled through. Immunostaining was performed as described in chapter 2.9.3. 
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 Mass spectrometry 
MALDI-TOF (Matrix Assisted Laser Desorption Ionization – Time-Of-Flight) mass spectrometry 
(MS) was used to identify protein fragments of SDS-PAGE samples. To prepare the samples for 
tryptic digestion, the corresponding bands were cut out of stained SDS gels and transferred into 
1 mL of MQ-H2O. After a tryptic digest, proteins were co-crystallized with organic acids. 
Desorption of protein fragments was triggered by a UV laser beam. The TOF measurements 
exposed mass-to-charge ratios of the ions. This data was compared with the MASCOT database to 
identify the analyzed proteins. All MS analyses were conducted by MS platform of the research 
group Cellular Proteomics (CPRO) at the HZI (Braunschweig, Germany).  
For intact mass analyses by ESI (Electrospray Ionization), the buffer of purified protein samples 
was changed to MQ-H2O to remove any residual salt by 3x complete buffer exchange on Viva Spin 
500 µL columns (Sartorius). The samples were immediately handed in for MS analysis. 
 Enzymatic in vitro activity test of recombinant Tmprss2 
The enzymatic activity of Tmprss2-WT and Tmprss2-D343N was analyzed through a preliminary 
activity assay in vitro. Recombinant hemagglutinin H1 produced in Hi5 cells (produced by 
Margitta Schürig, research group Recombinant Protein Expression, HZI) was used as a substrate 
for the reaction. 10 ng of either Tmprss2-D343N or Tmprss2-WT were mixed with 10 µg of H1 
and incubated in 50 mM Tris-HCl buffer, pH 7.4 with 150 mM NaCl at 37 °C. Control reactions 
without Tmprss2 were performed in parallel. Samples were taken after 3 h and 16 h and boiled in 
SDS sample buffer and SDS-PAGE was performed (§ 2.9.1). The samples were analyzed by 
Western blot (§ 2.9.3). H1 was detected with a rabbit α-PR8HA (H1) primary antibody and a goat 
α-rabbit AP-coupled secondary antibody (§ Table 2.44). 
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3 Results 
3.1 Establishment of a RMCE system in P. pastoris 
The generation of P. pastoris producer cell lines by homologous recombination is usually a time-
intensive task, because depending on the target protein, extensive expression screens are required 
to identify a high producer (“jackpot”) clone. The recombination mediated cassette exchange 
(RMCE) allows for the introduction of any gene of interest (GOI) into a specifically “tagged” 
genomic locus of a RMCE master cell line (MCL), which harbors an exchangeable RMCE cassette. 
This should result in clones with uniform product yields. Moreover, these product yields should 
scale with the expression of a model GOI / marker protein present inside the RMCE tagging 
cassette before the cassette exchange. Hence, the RMCE presents a promising approach for the fast 
generation of P. pastoris producer cell lines with predictable expression results.  
For this reason, it had to be evaluated, whether the RMCE system could be established in 
P. pastoris through an initial model system. Furthermore, it had to be tested, whether the cassette 
exchange would indeed result in producer clones with comparable expression levels of the GOI.  
 Experimental design of the RMCE system in P. pastoris 
The initial aim for the establishment of the RMCE system in P. pastoris was to develop a pilot 
system in order to provide a proof of principle for the functionality of the system in the yeast 
expression host. Therefore, a P. pastoris RMCE MCL should be generated through the insertion of 
an exchangeable RMCE cassette with all necessary genetic elements (“tagging”).  
The versatile multi-host vector pFlpBtM harbors all needed elements to serve as a donor vector for 
the RMCE (§ 1.4). Hence, the P. pastoris RMCE tagging cassette was designed to be compatible to 
pFlpBtM as a beneficial, straightforward way to also expand to the multi host expression system 
(mHost-XS) to P. pastoris. The exchange cassette of pFlpBtM relies on the presence of a stable, 
“endogenous” promoter upstream of the RMCE cassette to drive the expression of a gene of 
interest (GOI). The GAP promoter was selected to fulfill this task in P. pastoris, because it 
provides strong, constitutive gene expression. Concomitantly, it was decided to direct the RMCE 
tagging cassette to the genomic GAP locus by homologous recombination in the pilot phase to 
ensure comparability of the results without the risk of locus-dependent influences.  
The principal setup of the envisioned RMCE cassette is shown in Figure 3.1. The exchangeable 
cassette flanked by the FRT sites F3 and FWT resides downstream of the GAP promoter. The 
cassette comprises the gene encoding the red fluorescent protein RudolphRFP as a model GOI to 
track the expression level of a generated P. pastoris RMCE MCL. Moreover, the Sh ble selection 
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marker was inserted into the tagging cassette to enable stringent primary selection of the 
transformed clones. Downstream of the RMCE tagging cassette, an inactive selection gene 
(“selection trap”) is located. The selection trap lacks both an ATG start codon and a promoter in 
order to suppress its expression. The choice of a specific selection trap gene for P. pastoris was 
based on the fact that the yeast beneficially offers the use of amino acid biosynthesis genes as 
auxotrophic selection markers in combination with a suitable mutant strain. The application of an 
auxotrophic selection trap would enable a cost-efficient alternative selection method for exchanged 
clones in comparison to the cost-intensive antibiotic selection traps used in eukaryotic cell culture. 
Therefore, the His4 gene was selected to serve as a pioneer model for the establishment of an 
auxotrophic selection trap for P. pastoris (Δhis4). Consequently, the histidine auxotroph P. pastoris 
strain GS115 (his4) was selected to generate the model RMCE MCL.  
 
Figure 3.1. Schematic view of the envisioned RMCE tagging cassette in P. pastoris GS115.  
The RudolphRFP marker gene (RFP) and the Zeocin antibiotic selection gene Sh ble (ZeoR) are flanked by FRT 
F3 and FWT. PGAP: P. pastoris GAP promoter to drive expression of any model protein or exchanged GOI. Δhis4: 
His4-based selection trap without ATG start codon and promoter. The transcription terminators of RFP and 
Δhis4 as well as the promoter and the transcriptional terminator of ZeoR were omitted from graphical display 
for simplifying reasons. 
 Construction of the P. pastoris RMCE tagging vector and 
generation of the pilot RMCE master cell line 
For the generation of the P. pastoris RMCE MCL, the tagging vector was cloned with the desired 
features (§ 3.1.1), as described in detail in chapter 2.3. Briefly, the vector pGAPZα-A (Thermo 
Fisher Scientific) was chosen as a basis for the tagging vector, as it harbors the genomic GAP 
promoter. In the first step, the secretion signal sequence (MF-α ss) present on pGAPZα-A was 
deleted to allow for intracellular expression. Compared to pGAPZ-A (Thermo Fisher Scientific), 
the modified plasmid lacked an 8 bp spacer sequence between the BstBI and EcoRI restriction sites 
of the multi cloning site (“Δ8”). In addition, an Ampicillin resistance cassette was inserted into the 
vector for cost-efficient selection in E. coli. The resulting plasmid was designated as pGAPZAΔ8.  
In the next steps, the RMCE cassette and the Δhis4 gene were inserted into pGAPZAΔ8 
downstream of the GAP promoter. The 3’ border of the RMCE cassette was cloned to harbor a 
complemented Δhis4 gene (“ATG start codon – FRT FWT – Δhis4”) downstream of the TEF1/EM7 
promoter, replacing the Zeocin resistance gene (Sh ble) on the vector. The resulting vector was 
named pYEXs (“yeast exchange simulation”), because it harbors the sequence of a RMCE cassette 
with a complemented Δhis4 as it should look like after a cassette exchange. The vector pYEXs was 
used to clone a set of variant vector constructs to test the functionality and selectivity of Δhis4 
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under the control of different foreign promoters. The results of this test are presented in chapter 
3.1.3. The tagging vector was generated in two additional cloning steps from pYEXs. First, the 
Zeocin resistance cassette was inserted back into the vector, replacing the “TEF1/EM7 promoter – 
ATG” combination to render Δhis4 inactive again. The vector product was named pYTA (“yeast 
tagging”). Secondly, the RudolphRFP gene was incorporated into the MCS of pYTA downstream 
of the GAP promoter and FRT F3. The resulting tagging vector was designated as  
pYTA-RudolphRFP (Figure 3.2). 
 
Figure 3.2. Vector map of pYTA-RudolphRFP.  
The vector comprises a pBR322 ori, an ampicillin resistance cassette (AmpR) for bacterial selection. The RMCE 
tagging cassette flanked by FRT F3 and FRT FWT is located downstream of the GAP promoter. It includes 
RudolphRFP as a fluorescent marker gene and a Zeocin resistance (ZeoR) cassette for bacterial and yeast 
selection. Downstream of the RMCE cassette, the inactive selection trap Δhis4 is located (d(his4)). The image 
was created with the software Vector NTI Suite 8 (Thermo Fisher Scientific). Cyan arrows: eukaryotic 
promoters. Dark red arrows: prokaryotic promoters. Orange arrows: coding sequences and origin of 
replication (ori). Blue bars: transcriptional terminator sequences (TT). 
The tagging vector pYTA-RudolphRFP was linearized inside the GAP promoter and stably 
transformed into P. pastoris GS115 by electroporation to generate the RMCE MCL (§ 2.6.9). Low 
amounts of DNA (~25 ng) were used to avoid multi copy vector insertions. The transformed cells 
were selected on YPDS Zeocin agar plates. Eight single clones were isolated and tested by two 
PCR reactions from genomic DNA (§ 2.6.11). For simplification, clones will be designated 
according to the strain name and the vector (e. g. GS115/pYTA-RudolphRFP) from here on.  
The first PCR (PCR1) was performed to validate the presence of the integrated vector through the 
amplification of a fragment of the vector containing FRT F3 and RudolphRFP. The second PCR 
(PCR2) was conducted to differentiate between single copy clones and multi copy clones. Herein, a 
fragment was amplified, which would only be formed in case of tandem insertions of the vector 
pYTA-RudolphRFP
7887 bp
d(his4)
c myc
6xHis
AmpR
Zeo(R)
RudolphRFP
FRT F3
GAP promoter
TEF1 promoter
AmpR-Prom
EM7 promoter
PBR322 ori
AOX1 TT
His4 TT
CYC1 TT
CYC1 TT (partial)
FRT Fwt
BamHI (1647)
Eco RI (537)
HindIII (2882)
Avr II (191)
Bst BI (486)
Not I (1228)
Spe I (7883)
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into the genome. This was done to ensure comparability of the different clones and to prevent the 
risk of undefined RMCE reactions due the presence of recombinable cis elements in case of tandem 
copies. A schematic depiction of the PCR strategy and the results are shown in Figure 3.3. The 
used primers and the expected fragment sizes are listed in Appendix II. The majority of the clones 
(apart from clone 5) were identified as single insertion clones.  
 
Figure 3.3. Validation of P. pastoris RMCE MCL by genomic PCR.  
(A) The vector insertion is illustrated by the orange and grey colors of the GAP promoter from the vector and 
the genome, respectively. The PCR product to test the insertion of the vector into the genome is shown in red 
and spans over the gene of interest. A second PCR product (blue) can only occur in case of tandem insertions 
of the vector into the genome, as depicted for two inserted copies in the scheme. This allows differentiating 
between single copy and multi copy insertions. (B) The PCR products were loaded onto a 0.8% agarose gel, 
which was stained with ethidium bromide following gel electrophoresis. The bands indicate that all clones 
apart from clone 5 harbor single copy insertions of the vector. Numbers 1-8 indicate clone numbers. NC is a 
negative control of PCR 1 with genomic DNA of untransformed P. pastoris GS115. V1 and V2 are PCRs 1 and 2 
with vector DNA of pYTA-RudolphRFP. 
 Evaluation of the novel selection trap Δhis4 in P. pastoris 
The His4 gene was chosen as a model for a novel amino acid biosynthesis based / auxotrophic 
selection trap (Δhis4) in P. pastoris. The complementation of Δhis4 following a RMCE reaction 
should restore the prototrophy of the P. pastoris strain GS115 (his4), enabling it to grow on 
histidine drop-out minimal medium. To determine the applicability of Δhis4, two major key points 
had to be assessed: First, its selectivity in both complemented and non-complemented states and 
secondly, its expression under the control of the foreign promoters from putative RMCE donor 
vectors. The growth of P. pastoris cell lines harboring a complemented Δhis4 gene under the 
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control of different promoters was analyzed in comparison to the RMCE MCL with the supposedly 
inactive selection trap on selective minimal medium.  
For this, a set of vectors was cloned from pYEXs (§ 3.1.2), which harbors the complemented Δhis4 
gene under the control of the TEF1/EM7 promoter, as described in chapter 2.3. The TEF1/EM7 
promoter was known to be functional in P. pastoris. Hence, the main purpose of pYEXs-yeGFP 
was to evaluate the functionality of the complemented Δhis4. Additionally, two heterologous 
promoters were analyzed for their capability to induce the expression of the complemented Δhis4 
in P. pastoris. The first promoter was the human PGK1 (hPGK) promoter, present on the 
envisioned RMCE donor vector, pFlpBtM. The second promoter was the OpIE1 promoter from 
Orgyia pseudotsugata, which was a possible candidate to succeed the hPGK promoter used in the 
exchange cassette of pFlpBtM. In a first step to generate the respective vectors, the y-eGFP gene 
was cloned into pYEXs as a model GOI. This was done to additionally evaluate the intensity of the 
fluorescence of y-eGFP in comparison to RudolphRFP in this experiment. The resulting vector was 
named pYEXs-yeGFP. The two heterologous promoter candidates were then respectively cloned 
into pYEXs-yeGFP, replacing the TEF1/EM7 promoter. The vectors were designated as 
pYEXsPGK-yeGFP and pYEXsOpi-yeGFP. The vector maps are depicted in Appendix IV.1. 
The three pYEXs variants (pYEXs-yeGFP, pYEXsPGK-yeGFP and pYEXsOpi-yeGFP) were 
linearized and stably transformed into P. pastoris GS115 (§ 2.6.10). Primary selection of the 
transformed clones was performed on minimal dextrose medium (MD) plates without 
supplemented histidine. Following single clone isolation, the clones were validated for single 
vector copy insertion by genomic PCR (§ 2.6.11). As described in chapter 3.1.2, two PCR reactions 
were performed per sample to validate the genomic insertion of the vector and to identify single 
copy clones. The first PCR comprised a fragment of the promoter upstream of the selection trap 
and FRT FWT. The second PCR was used to amplify a product, which would only be formed in case 
of a tandem vector copies. A scheme of the PCR strategy and the PCR results are shown in Figure 
3.4. The expected band sizes and the used primers are shown in Appendix II.  
For each GS115/pYEXs variant, the single clones 3 and 6 were selected to perform the growth 
experiment. Additionally, the RMCE MCL clones GS115/pYTA-RudolphRFP 1 and 2 (§ 3.1.2) 
were also included in this experiment to assess the selectivity of the inactive Δhis4. All clones were 
serially diluted in 1 M sorbitol solution from freshly grown colonies and dropped onto MD 
(minimal dextrose) and MDH (MD + histidine) agar plates, as described in chapter 2.6.12. The 
growth of the clones after 48 h is depicted on Figure 3.5. The RMCE MCL could not grow on MD, 
but only on MDH. In contrast, all GS115/pYEXs variant clones were able to grow on MD at 
comparable levels. Based on these results, it could be concluded that Δhis4 is feasible as a selection 
trap in P. pastoris. It is inactive in the RMCE MCL and its functionality is only restored by 
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complementation. Furthermore, the “complementingly restored” His4 protein was expressed at 
selective levels under the control of all three tested promoters with visually comparable levels of 
growth. This shows that the heterologous hPGK and OpIE1 promoters do not present an obstacle 
for the use of pFlpBtM as a RMCE donor vector in P. pastoris.  
 
Figure 3.4. Validation of P. pastoris RMCE exchange simulation cell lines by genomic PCR.  
(A) The vector insertion is illustrated by the orange and grey colors of the GAP promoter from the vector and 
the genome, respectively. The PCR product to assess the insertion of the vector into the genome is shown in 
red. It covers the respective promoter region. A second PCR product (marked in blue) will only be formed, if 
the vector is inserted multiple times in tandem copies, as depicted for two inserted copies in the picture. 
Single insertion clones were desired to ensure comparability of the different variants. (B) The PCR products 
were loaded onto a 0.8% agarose gel, which was stained with ethidium bromide following gel electrophoresis. 
The digits indicate the clone numbers. Vector names indicate the stably transformed plasmid. Negative 
control reactions of PCR1 and PCR2 were performed with unmodified GS115 cells (N1-N4), while the positive 
controls were amplified from the respective vector DNA (V1-V4). Most of the analyzed clones were single 
insertion clones (no signal in PCR2), which were usable for further analysis. 
Finally, this experiment shows that the proposed concept of auxotrophic selection traps is 
applicable in P. pastoris. The feasibility of Δhis4 delivers a proof of principle. It is conceivable that 
the results obtained for Δhis4 can be transferred to other amino acid biosynthesis genes using 
respective auxotrophic mutant strains (e. g. arg4). Furthermore, the concept should be generally 
RESULTS 
 
 68  
usable independently of the RMCE system. All in all, the use of auxotrophic selection traps 
presents a novel, cost-efficient alternative to antibiotic selection traps in P. pastoris. 
 
Figure 3.5. Evaluation of selection trap Δhis4 by growth on selective minimal medium.  
The scheme on the left-hand side shows the schematic cassettes of each variant. The experiment was 
performed with clones 1 and 2 of the RMCE MCL (1) as well as clones 3 and 6 of each exchange simulation 
variant (2-4). All tested clones were identified as single insertion clones. The cells were respectively dropped 
onto agar plates with minimal dextrose medium (MD) and MD supplemented with histidine (MD+His) in 
three different dilutions. Growth was documented after 48 h at 30 °C (right-hand side of the figure). The 
RMCE MCL (1) with the putatively inactive Δhis4 gene could not grow on MD. In contrast, all exchange 
simulation cell lines (2-4) with the complemented Δhis4 (His4+) could grow on MD. The complementation of 
Δhis4 under the control of all three tested promoters (TEF1, hPGK and OpIE1) resulted in similar levels of 
growth. All clones could grow on the control agar plate (MD+His). 
 Evaluation of marker protein expression in the P. pastoris pilot 
RMCE master cell line 
During the selection trap analysis (§ 3.1.3) neither the pilot RMCE MCL nor the GS115/pYEXs 
variant clones visibly expressed RudolphRFP or y-eGFP under the control of the constitutive GAP 
promoter. Hence, the expression was analyzed and the role of several structural elements causing 
this possible bottleneck in expression was evaluated. 
3.1.4.1 Investigation of the influence of structural elements of the RMCE cassette on gene 
expression in P. pastoris 
The RMCE cassette of the pilot RMCE MCL was designed to be compatible to pFlpBtM as a 
donor vector. Hence, the FRT F3 site is located between the “endogenous” GAP promoter and the 
model GOI (RudolphRFP or y-eGFP). In regard of the expression cassette of the GOI, the presence 
of FRT F3 in this position comprises the major difference between the generated vectors 
pYTA/pYEXs and the commercially available pGAPZ vectors (Thermo Fisher Scientific). For this 
reason, it was speculated that FRT F3 in its current location might negatively influence the GAP 
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promoter based expression of the fluorescent marker proteins in P. pastoris. However, it was not 
known, how strong this influence was or whether it was caused by an unknown, exclusive cross-
interaction of FRT F3 and the GAP promoter. 
To evaluate this, the AOX1 promoter was cloned into the tagging vector pYTA-RudolphRFP, 
replacing the GAP promoter. The AOX1 promoter is the strongest available, native promoter in 
P. pastoris. If the expression of the combination “promoter – F3 – GOI” is not restored by this 
promoter, then it is conceivable that no other promoter would be able to overcome this bottleneck 
in P. pastoris. In addition to the AOX1 promoter, the modified tagging vector was designed to 
harbor the genomic 3’-AOX1 region downstream of the selection trap. This was done to mediate a 
more stringent single insertion of the tagging vector via double crossing over and gene 
replacement. In consequence of this strategy, the vector linearization to transform P. pastoris was 
performed with BglII. Since RudolphRFP harbors an internal BglII restriction site, it was replaced 
with mCherry in the AOX1 tagging vector. The final vector was named pYTAaox-mCherry. 
In addition to the AOX1 tagging vector, a set of “classical” GAP and AOX1 producer cell lines was 
generated for a comparative expression experiment of the fluorescent marker proteins 
RudolphRFP, y-eGFP and mCherry. The respective genes were cloned into the vectors 
pGAPZAΔ8 (§ 3.1.2) and pPICZ-A (Thermo Fisher Scientific). In total, six vectors were  
cloned: pPICZ-RudolphRFP, pPICZ-y-eGFP, pPICZ-mCherry, pGAPZAΔ8-RudolphRFP,  
pGAPZAΔ8-yeGFP and pGAPZAΔ8-mCherry. The detailed cloning strategy of all generated 
vectors is described in chapter 2.3. The vector maps are depicted in Appendix IV.2. The six test 
vectors and the AOX1 tagging vector were respectively linearized and transformed into P. pastoris 
GS115 as described in chapter 2.6.10. Positive clones for each transformed construct were selected 
on YPDS Zeocin agar plates. After single clone isolation, single copy insertion of the vector was 
evaluated by genomic PCR (§ 2.6.11) in two reactions, as described before in chapter 3.1.2. The 
first PCR (PCR1) was conducted to validate the stable integration of the vector. The second PCR 
(PCR2) was performed to identify single copy insertion clones. The expected band sizes of the 
PCR products and the used primers are listed in Appendix II. The results are depicted in Figure 3.6, 
Figure 3.7 and Figure 3.8.  
Two single insertion clones per vector transformation were isolated to evaluate the expression of 
the fluorescent proteins under the control of the AOX1 and the GAP promoter with and without 
FRT F3 residing between promoter and GOI. For all generated cell lines, the clones 1 and 2 were 
selected – except for GS115/pPICZ-RudolphRFP, for which the clones 2 and 3 were used. The 
selected clones were incubated in 100 mL shake flask cultures according to chapter 2.8.1. The 
previously generated GAP RMCE MCL was additionally included in the analysis (GS115/pYTA-
RudolphRFP, clones 1 and 2, § 3.1.2). For the expression of the fluorescent markers under the 
control of the GAP promoter, the clones were cultivated in BMDY medium (glucose as a carbon 
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source). For the AOX1 promoter driven expression of the marker proteins, the clones were first 
grown in BMGY medium (glycerol) and then transferred to BMMY medium to induce the 
expression (methanol as a carbon source). After 48 h of expression, samples of all cultures were 
taken and analyzed under UV light (330 nm) for visible fluorescence (Figure 3.9). 
Significantly visible expression was obtained from all six fluorochrome test cell lines without FRT 
F3. In contrast, both RMCE MCLs (AOX1 and GAP) did not show any expression. Even the strong 
AOX1 promoter did not restore the expression to visible levels. This shows that the bottleneck in 
expression cannot be overcome in this way. Moreover, in regard of the expression cassette 
“Promoter – GOI – Terminator”, the presence of FRT F3 between promoter and GOI comprises the 
major difference between the test cell lines and the RMCE MCLs. The expression was significantly 
hampered for both promoters only in the presence of FRT F3. This strongly supports the hypothesis 
that FRT F3 is the critical genetic element causing the negative impact on the expression of the 
fluorescent marker proteins (RudolphRFP and mCherry) in P. pastoris. 
 
Figure 3.6. Validation of P. pastoris fluorochrome expression test cell lines by genomic PCR.  
(A) Simplified scheme showing the PCR products of the stably inserted fluorochrome test vectors based on 
pPICZ-A. Orange/grey arrow: AOX1 promoter (bicolored to indicate the homologous recombination); blue 
box: origin of replication (ori); AOX1 (dark grey): genomic AOX1 gene. Two PCRs were performed to evaluate 
the clones. PCR 1 (red) comprises the GOI to validate the insertion of the vector into the genome. PCR2 (blue) 
will only be yield a product in case of tandem insertions, as depicted for two inserted vector copies in the 
figure. (B) Results of the electrophoresis of the PCR products on 0.8% agarose gels, which were stained with 
ethidium bromide. The vector names denote the respective plasmid used to transform P. pastoris GS115. The 
digits indicate the clone numbers. Negative control reactions were performed with unmodified GS115 cells 
(PCR1: N1-N3 / PCR2: N4). All clones showing a signal in PCR2 present multi copy clones and were not used 
in the further analysis. The majority of the clones present single copy insertions. 
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Figure 3.7. Validation of P. pastoris GAP fluorochrome expression test cell lines by genomic PCR.  
(A) Simplified scheme showing the PCR products of the stably inserted fluorochrome test vectors based on 
pGAPZAΔ8. Light orange/grey arrow: GAP promoter (bicolored to indicate the homologous recombination); 
blue box: origin of replication (ori); GAP (dark grey): genomic GAP gene. Two PCRs were performed to 
evaluate the clones. PCR 1 (red) comprises the GOI to validate the insertion of the vector into the genome. 
PCR2 (blue) will only be yield a product in case of tandem insertions, as depicted for two inserted vector 
copies in the figure. (B) Results of the electrophoresis of the PCR products on 0.8% agarose gels, which were 
stained with ethidium bromide. The vector names denote the respective plasmid used to transform P. pastoris 
GS115. The digits indicate the clone numbers. Negative control reactions were performed with unmodified 
GS115 cells (PCR1: N1-N3 / PCR2: N4). All clones showing a signal in PCR2 present multi copy clones and 
were not used in the further analysis. The majority of the clones present single copy insertions. 
 
 
Figure 3.8. Validation of the P. pastoris AOX1 
RMCE MCL by genomic PCR.  
(A) Simplified scheme showing the PCR products of 
the stably inserted tagging vector pYTAaox-
mCherry. Orange/grey arrow: AOX1 promoter; 
orange box: 3’-AOX1 region. Two PCRs were 
performed to evaluate the clones. PCR 1 (red) 
comprises the GOI to validate the insertion of the 
vector into the genome. PCR2 (blue) will only be 
yield a product in case of tandem insertions, as 
depicted for two inserted vector copies in the figure. 
(B) Results of the electrophoresis of the PCR 
products on 0.8% agarose gels, which were stained 
with ethidium bromide. The vector names denote 
the respective plasmid used to transform P. pastoris 
GS115. The digits indicate the clone numbers. Since 
the PCR reactions were performed in parallel to the 
ones used for the fluorochrome test cell lines, the 
control reactions are covered by samples N1-N4 in 
Figure 3.7. C1-C5 present single insertion clones 
showing only a signal in PCR1. 
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Figure 3.9. Expression of mCherry, y-eGFP and RudolphRFP under the control of the AOX1 promoter and 
the GAP promoter from P. pastoris GS115 transformed with vectors with or without FRT F3.  
Samples were documented after 48 h of expression under ambient light and UV light (330 nm). The 
fluorochrome test cell lines without FRT F3 are depicted by the name of the transformed fluorescent marker 
(mCherry, y-eGFP, RudolphRFP). The AOX1 RMCE MCL is depicted as F3-mCherry, the GAP RMCE MCL as 
F3-RudolphRFP. Two single insertion clones of each cell line were analyzed. The groups “AOX1 Promoter” 
and “GAP Promoter” indicate the clones expressing the GOI respectively under the control of the AOX1 or the 
GAP promoter. Empty GS115 cells served as a negative control (NC). All test cell lines without FRT F3 show 
visible fluorescence. In contrast, both RMCE MCL clones only display auto fluorescence (also visible for the 
NC), but do not show any expression of the respective RFP marker protein.  
3.1.4.2 Insertion of the GAP promoter inside of the AOX1 RMCE tagging cassette  
It was observed that the expression of fluorescent marker genes is hindered in the presence of FRT 
F3 between promoter and GOI. To initially test whether a different position of FRT F3 would 
provide a simple way to restore gene expression, the GAP promoter was inserted downstream of 
FRT F3 as part of the exchangeable cassette of the AOX1 tagging vector pYTAaox-mCherry. The 
resulting expression cassette of mCherry (“Promoter – mCherry – Terminator”) would be virtually 
identical to the vector pGAPZAΔ8-mCherry, which had led to visible marker expression in 
previous experiment (§ 3.1.4.1). If this modification would already restore expression, it would 
even conveniently allow using the existing AOX1 RMCE MCL (§ 3.1.4.1) with a modified RMCE 
donor vector to perform the cassette exchange.  
The GAP promoter was inserted into pYTAaox-mCherry between FRT F3 and mCherry (§ 2.3). 
The vector product was named pYTAaox-GAP-mCherry. The vector maps are depicted in 
Appendix IV.3. The vector was transformed into P. pastoris GS115 in two different ways. First, the 
vector was linearized inside the AOX1 promoter and the 3’AOX1 region to insert it into the 
genomic AOX1 locus. Thereby, a RMCE MCL was generated, which should lead to the expression 
of mCherry under the control of the GAP promoter. The resulting clones were named 
GS115/pYTAaox-GAP-mCherry(AOX1). Secondly, as an additional control, the vector was linearized 
inside the GAP promoter to direct it to the genomic GAP locus instead of the AOX1 locus. Thereby, 
the combination of AOX1 promoter and FRT F3 was placed upstream of the genomic GAP gene. 
The resulting clones were named GS115/pYTAaox-GAP-mCherry(GAP). A schematic overview of 
these insertions is presented in Figure 3.10A.  
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Primary selection and single clone isolation were performed on YPDS Zeocin plates. Following the 
primary selection, the control integration of the vector into the GAP locus (GS115/pYTAaox-GAP-
mCherry(GAP)) resulted in only five grown colonies with reduced growth rates. In contrast, a 
significantly higher amount of grown colonies was observed for GS115/pYTAaox-GAP-
mCherry(AOX1). The corresponding transformation plates after primary selection are depicted in 
Figure 3.10B. Single clones were isolated for GS115/pYTAaox-GAP-mCherry(AOX1) and 
GS115/pYTAaox-GAP-mCherry(GAP). 
 
Figure 3.10. Overview of the respective transformations of pYTAaox-GAP-mCherry into P. pastoris GS115.  
(A) The scheme of pYTAaox-GAP-mCherry integrating into the genomic AOX1 locus (red; AOX1-F3-GAP 
RMCE MCL) or the GAP locus (blue; control cell line) is shown. (B) YPDS Zeocin agar plates of the 
transformed GS115 clones after growth for 72 h of growth at 30 °C. It is shown that the insertion of the vector 
into the AOX1 locus led to significantly higher amounts of colony forming units compared to the insertion 
into the GAP locus. The RFP mCherry is not expressed at visible levels.  
The purified clones were validated by genomic PCR (§ 2.6.11). Two reactions per clone were 
performed to verify the integration of the vector into the genome and to identify single insertion 
clones, as previously described (§ 3.1.2). A schematic overview and the results are shown in Figure 
3.12 (A and B). The used primers and the expected band sizes are listed in Appendix II. All clones 
of GS115/pYTAaox-GAP-mCherry(AOX1) were shown to be single insertion clones. In contrast, the 
five clones of GS115/pYTAaox-GAP-mCherry(GAP) were proven to be false-positives by the 
genomic PCR analysis. The isolated clones were respectively streaked out again on fresh YPD agar 
RESULTS 
 
 74  
plates to assess the expression of mCherry in comparison to the previously tested clones 3 and 6 of 
GS115/pGAPZAΔ8-mCherry (§ 3.1.4.1). The plates were documented after 72 h of incubation 
(Figure 3.11C). No expression of mCherry was observed from GS115/pYTAaox-GAP-
mCherry(AOX1) or the false-positive clones of GS115/pYTAaox-GAP-mCherry(GAP). However, 
mCherry was visibly expressed from GS115/pGAPZAΔ8-mCherry.  
Taken together, the results show that the expression of mCherry was not restored by placing the 
GAP promoter inside the AOX1 tagging cassette. The “AOX1 promoter – FRT F3” combination 
upstream of the GAP promoter is interfering with the activity of the downstream GAP promoter. 
This was deduced for two reasons. First, the integration of the vector into the AOX1 locus resulted 
in a lack of fluorescent cells. The substantial difference between pYTAaox-GAP-mCherry and the 
pGAPZAΔ8 derived fluorochrome test vectors (§ 3.1.4.1) regarding the expression cassette “GAP 
promoter – mCherry – Terminator” is the presence of the upstream “AOX1 promoter – FRT F3” 
combination. Secondly, the control insertion into the GAP locus did not yield any positive clones. 
Directed insertion should result in the “AOX1 promoter – FRT F3” combination residing upstream 
of the endogenous GAP gene (Figure 3.10A). If the GAP promoter is indeed knocked out by this 
combination, then this would result in a lack of glyceraldehyde-3-phosphate dehydrogenase (GAP). 
This would explain the notable absence of positive clones, since the GAP is an essential enzyme 
for cell maintenance and survival. However, the experiment left open which of the two elements 
(FRT F3 site or AOX1 promoter) was responsible for the lack of expression.  
FRT F3 had already been shown to lead to a lack of expression in a position between promoter and 
GOI (§ 3.1.4.1). Hence, it might still play a role in its current position upstream of the GAP 
promoter. The AOX1 promoter could also be the responsible element, as it is tightly repressed 
under glucose conditions. This regulatory repression might have influenced the downstream 
residing GAP promoter. Finally, the lack of expression could have been caused by an undefinable 
influence through combined effects by overlapping sequences or spacing of the genetic elements. 
In the end, the results clearly show that the modified RMCE MCL GS115/pYTAaox-GAP-
mCherry(AOX1) did not present a viable alternative for the establishment of the RMCE in P. pastoris.  
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Figure 3.11. Analysis of the AOX1-F3-GAP RMCE MCL and the respective control insertion.  
(A) Simplified scheme of the possible PCR products following the insertion of pYTAaox-GAP-mCherry into 
the AOX1 or the GAP locus of P. pastoris GS115. Dark orange arrow: AOX1 promoter; dark orange box: 
3’AOX1; green arrow: FRT F3; light orange/grey arrow: GAP promoter (bicolored depiction indicates 
homologous recombination). Two PCRs were performed to evaluate the clones. PCR 1 (red) comprises the 
GOI to validate the insertion of the vector into the genome. PCR2 (blue) will only yield a product in case of 
tandem insertions, as indicated for two vector copies in the picture. (B) Results of the electrophoresis of the 
PCR products on 0.8% agarose gels stained with ethidium bromide. The digits represent the clone numbers. 
The control reactions apply for both sets of clones. For N1 and N2, genomic DNA from untransformed GS115 
cells was used as a negative control. For V1 and V2, the PCR was conducted with the vector as a positive 
control. None of the AOX1-F3-GAP RMCE MCL clones showed tandem insertions. All of the control clones 
(GAP insertion) were false positives, which did not show any PCR product. (C) Restreaks of the clones on 
YPD agar plates. Digits indicate the clone numbers. As a positive control, clones 3 and 6 of 
GS115/pGAPZAΔ8-mCherry (§ 3.1.4.1) were additionally incubated in two technical replicates (A, B). Only 
the positive control showed visible expression of mCherry after incubation at 30 °C for 72 h.  
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3.1.4.3 Design and generation of modified P. pastoris RMCE master cell lines 
In the previous experiments, it was observed that the pilot RMCE MCL (GS115/pYTA-
RudolphRFP) did not show any expression of RudolphRFP. FRT F3 was identified to cause the 
lack of expression in a position between promoter and GOI (§ 3.1.4.1). However, the mechanism of 
this reduction in expression remained unclear. The bottleneck in expression could not be solved by 
placing the GAP promoter inside the tagging cassette of pYTAaox-mCherry (§ 3.1.4.2). Hence, 
new variants of the RMCE tagging cassette were designed and generated by repositioning FRT F3. 
The experiment was conducted to evaluate three important key points.  
1. It should be validated that FRT F3 was the single, specific element inside the tagging vector to 
be responsible for the observed lack of expression.  
2. Furthermore, it should be assessed, if the negative influence of FRT F3 on the expression of 
the model GOIs occurs on the level of transcription or the level of translation. 
3. Finally, a viable alternative to the pilot RMCE MCL with restored expression of the GOI 
should be identified in order to establish the RMCE system in in P. pastoris. 
To do this, a new set of P. pastoris RMCE tagging vectors was designed and cloned to generate 
additional RMCE MCL variants. All vectors were designed to be directed to the genomic GAP 
locus by homologous recombination. In accordance, the GAP promoter was selected to drive the 
expression of the model GOI RudolphRFP in the modified RMCE tagging cassettes. This was done 
to ensure optimal comparability of the different RMCE MCL variants, while also excluding any 
influences by the genomic locus or genetic upstream elements (e. g. the AOX1 promoter). In total, 
four modified variants of the initial tagging vector pYTA-RudolphRFP were generated. For 
simplification, pYTA-RudolphRFP will be referred to as variant V1 from here on. The detailed 
cloning strategy of the generated vectors is described in chapter 2.3. The respective vector maps are 
depicted in Appendix IV.4. 
For variant V2, FRT F3 was deleted from pYTA-RudolphRFP (“ΔF3”) to evaluate, whether FRT F3 
comprised the exclusively responsible genetic element for the observed lack of expression. The 
vector product was named pYTAΔF3-RudolphRFP. Variant V3 was based on the hypothesis that 
FRT F3 in its original position between promoter and GOI would be transcribed to the 5’-UTR 
(untranslated region) of the mRNA. FRT sites comprise short inverted sequence repeats. It is 
conceivable that the transcription of F3 results in the formation of a secondary structure in the 5’-
UTR of the mRNA, which might negatively influence the protein translation. To evaluate this 
hypothesis, FRT F3 was moved into the promoter region of the GAP promoter (“F3-PR”) on pYTA-
RudolphRFP upstream of its TATA box. Thereby, FRT F3 was eliminated from the transcribed 5’-
UTR. The resulting tagging vector V3 was designated as pYTAF3PR-RudolphRFP.  
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Variant V4 was generated to mimic the sequence used to complement the selection trap Δhis4, 
which had resulted in the expression of His4 at selective levels (§ 3.1.3). Hence, the presence of 
FRT FWT in the 5’ region of the mRNA did apparently not cause a complete loss of expression, in 
contrast to what was observed for FRT F3. In silico RNA secondary structures predictions with 
RNAFold (University of Vienna, Vienna, Austria) displayed similar minimum free energies for 
FRT F3 (-16.06 kcal/mol) and FRT FWT (-15.28 kcal/mol). Therefore, the influence of their 
secondary structures should be comparable. However, unlike F3, FWT is part of the open reading 
frame (ORF). F3 on the other hand resides in the 5’-UTR upstream of the ATG start codon. This 
positional difference could possibly be critical for the expression of the respective gene. To 
evaluate this, the sequence preceding FRT FWT in pFlpBtM (starting with the ATG start codon for 
the selection trap complementation) was inserted upstream of FRT F3 inside pYTA-RudolphRFP 
(“ATG-F3”). The vector product was named pYTAatgF3-RudolphRFP.  
In the final variant V5, the GAP promoter was repositioned downstream of FRT F3 inside the 
RMCE cassette. This setup is “essentially identical” to the above-described vector pYTAaox-GAP-
mCherry (§ 3.1.4.2), but without the risk of any influence caused by the upstream AOX1 promoter. 
To ensure optimal comparability to the other variants (V1-V4), tagging vector V5 should also be 
directed to the genomic GAP locus. However, in variant V5, the GAP promoter was part of the 
RMCE cassette. Consequently, it could not be used as a homologous sequence to direct the tagging 
vector to the GAP locus. This would compromise the RMCE cassette, similar to the previously 
described control insertion of pYTAaox-GAP-mCherry into the GAP locus (see Figure 3.10A, 
page 73, blue box). Hence, to enable the integration at the correct position, a suitable chromosomal 
upstream region of GAP (“URG”) was needed to mediate the homologous recombination. The 
URG was selected from the chromosomal DNA sequence of P. pastoris GS115, comprising the 
first 508 bp upstream of the genomic GAP promoter (Genbank #FN392320, positions 809,079 –
 809,598). Advantageously, the URG harbors a recognition site for SphI, which was usable for 
vector linearization. To clone the tagging V5, the vector pYTA-RudolphRFP (V1) was modified in 
multiple cloning steps. Briefly, the combination “URG – F3 – GAP promoter – RudolphRFP” was 
inserted into the vector in place of the “GAP promoter – F3 – RudolphRFP” combination. The 
resulting vector was named pYTAUR-RudolphRFP.  
The RMCE MCL V1 (GS115/pYTA-RudolphRFP; GS115/V1) had already been generated as 
described in chapter 3.1.2. To generate the new variants, the tagging vectors V2 to V5 were 
linearized and transformed into P. pastoris GS115. The empty tagging vector pYTA was also 
linearized and transformed into GS115 to create a negative control (NC) for the expression 
analysis. The existing clones of GS115/pGAPZAΔ8-RudolphRFP (§ 3.1.4.1) were selected as a 
positive control for the expression experiments (PC). A schematic overview of the seven cell lines 
(GS115/V1-V5, GS115/NC and GS115/PC) is depicted in Figure 3.12.  
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Figure 3.12. Schematic overview of the different P. pastoris RMCE MCL variants.  
The figure depicts the genetic key elements of the RMCE MCL variants (V1 to V5) as well as the positive and 
negative control cell lines (PC and NC). The main difference between variants V1-V5 is the position or 
presence of FRT F3, which flanks the 5’ border of the RMCE cassette. For simplification, the transcriptional 
terminator of RudolphRFP (Rudolph), the promoter and transcriptional terminator of the Zeocin resistance 
cassette (ZeoR) and the vector elements downstream of the selection trap Δhis4 have been omitted from 
graphical display. All vectors were inserted into the genomic GAP locus of P. pastoris. Therein, the GAP 
promoter (PGAP) is located downstream of the genomic upstream region of GAP (URG). The ATG start codon 
of RudolphRFP and the TATA box of the GAP promoter are specifically denoted in the scheme, since they were 
subject to modifications in V3 and V4, respectively. Dual colors indicate the regions that were used to perform 
the homologous recombination (PC, NC and V1-V4: PGAP; V5: URG).  
Eight single colonies of each of the newly generated cell lines (GS115/V2-V5 and GS115/NK) 
were isolated and analyzed by genomic PCR (§ 2.6.11). Two PCRs were carried out per clone to 
verify the stable transformation of the vector and to identify single insertion clones. The first PCR 
product (PCR1) comprised a fragment spanning over the URG and RudolphRFP. The second PCR 
product (PCR2) could only be amplified in case of multi copy clones (as described in chapter 
3.1.2). The forward primer in PCR1 (s_gGAP-F) binds to a genomic DNA sequence upstream of 
the URG. Using this primer, the PCR1 product will only be formed, if the vector is inserted in the 
correct genomic locus. For this reason, the previously tested eight respective clones of GS115-
pYTA-RudolphRFP and GS115-pGAPZAΔ8-RudolphRFP were also included in the PCR analysis. 
The expected band sizes of the PCR products and the used primers are listed in Appendix II. The 
results of the PCRs are depicted in Figure 3.13.  
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Figure 3.13: Validation of the new P. pastoris RMCE MCL variants by genomic PCR.  
(A) Simplified scheme showing the PCR products of the vector insertion into the GAP locus of P. pastoris. 
Orange/grey arrow: GAP promoter; grey/ochre: URG (bicolored elements indicate the homologous 
recombination). Green: Amp resistance cassette; GAP (dark grey): genomic GAP gene. Two PCRs were 
performed to evaluate the clones. PCR 1 (red) comprises the GOI to validate the insertion of the vector into the 
genome. PCR2 (blue) will only yield a product for multi copy clones (depicted for two inserted vector copies 
in the picture). Single insertion clones were desired to ensure comparability between different clones. (B) 
Results of the electrophoresis of the PCR products on 0.8% agarose gels, which were stained with Roti Safe. 
V1-V5, PC and NC denote the cell lines (§ Figure 3.12). Digits indicate the clone numbers. Control reactions 
were performed with the vector and genomic DNA of the empty GS115 strain (N1, N2). The clones without a 
signal in PCR2 comprised single insertion clones, which could be used for further analysis. 
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Three validated single insertion clones were retained for each variant to serve as biological 
replicates in the following experiments. The clones are denoted in Table 3.1. 
Table 3.1. Retained single insertion clones of the GAP RMCE MCL variants for the expression analysis. 
Name of transformed vector Clone numbers 
V1. GS115/pYTA-RudolphRFP 1, 2, 3 
V2. GS115/pYTAΔF3-RudolphRFP 1, 2, 3 
V3. GS115/pYTAF3PR-RudolphRFP 1, 2, 3 
V4. GS115/pYTAatgF3-RudolphRFP 2, 3, 4 
V5. GS115/pYTAUR-RudolphRFP 1, 2, 3 
PC. GS115/pGAPZAΔ8-RudolphRFP 1, 2, 3 
NC. GS115/pYTA (empty) 1, 2, 4 
 
3.1.4.4 Expression analysis of the modified RMCE master cell lines to evaluate the influence 
of FRT F3 on gene expression 
The negative influence of FRT F3 on gene expression in P. pastoris should be evaluated on two 
comparatively evaluated layers. First, the production of RudolphRFP was quantified using flow 
cytometry. Secondly, the transcription levels of the RudolphRFP gene were assessed by 
quantitative reverse transcription PCR (RT-PCR). The analyses were performed with three 
biological single insertion clones of the modified RMCE MCLs V1 to V5 as well as the control cell 
lines (§ 3.1.4.3, Table 3.1). Each biological clone was used in technical quadruplicates. Hence, 84 
samples were analyzed in total (four replicates x three clones x seven variants).  
3.1.4.4.1 High-throughput expression analysis of RudolphRFP 
For the expression analysis, all clones were cultivated in 96-deepwell-plates with liquid buffered 
minimal dextrose (BMD) medium. The red fluorescence was measured after 48 h of expression by 
flow cytometry (§ 2.7.3). The averaged red fluorescence (x-mean) over the counted cell population 
was used as the measure to compare the samples. The data analysis was conducted using the mean 
value of the respective technical quadruplicates and the biological triplicates (RFmean;Rud). Student’s 
t-tests were performed to validate the statistical significance of the data. A graphical depiction of 
the results is shown in Figure 3.14. 
To compare the relative red fluorescence of the samples, the RFmean;Rud of the PC was set to 100% 
by definition and the remaining values were normalized accordingly. The auto-fluorescence of 
P. pastoris leaks into the red channel of the flow cytometer. Hence, the RFmean;Rud of the NC was set 
to 0 by definition (i. e. subtracted from each of the other values), as this variant does not harbor the 
RudolphRFP gene. As expected from the previous experiments (§ 3.1.4.1), no expression was 
measurable from V1. In contrast, the expression was fully restored in V2 and V5 compared to the 
PC. Like the PC, V2 and V5 do not harbor FRT F3 between GAP promoter and RudolphRFP. The 
variants V3 and V4 only show a partially restored expression. To fully interpret these results, it was 
necessary to assess the transcription levels of RudolphRFP through RT-PCR first. 
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Figure 3.14. Relative red fluorescence of the different RMCE MCL variants.  
Mean red fluorescence was measured by flow cytometry after 48 h of expression using four technical 
replicates of three biological clones of each variant (V1 to V5) as well as, including positive control (PC) and 
negative control (NC). The fluorescence values per clone were averaged and normalized to the PC and the NC 
(defined as 100% and 0%, respectively). The results are shown on the left-hand side. RudolphRFP was not 
expressed in V1. V2 and V5 show comparable expression to the PC. V3 and V4 display reduced expression. A 
scheme of the cassettes is shown on the right-hand side. U: URG, G: GAP promoter, T: TATA box, F3/Fw: FRT 
sites F3 and FWT, A: ATG start codon, R: RudolphRFP, Z: Zeocin resistance cassette, Δ: Δhis4 gene. Student’s t-
test was performed to evaluate statistical significance of the results (* = P < 0.05; ** = P < 0.01; *** = P < 0.001). 
3.1.4.4.2 RudolphRFP Transcription Analysis by RT-PCR 
The RT-PCR and the data evaluation were performed as described in detail in chapter 2.6.15. 
Briefly, the same set of 84 clones was grown overnight and the total RNA was isolated. The cDNA 
was synthesized using an Oligo(dT)18 primer to preferentially amplify the poly-adenine tailed 
mRNA. For every cDNA synthesis reaction, a control was set up without reverse transcriptase (no 
reverse transcriptase, NRT control). The RT-PCR was set up with the fluorescent marker EvaGreen 
(Bio-Rad). EvaGreen solely causes a fluorescent signal by interacting with dsDNA. Since the 
synthesized cDNA is single-stranded, EvaGreen will only generate a signal by binding to newly 
amplified dsDNA PCR products during the RT-PCR.  
The RT-PCR was performed with three primer pairs (listed in 2.6.15.2) to respectively amplify  
RT-fragments of RudolphRFP and the two housekeeping genes as controls: the genes encoding 
beta-actin (ACT1) and phosphoglycerate kinase 1 (PGK1). The synthesized cDNAs and the 
respective NRT controls were individually used as PCR templates. Additionally, control reactions 
without template (NTC; no template controls) were performed. The fluorescence signal was 
measured every PCR cycle. Both the NRT and the NTC control reactions did not display 
significant fluorescence over the course of 40 PCR cycles. By this, two possible contaminations 
were excluded, which could lead to false positive signals. First, as no signal was obtained for the 
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NRT control reactions, no genomic DNA was present in the synthesized cDNA samples. Hence, 
the measured signals were neither caused by EvaGreen interacting with genomic dsDNA nor by 
genomic DNA serving as a false-positive PCR template. Secondly, the negative NTC reactions 
proved that the PCR reaction mixes were not contaminated with DNA or oligonucleotides. These 
contaminations could otherwise also have resulted in a false signal. Therefore, the obtained 
fluorescence signals of the conducted RT-PCR experiments could directly be correlated to the 
cDNA templates and by that, to the relative mRNA transcript levels.  
The data was evaluated according to the comparative CT (cycle threshold) method, which gives 
access to the fold change of the transcription rates of analyzed genes (§ 2.6.15.3). The CT describes 
the PCR cycle in which the fluorescent signal of a sample surpasses the threshold level that is 
defined by the background fluorescence. Thus, the CT marks the cycle at which the PCR products 
become detectable. The more of the amplifiable PCR template for a primer set is originally present 
in the cDNA, the earlier the CT is reached. The composition of the cDNA reflects that of the 
(m)RNA it was synthesized from. Hence, the CT provides a measure for the amount of transcript in 
a sample. For this reason, the CT value allows putting different samples into relation to each other.  
The detailed calculations for the data analysis are presented in chapter 2.6.15.3. For the 
calculations, the CT of the NC was defined as 40, because it did expectedly not show any signal for 
the mRNA of RudolphRFP (not present in this cell line). In the first step, the readouts of 
RudolphRFP were normalized per sample. Thereby, the readouts for the mRNA of the control gene 
PGK1 served as a reference, resulting in the ΔCT value. The ΔCT values of the RudolphRFP 
transcripts in each tested cell line (V1 to V5 and the NC) were then put into relation to the ΔCT of 
the PC, which was set to 1 (i. e. 100 %) by definition. This resulted in the respective ΔΔCT values, 
which were used to calculate the relative fold change of the RudolphRFP mRNA in each sample 
compared to the PC (2-ΔΔCT).  
Likewise, the fold change of the ACT1 was calculated to evaluate the uniformity and comparability 
of the different samples, since ACT1 (like PGK1) should be transcribed at similar levels in all 
tested cell lines. The results of the transcription analysis are depicted in Figure 3.15. The samples 
of V1, V2 and V5 displayed similar amounts of RudolphRFP transcript compared to the PC. 
Variants V3 and V4 only showed reduced transcription levels. In contrast to the RudolphRFP 
transcripts, the ACT1 control showed no significant differences between the cell lines according to 
Student’s t-test. Hence, the obtained results are comparable. 
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Figure 3.15. Analysis of the RudolphRFP mRNA levels in the RMCE MCL variants by RT-PCR.  
The RT-PCR was conducted with EvaGreen using the cDNA of each variant (V1-V5) as well as the positive 
control (PC) and the negative control (NC). The data of a total of 84 clones was analyzed (7 cell lines x 3 
biological clones per variant x 4 technical replicates). The obtained values were averaged and the fold change 
of the transcripts was calculated by the comparative CT method. Student’s t-test was performed to evaluate 
statistical significance of the results (* = P < 0.05; ** = P < 0.01; *** = P < 0.001). The graph on the top left-hand 
side displays the fold change (2-ΔΔCT) of the transcripts of the GOI RudolphRFP in the different cell lines in 
relation to the PC, which was defined as 100%. V1, V2 and V5 show comparable mRNA transcription levels to 
the PC. V3 and V4 show reduced transcription levels. Bottom left-hand side: The same test was performed 
with ACT1 as a control gene. No significant differences were observed in the different samples, which proved 
that the obtained RT-PCR data sets of each sample were comparable. The principal design of the cassettes is 
denoted on the right-hand side. U: URG, G: GAP promoter, T: TATA box, F3/Fw: FRT sites F3 and FWT, A: 
ATG start codon, R: RudolphRFP, Z: Zeocin resistance cassette, Δ: Δhis4 gene.  
3.1.4.4.3 Evaluation of the combined results of the expression screening and the RT-PCR 
The influence of FRT F3 on gene expression was evaluated using the combined results of the 
conducted analyses of the expression and transcription of the RudolphRFP gene (§ 3.1.4.4.1 and 
3.1.4.4.2). As expected from previous observations (§ 3.1.2), RudolphRFP was not expressed at 
detectable levels from the GS115/V1 RMCE MCL, in which FRT F3 is located between the GAP 
promoter and the GOI (§ Figure 3.14). Interestingly however, RudolphRFP was still transcribed at 
comparable levels to the PC (§ Figure 3.15). Thus, it can be concluded that the loss of expression in 
V1 is caused at the level of translation. In contrast to V1, the variants V2 and V5 displayed 
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comparable expression levels of RudolphRFP in relation to the PC (§ Figure 3.14; Figure 3.15). V2 
and V5 harbor identical expression cassettes for RudolphRFP compared to the PC, comprising the 
combination “GAP promoter – GOI – AOX1 transcriptional terminator”. The absence of FRT F3 in 
the tagging vector V2 (and thus, the generated cell line V2) marks the only difference to V1. This 
shows that FRT F3 is indeed the single, critical genetic element responsible for the observed lack of 
expression of RudolphRFP. Moreover, the restored expression in V5 also indicates that FRT F3 was 
not the exclusively critical genetic element for the diminished expression in the AOX1-GAP 
RMCE MCL (GS115/pYTAaox-F3-GAP-mCherry; § 3.1.4.2). Instead, it is possible that the lack 
of expression in this cell line was either caused by the AOX1 promoter or by a combined effect of 
several genetic elements. However, this was not further analyzed, as V5 already displayed a fully 
restored expression of RudolphRFP with a virtually identical setup in terms of the RMCE cassette.  
The variants V3 and V4 showed measurable expression of RudolphRFP in contrast to V1. Still, the 
expression levels were significantly reduced compared to the PC, V2 and V5 (see Figure 3.14). 
Interestingly, these reduced expression levels coincide with likewise reduced transcription levels 
(see Figure 3.15). Considering the aforementioned conclusions, it was assumed that the expression 
was restored in V3 by removing FRT F3 from the 5’-UTR of the mRNA. However, the insertion of 
FRT F3 inside the GAP promoter probably resulted in reduced transcriptional activity. In V4, the 
transcribed FRT F3 site is located in the 5’-region of the ORF. Speculatively, this might negatively 
affect mRNA stability, resulting in reduced amounts of transcript. This might also apply to the 
mRNA of the selection trap Δhis4 (§ 3.1.3). However, it would be irrelevant in the latter case, as 
the complementing expression of His4 is sufficient for selectivity. In the end, these findings were 
not subjected to further analysis, as the reduced expression levels render V3 and V4 unfeasible to 
establish the RMCE system in P. pastoris.  
In the end, the RMCE MCL variant V5 presents the most viable alternative for the establishment of 
the RMCE system, as it features a fully restored expression in the presence of an intact RMCE 
cassette flanked by FRT F3 and FRT FWT. Consequently, it was used to perform a first cassette 
exchange via RMCE.  
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 Evaluation of the exchangeability of the RMCE cassette in the 
modified P. pastoris RMCE master cell line V5 
Based on the results of the expression analysis, the RMCE MCL variant GS115/V5 was chosen to 
establish the RMCE method in P. pastoris. The required presence of a promoter inside the RMCE 
cassette to express the GOI renders GS115/V5 incompatible to the originally envisioned RMCE 
donor vector pFlpBtM. Therefore, a P. pastoris exclusive RMCE donor vector had to be cloned. 
This was done by modifying pYTAUR-RudolphRFP. In the first step, RudolphRFP and the Zeocin 
resistance cassette were replaced with a fragment from pYEXs-yeGFP comprising the y-eGFP 
gene and the “TEF1 promoter – ATG start codon” combination. The vector product was named 
pYEXsUR-yeGFP, as it harbors the complemented Δhis4 gene, similar to the previously described 
pYEXs vectors used for the evaluation of Δhis4 (§ 3.1.3). In the next step, Δhis4 was deleted from 
the vector backbone in order to prevent false-positive clones during the RMCE experiment. The 
final RMCE donor vector was named pYEXUR-yeGFP (§ Figure 3.16). The detailed cloning steps 
are described in chapter 2.3. The vector map of pYEXsUR-yeGFP is shown in Appendix IV.5. 
 
 
Figure 3.16. Vector map of the RMCE donor vector pYEXUR-yeGFP.  
The vector is based on pYTAUR-RudolphRFP. It comprises a pBR322 ori and an ampicillin resistance cassette. 
The RMCE cassette is flanked by FRT F3 and FWT. It includes y-eGFP as a model GOI and the TEF1/EM7 
promoter and an ATG start codon to complement the selection trap upon cassette exchange. The Δhis4 gene 
was deleted from the vector. The image at the top was created with Vector NTI Suite 8 (Thermo Fisher 
Scientific). Teal arrows: eukaryotic promoters and URG. Dark red arrows: prokaryotic promoters. Orange 
arrows: coding sequences and origin of replication (ori). Blue bars: transcriptional terminators (TT). Below, a 
depiction of the exchange cassette is shown. 
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FRT F3
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EM7 promoter
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In addition to the donor vector, a preliminary helper vector was cloned to deliver the required Flp 
recombinase for the RMCE reaction. A detailed description of the vector generation is provided in 
chapter 2.3. Briefly, the helper vector was designed based on the episomal PARS1 plasmid pBGP1 
(§ 2.2). Since pBGP1 is based on pGAPZα-A (Thermo Fisher Scientific), it features the Zeocin 
resistance gene Sh ble for primary selection in P. pastoris. The RMCE MCL is already Zeocin 
resistant from the transformed tagging vector. Therefore, the Sh ble gene on pBGP1 was exchanged 
for the Tn903 kanamycin resistance gene to enable selection on the antibiotic Geneticin (G418). 
Furthermore, the MF-α secretion signal was deleted from the vector. The resulting vector was 
named pBGP1KΔ8. Finally, the Flp gene from pOG44 (Thermo Fisher Scientific) was cloned into 
the vector, resulting in the final helper vector pBGP1KΔ8-FlpWT (Figure 3.17). 
 
Figure 3.17. Vector map of pBGP1KΔ8-FlpWT. 
The vector is based on pBGP1. It comprises a pBR322 ori, an ampicillin resistance cassette and a PARS1 
sequence for episomal replication. The Flp gene is expressed constitutively from this plasmid under the 
control of the GAP promoter. In place of the original Zeocin resistance gene, then kanamycin resistance gene 
Tn903 inserted for direct selection with G418 in P. pastoris. The image was created with Vector NTI Suite 8 
(Thermo Fisher Scientific). Teal arrows: eukaryotic promoters. Dark red arrows: prokaryotic promoters. 
Orange arrows: coding sequences and ori. Blue bars: transcriptional terminator sequences. The letter d in the 
displayed vector name stands for Δ. 
To perform the RMCE, both pYEXUR-yeGFP and pBGP1KΔ8-FlpWT were co-transformed into 
the P. pastoris RMCE MCL V5 (§ 3.1.4.4). For the initial experiment a mass ratio of 1:4  
(20 ng + 80 ng) was applied. As a negative control for the reaction, each vector was singly 
transformed into the RMCE MCL. In addition, one transformation was carried out with MQ-H2O 
instead of vector DNA. A positive control was generated using the vector pYEXsUR-yeGFP, 
which harbors the complemented Δhis4 gene. The vector was linearized and transformed into 
P. pastoris GS115 (§ 2.6.10) for the generation of an exchange simulation cell line by homologous 
pBGP1Kd8-FlpWT
6031 bp
AmpR
c myc
6xHis
KanR Tn903
Flp-WT
PARS1
TEF1 promoter
GAP promoter
AmpR-Prom
EM7 promoter
PBR322 ori
AOX1 TT
BamHI (2201)
Nco I (2686)
Avr II (191)
Not I (1782)
Sac II (1773)
Xho I (2720)
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recombination, as described in chapter 3.1.3. The transformed cells were selected by growth on 
MD (minimal dextrose) agar plates with 300 µg/mL G418. The cells were also plated in parallel 
onto MDH agar plates (MD supplemented with histidine) as an additional control. 
All transformation samples showed growth on the MDH plates. This proved that all transformation 
samples after the electroporation still included living cells. For the positive control strain 
(GS115/pYEXsUR-yeGFP), over 100 colonies were grown on MD. No growth was observed for 
any of the negative control samples transformed with the individual vectors or MQ-H2O on MD 
plates. In contrast, for the cells that had been co-transformed with both vectors (RMCE reaction) 
four colonies were formed on the MD agar plate. The four colonies were purified and thereafter 
respectively dropped onto fresh MD and MDH agar plates. The RMCE MCL V5 
(GS115/pYTAUR-RudolphRFP) and untransformed GS115 cells were included in this experiment 
as controls. The agar plates after 48 h of growth are shown in Figure 3.18. Only the four putatively 
exchanged clones could grow on MD. Furthermore, these four clones showed a green staining, 
indicating the expression of y-eGFP. In contrast, GS115 and GS115/pYTAUR-RudolphRFP could 
only grow on MDH. GS115/pYTAUR-RudolphRFP displayed a magenta staining due to the 
expression of RudolphRFP. 
 
Figure 3.18. Evaluation of the exchanged RMCE producer clones by growth on selective minimal medium.  
The experiment was performed with the four putatively exchanged producer clones, which were generated 
through the RMCE reaction (RMCE1-4). In addition, the RMCE MCL V5 (GS115/pYEXsUR-yeGFP) and 
untransformed GS115 cells were included in the experiment as controls. The cells were respectively dropped 
onto agar plates with minimal dextrose medium (MD) and MD supplemented with histidine (MD+His) in 
three different dilutions. Growth was documented after 48 h at 30 °C. Only the four exchanged clones could 
grow on MD. The RMCE MCL V5 exhibited magenta staining. The clones RMCE1-4 showed green staining. 
A preliminary flow cytometric analysis of these clones was conducted (§ 2.7.3). Untransformed 
P. pastoris GS115 cells served as a negative control. The RMCE MCL V5 (GS115/pYTAUR-
RudolphRFP) and a visually green fluorescent clone of the positive control transformation agar 
plate (GS115/pYEXsUR-yeGFP) were also measured for comparison. All four putatively 
exchanged clones exhibited green fluorescence instead of their original red fluorescence. This 
shows that the RMCE reaction in P. pastoris was successful and that the cassettes were exchanged 
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(§ Figure 3.19). It is notable that the mean green fluorescence of all four clones was of similar 
magnitude. This indicates that the RMCE indeed leads to the generation of clones with predictable, 
uniform expression results in P. pastoris, as originally desired (§ Table 3.2).  
 
Figure 3.19. Flow cytometry of putatively exchanged RMCE clones. 
Red and green channels were detected during the analysis (RED-HLog, GRN-HLog) with a Guava EasyCyte 
Mini flow cytometer. The events were gated by the living cells (named “Gesamtzellen” in the figure). The 
counted events are depicted on the y-axis. 10,000 cells were counted per sample. The detected fluorescence on 
is shown on a logarithmic scale on the x-axis. The RMCE master cell line V5, expressing RudolphRFP, was 
used as a control (red). Furthermore, “empty” GS115 cells were measured to assess the influence by auto-
fluorescence (grey). GS115/pYEXsUR-yeGFP generated by homologous recombination served as a positive 
control (green). The exchanged clones (black) exhibit green fluorescence, while showing a loss of red 
fluorescence. The RMCE exchange clones are indicated by the numbers 1 to 4. The fluorescence of 
RudolphRFP was observed to be leaking into the green channel of the Guava EasyCyte.  
  
  RESULTS 
 89  
The positive control clone (GS115/pYEXsUR-yeGFP) displays a three times higher green 
fluorescence than the four exchanged clones. As described above, this clone was randomly picked 
based on its visibly green fluorescence. Assumingly, it presents a jackpot clone. The higher 
expression level of y-eGFP could be related to multi copy insertions of the vector or to other 
undefined effects. For example, the random insertion of the vector into the genome could cause 
unpredictable expression results and might also lead to the increased expression level. However, 
this was not investigated any further in this PhD thesis. 
Table 3.2. Gated mean fluorescence values of the putatively exchanged RMCE clones. 
Name Mean Red Fluorescence Mean Green Fluorescence 
GS115 “empty” (control) 30.93 5.59 
GS115/V5 (MCL) 100.5 24.63 
GS115/pYEXsUR-yeGFP (PC, HR) 49.35 331.82 
GS115/yeGFP-Exchange1 35.11 125.36 
GS115/yeGFP-Exchange2 35.13 126.24 
GS115/yeGFP-Exchange3 34.16 121.29 
GS115/yeGFP-Exchange4 34.59 124.25 
 
All in all, the RMCE reaction in this experiment (albeit not yet optimized) provides a proof of 
principle for the functionality of the RMCE system in P. pastoris. The system could be established 
using a modified RMCE cassette (V5), which harbors the promoter to drive the expression of the 
GOI downstream of FRT F3. The presented model system, which was designed and established in 
this work, provides a basis for the future generation of P. pastoris RMCE MCLs. These new 
RMCE MCLs could for example be generated by random tagging in order to introduce the RMCE 
tagging cassette into favorable, yet uncharacterized genomic loci for stable protein production in 
P. pastoris. Notably, the model GOI y-eGFP is uniformly expressed in the four exchanged 
producer clones, which indicates that the productivity is predictable. Thus, the RMCE system 
would circumvent the need for extensive expression screens, which is up to date a time-consuming 
drawback of recombinant protein expression in P. pastoris.  
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3.2 Secretory expression of mouse Tmprss2  
P. pastoris is a powerful expression host, particularly for the secretory expression of proteins like 
proteases and for the production of membrane proteins. The previous section of this work (§ 3.1) 
dealt with the optimization of the expression host P. pastoris for the efficient generation of 
producer cell lines. This section deals with the production of a difficult to express target protein - 
mouse Tmprss2. Tmprss2 is a type II transmembrane protease (TTSP) present in the airway 
epithelium. Tmprss2 was shown to be an essential key player for influenza A virus (IAV) infection. 
The viral surface protein hemagglutinin (HA) mediates the entry of the IAV into the host cells only 
after proteolytic activation. Tmprss2 is the critical protease in vivo to activate monobasic HAs such 
as H1 (§ 1.7.1). Consequently, Tmprss2 deficient mice were protected from IAV infection. At the 
same time, these mice did not show any discernible phenotype compared to the wildtype. This 
makes Tmprss2 an interesting drug target for structure-based drug design (SBDD).  
The aim of this work was to establish a reliable protocol to produce sufficiently high amounts of 
mouse Tmprss2 for crystallization and structural analysis. The whole ectodomain of Tmprss2, 
which contains the catalytic serine protease domain, was selected for secretory expression (§ 1.7.2). 
For simplification, the extracellular domain / ectodomain of mouse Tmprss2 will be referred to as 
“Tmprss2” from here on, unless specifically stated otherwise. To perform SBDD, the structural 
resolution of the interaction surface between Tmprss2 and its viral substrate HA H1 is of great 
interest. To enable co-crystallization of Tmprss2 and HA H1, the protein was additionally 
expressed in a mutant form with diminished catalytic activity (D343N). The expression of the 
active “wildtype” form of Tmprss2 (Tmprss2-WT) and Tmprss2-D343N was tested in several 
eukaryotic expression hosts to find the optimal system for the production.  
 Initial expression of Tmprss2 in Pichia pastoris 
The expression of Tmprss2 in P. pastoris was conducted under the control of the strong, methanol-
induced AOX1 promoter in combination with the mutS strain KM71H. The recombinant Tmprss2 
construct comprises the ectodomain of the native, full length protein that ranges from amino acid 
109 to 490 (gene position 325 bp to 1470 bp). The mutant form contains a single point mutation at 
position 1027 bp of the full length gene, which translates to amino acid 343. The wildtype gene 
harbors the codon GAC, which codes for aspartic acid (Asp, D). In D343N, this codon is changed 
to AAC, which codes for arginine (Arg, N). The plasmid pPICZα-A (Thermo Fisher Scientific) was 
selected as an expression vector for P. pastoris. In addition to the AOX1 promoter, pPICZα-A 
contains the MF-α secretion signal sequence (MF-α ss) to mediate the secretion of the target 
protein. For detection and purification, a C-terminal 1x Flag and 8xHis double tag was fused to 
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Tmprss2. Upstream of the tags a TEV protease cleavage site was inserted to allow for the removal 
of the tag prior to crystallization. A scheme is of the construct depicted in Figure 3.20. 
 
 
Figure 3.20. Schematic overview of the Tmprss2 constructs for expression in P. pastoris.  
Top: The mating factor α secretion signal (MF-α ss) is fused N-terminally to the protein to direct it to the 
supernatant. The mutant form features an amino acid replacement of the aspartic acid of the catalytic triad to 
asparagine (D343N). C-terminally, a Flag and an 8xHis tag are fused to the protein for purification and 
detection. Upstream of the tags, a TEV protease site is located to cleave the tags off. LDLA: Low-density 
lipoprotein receptor class A, SRCR: Scavenger receptor cysteine-rich domain. Bottom: Sequence alignment of 
the translated sequences of Tmprss2 used in the recombinant constructs (from position 109 of the full protein). 
The amino acids belonging to the catalytic triad are marked by blue arrows. The mutation D343N is visible at 
position 235 of the alignment figure. 
The Tmprss2 constructs were cloned into the MCS of pPICZα-A, resulting in the vectors  
pPICZα-Tmprss2-WT and pPICZα-Tmprss2-D343N. The detailed cloning strategy is described in 
chapter 2.3. The expression vectors were linearized and respectively transformed into P. pastoris 
KM71H. Primary selection was conducted on YPDS Zeocin (100 µg/mL) agar plates. The single 
clone isolation was performed with an initial number of 2 x 24 clones, which were spread on 
multiple YPD agar plates with different concentrations of Zeocin (100, 250, 500, 1000 µg/mL) to 
select for multi copy clones. The clone numbers were set to use even hundreds (0-99, 200-299, 
400-499 etc…) for Tmprss2-WT and odd hundreds (100-199, 300-399 etc…) for Tmprss2-D343N 
by definition. The selected clones are listed in Table 3.3, ranking by the highest Zeocin 
concentration still allowing growth of the transformants. 
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Table 3.3. Survival of the initially analyzed Tmprss2 clones on different Zeocin concentrations. 
All transformants showed growth at a Zeocin concentration of 100 µg/mL. 
Highest concentration of 
Zeocin survived [µg/mL] 
Tmprss2-WT Clones Tmprss2-D343N Clones 
1000 17 116, 118 
500 18, 19, 20 117, 119 
250 21 102-115, 121-124 
 
3.2.1.1 Small-scale test expression of Tmprss2 in P. pastoris 
The WT clones 16 to 21 and the D343N clones 115 to 120 were selected for an initial expression 
test, as these two sets included clones that were able to survive on 1000 µg/mL (17, 116 and 118), 
500 µg/mL (18, 19, 20, 115, 117 and 119), 250 µg/mL (21, 115) and 100 µg/mL (16, 120) Zeocin.  
The expression of Tmprss2 was tested in a 50 mL scale (250 mL preculture), as described in 
chapter 2.8.1. The expression was conducted for 72 hpi (hours post induction). To maintain the 
induction, methanol was added every 24 hpi to a final concentration of 0.5 % (v/v). The harvested, 
clear supernatant was dialysed against 50 mM sodium phosphate buffer, pH 7.4 with 300 mM NaCl 
(§ 2.8.7). Subsequently, Tmprss2 was purified by affinity capture with MagneHis magnetic beads 
(Promega) and eluted into 50 µL of elution buffer (§ 2.8.9). The samples were analyzed by SDS-
PAGE and Western blots (§ 2.9). Figure 3.21 depicts the results of the SDS-PAGE and the Western 
blot of the elution fractions. It was observed that P. pastoris secretes soluble Tmprss2 to the 
supernatant. Furthermore, the protein is likely glycosylated, judging from the smear of the protein 
bands towards higher molecular weights, which was particularly visible for the ~45 kDa band of 
Tmprss2-D343N.  
The affinity capture of Tmprss2 from 50 mL of culture supernatant into an eluate of 50 µL equals a 
1000-fold concentration. Even then, Tmprss2-WT is only visible on the Western blot. This 
indicates an overall very low expression level of the protein, which is also considerably lower than 
the expression level of Tmprss2-D343N. Among the tested clones, the ones that had survived on 
higher Zeocin concentrations were also producing higher amounts of Tmprss2. Clones 17 and 116 
were respectively shown to deliver the strongest expression of Tmprss2-WT and Tmprss2-D343N 
(Figure 3.21). It is conceivable that the higher copy number of the inserted vector (which goes hand 
in hand with a higher resistance against Zeocin) resulted in the higher product yields.  
The Western blot (see Figure 3.21B) furthermore allowed to draw conclusions about the desired 
knockdown of the protease activity of Tmprss2 by the mutation D343N. As a putative zymogen, 
Tmprss2 would cleave itself upstream of the serine protease domain, resulting in two split 
fragments of ~15 kDa and ~30 kDa. These fragments usually stay linked by a conserved disulfide 
bond. Under the denaturing conditions of the SDS-PAGE preceding the Western blot, two bands 
were expected. First, the unprocessed protein should form a band at ~45 kDa (neglecting the 
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contribution to the mass by glycosylation). Secondly, the processed be visible at ~30 kDa, as only 
the C-terminal fragment can be detected by the presence of the tag (Figure 3.21A). The observed 
bands on the Western blot fit to these expectations (Figure 3.21B). Tmprss2-WT showed a 
dominant band at ~30 kDa (blue arrow in Figure 3.21). This indicates that the protein is virtually 
completely processed. In contrast, Tmprss2-D343N was mostly unprocessed, as evident by the 
visibly dominant band at ~45 kDa (black arrow in Figure 3.21) and only a faint signal at ~30 kDa.  
 
Figure 3.21. Tmprss2 test expression in P. pastoris. 
(A) Zymogenic cleavage of Tmprss2 should result in two fragments of ~15 kDa and ~30 kDa under 
denaturing conditions as opposed to the unprocessed form (~45 kDa). On Western blots, only the C-terminal 
fragment is detectable due to the location of the tags targeted by the primary antibody. (B) The wildtype form 
is completely processed (16 to 21, blue arrow), while the mutant form is mostly unprocessed (115 to 120, black 
arrow). Clones 17 and 116 showed the strongest expression levels. Tmprss2-WT is expressed at significantly 
lower levels than Tmprss2-D343N. Even the expression from clone 17 is not detectable on the stained SDS gel. 
The SDS gel was stained with InstantBlue. The Western blot was performed with a primary mouse α-Flag 
mAb and a secondary goat AP-conjugated α-mouse pAb. Colorimetric AP staining was performed with NBT 
and BCIP. Mw standard (M): PageRuler Prestained Plus. 
The fact that the mutant form D343N is mostly unprocessed indicates that the interference or 
processing activity through host proteases is negligible. On the one hand, these observations 
confirm that the 30 kDa band of Tmprss2-WT is highly likely the result of the autocatalytic 
activation of Tmprss2. On the other hand, the mutant form D343N indeed led to a major 
knockdown of the protease activity of Tmprss2. 
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The optimal time to harvest the culture post methanol induction was evaluated. For this, the clones 
17 (WT) and 116 (D343N) were respectively cultivated in 100 mL expression cultures (from 
500 mL of preculture) as described in chapter 2.8.1. Samples were taken every 24 h for a total time 
of six days post induction. Total cell extracts were generated by mechanical cell disruption 
(§ 2.8.4). The culture supernatant as well as the soluble and insoluble cell lysate fractions upon 
centrifugation were analyzed for the presence of Tmprss2 by Western blot (see Figure 3.22).  
 
Figure 3.22: Expression test to evaluate the amount of Tmprss2 secretion and optimal harvesting time. 
The expression was conducted in 100 mL shake flask cultures for 144 hpi (hours post induction) with clones 
KM71H/pPICZα-Tmprss2-WT 17 and KM71H/pPICZα-Tmprss2-D343N 116. SDS-PAGE and Western blots 
were performed of all fractions (culture supernatant, soluble and insoluble cell extract fractions). Upper line: 
Western blot, supernatant. Second line: SDS-PAGE and Western blot, soluble extract. Lower line: SDS-PAGE 
and Western blot, insoluble extract. The SDS gels show uniform signals and thereby, comparability of the 
samples. Tmprss2 was detected in the Western blots. Tmprss2-D343N was showed two bands at ~45 kDa 
(black arrow) and ~30 kDa (blue arrow) in the supernatant. Tmprss2-WT only showed a band at ~30 kDa. 
Starting from 72 hpi first signs of degradation of the target protein in the supernatant are visible. For the cell 
extracts, Tmprss2 was only detected in the insoluble fraction. Tmprss2-WT was expressed at significantly 
lower rates than Tmprss2-D343N. Staining of the SDS gels was performed with InstantBlue. The Western blot 
was conducted with a primary mouse α-Flag mAb and a secondary goat AP-conjugated α-mouse pAb. 
Colorimetric AP staining was performed with NBT and BCIP. Mw standard (M): PageRuler Prestained Plus. 
  
  RESULTS 
 95  
Starting from 72 hpi, the supernatant samples show visible degradation of Tmprss2. For this 
reason, 48 hpi was selected as the optimal time to harvest the supernatant. The cell extract samples 
showed only faint signs of the target protein in the insoluble fraction, which was expected due to 
the protein being transported through the secretory pathway of P. pastoris. It was concluded that 
the low yields of Tmprss2 are not caused by significant amounts of improperly folded Tmprss2 
getting stuck inside the ER of the cells. 
3.2.1.2 Screening for “jackpot” clones (high producers) of Tmprss2 in P. pastoris 
Following the initial test expression experiments, it was assessed, whether higher expressing clones 
for Tmprss2 could be identified. To do this, a high-throughput expression screen of 70 additional 
clones each for Tmprss2-WT (25 to 94) and Tmprss2-D343N (125 to 194) was conducted. An 
overview of these clones is presented in Table 3.4.  
Table 3.4. Survival of the second batch of analyzed Tmprss2 clones on different Zeocin concentrations. 
All transformants showed growth at a Zeocin concentration of 100 µg/mL. 
Highest concentration of 
Zeocin survived [µg/mL] 
Tmprss2-WT Clones Tmprss2-D343N Clones 
1000 35, 71, 87, 93 170, 183, 187, 194 
500 62, 89, 91, 94 126, 130, 177 
250 34-39, 63-66,  
 
The strongest clones of the initial test expression (KM71H/pPICZα-Tmprss2-WT 17 and 
KM71H/pPICZα-Tmprss2-D343N 116) were included in the experiment as a reference to correlate 
the expression of the new clones. The expression was conducted in 500 µl BMMY expression 
cultures for 48 hpi (§ 2.8.1). For a fast, relative evaluation of the expression of Tmprss2, slot blots 
were performed (§ 2.9.4). Briefly, the culture supernatants were respectively harvested after the 
expression and directly blotted onto a PVDF membrane. Thereafter, immunostaining was 
conducted to detect Tmprss2, as described before for the Western blots (§ 3.2.1). The results are 
depicted in Figure 3.23.  
None of the new clones produced higher amounts of Tmprss2 than clones 17 (Tmprss2-WT) and 
116 (Tmprss2-D343N), which were consequently designated as the maximal producer clones. As 
observed before, the expression tends to scale roughly with the vector copy number, evident by the 
ability of the clones to survive on higher Zeocin concentrations. Congruently with the results from 
the initial test expression, Tmprss2-WT was produced at significantly lower amounts than 
Tmprss2-D343N in all screened clones. The only difference between the two proteins is the single 
point mutation that causes the diminished protease activity of Tmprss2-D343N. Thus, the different 
expression levels of the two constructs could be explained by the fact that Tmprss2-WT is still 
active. Tmprss2-WT might be interacting in some way with the host cell environment, thereby 
negatively influencing its own production or its own half-life.  
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Figure 3.23: Expression screening of Tmprss2 in 
P. pastoris using slot blot. 
Clones of KM71H/pPICZα-Tmprss2-WT (25-94) and 
KM71H/pPICZα-Tmprss2-D343N (125-194) were 
screened in high-throughput for the expression of the 
respective Tmprss2 form. The expression was 
conducted in 500 µL BMMY for 48 hpi. 300 µL of the 
culture supernatant were loaded onto the slot blots. 
Clones 116 (D343N) and 17 (WT) were included in the 
expression screen as comparative controls. The 
negative control/NC (supernatant from 
untransformed cells) did not show any signal. This 
indicates no cross interference by natively secreted 
host proteins with the immunostaining. None of the 
screened clones was stronger than clones 116 and 17 
for the expression of Tmprss2. The expression 
patterns correlate to multi insertions of the vector. 
The slot blot was conducted with a primary mouse α-
Flag mAb and a secondary goat AP-conjugated α-
mouse pAb. Colorimetric AP staining was performed 
with NBT and BCIP. 
 
 
 Analysis of the quantity and quality of Tmprss2 expressed in 
P. pastoris 
3.2.2.1 Large-scale production of Tmprss2 in P. pastoris 
The previous experiments showed that Tmprss2 is difficult to express in high amounts in 
P. pastoris. Since high amounts of pure protein are needed for crystallization, the yields of 
Tmprss2 from the current P. pastoris jackpot clones were quantified to obtain a basis for further 
improvements. For this purpose, the expression was scaled-up to 2x 1 L shake flask scale cultures 
(10 L of pre-culture) in BMMY medium with clones 17 (WT) and 116 (D343N), as described in 
chapter 2.8.1. The concentrated cultures had comparable cell densities at 0 hpi (OD595 of 50 and 56 
for the cultures of clones 17 and 116, respectively). The expression was conducted for 48 hpi. The 
cell-free supernatant was concentrated to 500 mL and diafiltered for Ni-NTA affinity capture of 
Tmprss2 (§ 2.8.7). Tmprss2-WT and Tmprss2-D343N were respectively captured using a 1 mL Ni-
NTA column (§ 2.8.11). The eluent fraction was collected in a series of 1 mL fractions.  
SDS-PAGE and Western blots of the fraction samples were performed. Tmprss2 was successfully 
captured as shown in Figure 3.24. In contrast to the mutant form, the purified Tmprss2-WT was 
only detectable on Western blot. Tmprss2-D343N elution fractions 3 to 8 were pooled and dialyzed 
to remove imidazole. For Tmprss2-WT, the elution fraction 4 was separately dialyzed, while the 
  RESULTS 
 97  
remaining elution fractions from 2 to 10 were additionally pooled for dialysis. After the dialysis, 
the protein concentration was measured with a Nanodrop (§ 2.6.14).  
Tmprss2-D343N was quantified at 0.3 mg total (0.15 mg/L). Tmprss2-WT was not quantifiable 
from elution fraction 4. Even by pooling all Tmprss2-WT elution fractions and concentrating them 
with a Vivaspin 6 (MWCO 5 kDa) column to 50 µL, quantification was not possible.  
 
Figure 3.24. Affinity capture of Tmprss2 from 2 L of P. pastoris expression culture. 
Tmprss2-WT and Tmprss2-D343N were expressed in shake flasks (2 L scale) and respectively captured on a 
1 mL Ni-NTA column. SDS-PAGE and Western blot are shown with the harvested culture supernatant (S), the 
flow through of the Ni-NTA column (F), the wash fraction (W) and the elution fractions (0-10). Tmprss2 was 
completely captured from the supernatant. (A) Tmprss2-WT. The protein was only visible on the Western 
blot. All elution fractions were retained for further analysis. (B) Tmprss2-D343N. The elution fractions 3 to 8 
were retained for further analysis. Staining of the SDS gel was performed with InstantBlue. The Western blot 
was performed with a primary mouse α-Flag mAb and a secondary goat AP-conjugated α-mouse pAb. 
Colorimetric AP staining was performed with NBT and BCIP. Mw standard (M): PageRuler Prestained Plus. 
The cultivation of P. pastoris in a bioreactor offers optimized process conditions. Apart from the 
control of the pH and the temperature, the bioreactor allows for better aeration to cultivate at higher 
cell densities compared to shake flasks (200 - 300 OD595 units/mL). Moreover, by application of a 
methanol sensor driven methanol feeding pump a defined level of methanol can continuously be 
maintained in the bioreactor. This allows for a constant and more efficient induction by methanol. 
It was tested whether these conditions would lead to a quantifiable improvement of the expression 
yields of Tmprss2 in comparison to shake flask cultures.  
The expression was conducted in a 2 L scale in a Labfors bioreactor (§ 2.8.1). The clone 
KM71H/pPICZα-Tmprss2-D343N 116 was selected to perform the initial experiment, as its 
expression yields could be directly compared to the shake flask experiments. The methanol 
induction was maintained for 48 hpi. During the process, the reactor reached an OD595 of ~200 
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units. The total culture supernatant (~1.6 L) was harvested, concentrated to 500 mL and diafiltered 
for affinity capture (§ 2.8.7). Tmprss2-D343N was captured on a 5 mL HisTALON column using 
an ÄKTAFPLC (§ 2.8.11). The eluent fraction was collected in a series of 1 mL fractions. The 
purification process was analyzed by SDS-PAGE and Western blot. The results are depicted in 
Figure 3.25. Tmprss2-D343N was successfully captured. The elution fractions C1 to C9 were 
pooled and dialyzed to remove the residual imidazole (§ 2.8.7). Finally, the protein concentration 
was quantified via Nanodrop (§ 2.6.14) at 0.6 mg total (0.3 mg/L culture volume). This presents a 
two-fold increased yield compared to the 2 L shake flask culture. The purified material was used to 
test, whether Tmprss2 could be deglycosylated. Furthermore, it was tested, whether the protein was 
still intact under native conditions, as this could not be concluded under the denaturing conditions 
of SDS-PAGE and Western blot. 
 
Figure 3.25. Protein purification of Tmprss2-D343N from clone 116 in 2 L bioreactor scale. 
The purification of Tmprss2-D343N was analyzed with an ÄKTAFPLC. The samples of different fractions 
were loaded onto the gel. SN: Concentrated and diafiltered reactor supernatant. FT: Flow through of the 
HisTALON column. A7: Wash fraction. B8 - G7: Elution fractions, which had shown a UV signal during the 
ÄKTA run. NC: Negative control (culture supernatant of P. pastoris KM71H/pPICZα-A). PC: Positive control; 
Tmprss2-D343N from P. pastoris KM71H/pPICZα-Tmprss2-D343N C116 (processed and partially degraded, 
but still sufficient as a Western blot control). Staining of the SDS gel was performed with InstantBlue. Western 
blot detection was performed with a primary mouse α-Flag mAb and a secondary goat AP-conjugated α-
mouse pAb. Colorimetric AP staining was performed with NBT and BCIP. Mw standard (M): PageRuler 
Prestained Plus. Fractions C1 - C9 contained the target protein and were pooled for further analysis. 
3.2.2.2 Deglycosylation of Tmprss2 expressed in P. pastoris  
A homogeneous glycosylation pattern consisting of small type glycans on the surface of a target 
protein is generally less flexible, which is beneficial for the formation of protein crystals. In the 
previously described experiments, a glycosylation smear, assumedly caused by a heterogenous 
glycosylation pattern, was particularly visible at the ~45 kDa band of the stronger expressed 
Tmprss2-D343N (§ 3.2.1, Figure 3.21). Therefore, a deglycosylation test was conducted. 
P. pastoris applies glycosylation of the high mannose type. Hence, it was evaluated, whether 
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glycan cleavage would be possible with Endo Hf (New England Biolabs). For this, 1 µg  
Tmprss2-D343N was incubated with varying amounts of Endo Hf (§ 2.8.12). SDS-PAGE and 
Western blot were performed for analysis. The results are shown in Figure 3.26. Endo Hf was able 
to deglycosylate Tmprss2-D343N under both native and denaturing conditions.  
 
Figure 3.26: Deglycosylation test of Tmprss2-D343N with Endo Hf. 
Deglycosylation of ~1 µg Tmprss2-D343N expressed in P. pastoris KM71H was conducted according to NEB’s 
manual with 1,000, 3,000 and 5,000 U of Endo Hf (indicated by “1k, 3k, 5k”) at 37 °C for 1 h. In addition, a 
reaction without Endo Hf was set up (“-“). Tmprss2-D343N served as a positive control (PC) that had not been 
subjected to the reaction mix or to 37 °C. Additionally, a sample only comprising Endo Hf (“Endo”) was 
added as a negative control. Tmprss2-D343N was deglycosylated under both denaturing and native 
conditions. This is shown by the significantly reduced glycosylation smear and the lower molecular weight 
(red arrows) in comparison to the glycosylated samples (black arrow). Staining of the SDS gel was performed 
with InstantBlue. The Western blot was conducted with a primary mouse α-Flag mAb and a secondary goat 
AP-conjugated α-mouse pAb. Colorimetric staining was done with NBT and BCIP. Mw standard (M): 
PageRuler Prestained Plus. 
3.2.2.3 Validation of the protein quality of Tmprss2 expressed in P. pastoris  
The quality of Tmprss2 was validated to ensure that the observed pattern of two bands (~45 kDa 
and ~30 kDa) on SDS-PAGE and Western blot (§ Figure 3.21) was indeed related to zymogenic 
self-processing and not to protein degradation. For this, Tmprss2-D343N was analyzed by two 
methods. First, an intact protein mass determination (ESI-LC/MS) was performed. Purified 
Tmprss2-D343N was deglycosylated with Endo Hf under native conditions and captured by 
MagneHis magnetic beads (§ 2.8.9). A quality check of the eluent fraction was performed by  
SDS-PAGE and Western blot. Thereafter, the buffer of the protein was changed to MQ-H2O 
(§ 2.9.5) and the ESI-LC/MS was done by in the MS platform of the research group Cellular 
Proteomics at the HZI Braunschweig. The results show that Tmprss2 was still intact, despite the - 
by then - significant ~30 kDa band on the Western blot (Figure 3.27, arrow). Consequently, this 
indicates that the observed band pattern on SDS-PAGE and Western blot is a result of zymogenic 
cleavage due to the rest activity of Tmprss2-D343N. Furthermore, it shows that the split halves of 
Tmprss2 remain covalently disulfide-bonded to each under native conditions. 
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Figure 3.27. Intact ESI-LC/MS of Tmprss2-D343N after deglycosylation with Endo Hf. 
Deglycosylation of Tmprss2-D343N was conducted with 5,000 U of Endo Hf for 3 h at 37 °C under native 
conditions. The deglycosylated sample (Deglyc.) was analyzed by SDS-PAGE and Western blot (left-hand 
side) in comparison to the glycosylated protein (D343N). Staining of the SDS gel was performed with 
InstantBlue. The Western blot was performed with a primary mouse α-Flag mAb and a secondary goat AP-
conjugated α-mouse pAb. Colorimetric staining was done with NBT and BCIP. Mw standard (M): PageRuler 
Prestained Plus. The ESI-MS (right-hand side) showed at strong peak at the size of ~45 kDa. This indicates 
that Tmprss2-D343N is still an intact protein comprising the full ectodomain. 
The integrity of Tmprss2-D343N was additionally tested by Native PAGE. For this, the 
unquantifiable eluate concentrate of the Tmprss2-WT affinity capture was added to Tmprss2-
D343N (~15 µg) at a volumetric ratio of 1:2. A control sample of Tmprss2-D343N was handled 
equally, but without the addition of Tmprss2-WT. The samples were checked by SDS-PAGE and 
Western blot. Tmprss2-D343N was completely processed in the presence of Tmprss2-WT, as 
indicated by the dominant 30 kDa fraction on the Western blot (Figure 3.28, blue arrow). This 
provides an initial proof of activity, as it is conceivable that Tmprss2-WT has exerted the cleavage 
of Tmprss2-D343N. It further shows that the rate of the zymogenic activation of Tmprss2-D343N 
can be significantly increased by the addition of Tmprss2-WT. Native PAGE was performed as 
described in chapter 2.9.2 with both unprocessed and processed Tmprss2-D343N. Both samples ran 
at the same size of ~45 kDa (Figure 3.28). This shows that the protein is intact under native 
conditions, supporting the results of the intact mass determination (Figure 3.27). Hence, the 
~30 kDa band under denaturing conditions (SDS-PAGE / Western blot) is indeed caused by the 
disruption of the internal disulfide bond of processed Tmprss2. 
In summary, recombinant Tmprss2 could be successfully expressed in P. pastoris KM71H, albeit at 
low yields. The mutant form D343N was expressed at 0.15 mg/L in shake flasks and 0.3 mg/L in a 
bioreactor. The active wildtype form was expressed at significantly lower levels and could not be 
quantified from 2 L of shake flask expression culture. However, it displayed sufficient proteolytic 
activity to facilitate the zymogenic cleavage of the mutant form. Furthermore, Endo Hf was 
identified as a feasible endoglycosidase to catalyze the deglycosylation of Tmprss2 expressed in 
P. pastoris. Lastly, the protein quality was verified by intact mass determination and Native PAGE, 
which showed that Tmprss2 was intact following deglycosylation and proteolytic activation.  
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The primary aim of this project was to establish a protocol to generate the required amounts of 
Tmprss2 for further analyses. For this reason, the feasibility of different eukaryotic expression 
hosts for the production of Tmprss2 was tested, before further attempts were made to improve the 
expression yield in P. pastoris. 
 
Figure 3.28. Catalytic cleavage and NativePAGE of Tmprss2-D343N. 
Left-hand side: Tmprss2-D343N was completely processed through the addition of an unquantifiable amount 
of Tmprss2-WT after 3 h at 37 °C (D343N+WT). This resulted in a single, dominant ~30 kDa band on SDS-
PAGE and Western blot (blue arrow). An equally handled control without the addition of Tmprss2-WT still 
showed an additional, significant 45 kDa band (D343N). Staining of the SDS gel was performed with 
InstantBlue. The Western blot was performed with a primary mouse α-Flag mAb and a secondary goat AP-
conjugated α-mouse pAb. Colorimetric staining was done with NBT and BCIP. Mw standard (M): PageRuler 
Prestained Plus. Right-hand side: The Native PAGE revealed that the processed Tmprss2-D343N is still an 
intact protein comprising the full ectodomain. The completely processed and the untreated sample 
respectively form a single band at ~45 kDa (black arrow). In addition to the undiluted samples (1:1), two 
dilutions were loaded onto the gel (1:10 and 1:20). Only the undiluted sample showed a visible signal. The 
staining of the Native PAGE was performed with Coomassie G250. Mw standards: Amersham HMW  
(66 – 669 kDa) and LMW (14.4 – 97 kDa) standards. 
 Evaluation of eukaryotic cell lines as expression hosts for 
Tmprss2 using the multi-host expression system 
Since both Tmprss2-WT and Tmprss2-D343N were expressed at low levels in P. pastoris, the 
expression was assessed in a number of eukaryotic systems in order to find a better expression host. 
The expression of Tmprss2 was analyzed in HEK293-6E cells, SF21 and Hi5 insect cells. For the 
test expression in HEK293-6E cells, the multi-host vector pFlp-BtM-III was used (§ 1.4 and 2.2). It 
harbors the strong CMV promoter to express the GOI and an EBV oriP for episomal replication of 
the plasmid and its propagation to the daughter cells during mitosis. For the generation of 
recombinant EmBacY baculovirus to enable baculoviral expression in insect cells (BEVS), a newly 
developed derivative of pFlpBtM-III was used (pFlpBtM-III-insect). It harbors the “hr5 – OpiE2 – 
p10” promoter combination to enhance the baculoviral expression in insect cell lines. The 
IgG secretion signal sequence, present on both pFlpBtM-III variants, was used to mediate the 
secretion of Tmprss2 into the culture supernatant.  
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The expression vectors were generated by respectively cloning the genes Tmprss2-WT and 
Tmprss2-D343N (including the tags; § 3.2.1, Figure 3.20) from the generated pPICZα vectors into 
pFlpBtM-III and pFlpBtM-III-insect (see details in chapter 2.3).  
3.2.3.1 Transient expression test of Tmprss2 in HEK293-6E cells  
The vectors pFlpBtM-III-Tmprss2-WT and pFlpBtM-III-Tmprss2-D343N were used to transiently 
transfect 30 mL suspension cultures of HEK293-6E cells (§ 2.7.4). The transfection was monitored 
by the constitutive expression of GFPq from the co-transformed vector pTTo/GFPq. The 
expression was conducted for 96 hpt (hours post transfection). Daily samples were taken and 
analyzed by flow cytometry for GFP fluorescence (§ 2.7.3). About 90 % of the cells expressed 
GFPq in the experiment, indicating a high efficiency of the transfection. The cells were additionally 
counted and the vitality was calculated (§ 2.7.1). The cultures maintained high vitality of about 
90 % during the experimental run. A graphical overview is depicted in Figure 3.29 
 
 
Figure 3.29. Graphical overview of the transfection of HEK293-6E cells for the expression of Tmprss2. 
The graphical data for two independently performed experiments is shown. The cells were counted manually 
with a Neubauer hemocytometer and the vitality was assessed by trypan blue staining. The GFPq expression 
was monitored by flow cytometry. The data is listed in detail in Appendix III. 
The expression was analyzed with 1 mL samples that were taken at 0, 24, 72 and 96 hpt. The total 
supernatants of the harvested expression cultures were concentrated twenty-fold by TCA 
precipitation (§ 2.8.6). The cell pellets were lysed according to chapter 2.8.5. The supernatant 
samples as well as the soluble and insoluble cell lysate fractions were analyzed by SDS-PAGE and 
Western blot. The results of the experiment are depicted in Figure 3.30. Despite the high level of 
GFP expression, Tmprss2-WT and Tmprss2-D343N were not expressed at detectable levels. 
Therefore, the expression of Tmprss2 was not further pursued in HEK293-6E cells, as they did not 
present a viable alternative to P. pastoris. 
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Figure 3.30. Tmprss2 expression analysis of HEK293-6E cells. 
Top line: Samples of the culture supernatant (taken at 0, 24, 48, 72 and 96 hpt) were analyzed for the presence 
of Tmprss2-WT and Tmprss2-D343N by SDS-PAGE and Western blot. Additionally, the harvested total 
culture supernatant was TCA precipitated and included in the analysis. Moreover, the soluble and insoluble 
cell lysate fractions of Tmprss2-D343N (middle line) and Tmprss2-WT (bottom line) were analyzed. Neither 
Tmprss2-D343N nor Tmprss2-WT could be detected in any of the samples. Staining of the SDS gels was 
performed with InstantBlue. The Western blots conducted with a primary mouse α-Flag mAb and a 
secondary goat AP-conjugated α-mouse pAb. Colorimetric staining was done with NBT and BCIP. Tmprss2-
D343N from P. pastoris KM71H/pPICZα-Tmprss2-D343N clone 116 served as a positive control for the 
Western blots (PC). Mw standard (M): PageRuler Prestained Plus. 
3.2.3.2 BEVS expression test of Tmprss2 in SF21 and Hi5 insect cells 
For the test expression of Tmprss2 in insect cells, recombinant bacmids (EmBacY) were generated 
with the vectors pFlpBtM-III-insect-Tmprss2-WT and pFlpBtM-III-insect-Tmprss2-D343N 
(§ 2.7.5). The bacmids were transfected into SF21 insect cells to amplify the recombinant 
baculovirus. The resulting virus stock (virus amplification 1 / VA1) was used at a volumetric ratio 
of 1:10 to respectively infect 120 mL cell cultures of SF21 and Hi5 (§ 2.8.3). The rate of the 
infection was monitored by flow cytometry through the constitutive expression of YFP from the 
bacmid backbone (§ 2.7.3). The cells were counted and the vitality was calculated (§ 2.7.1). 
Furthermore, a CASY Counter was used to track the increase of the cell diameter, which is a 
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frequently observed effect of the baculoviral infection (§ 2.7.2). A graphical overview of the data is 
presented in Figure 3.31.  
 
Figure 3.31: Graphical overview of the infection of SF21 and Hi5 cells for the expression of Tmprss2. 
The graphical data depicts the daily assessed growth and infection parameters. The cells were counted 
manually with a Neubauer hemocytometer. The vitality was assessed by trypan blue staining. The YFP 
expression of EmBacY was monitored by flow cytometry in the GFP channel. The mean and the peak diameter 
were analyzed with a CASY counter. The infection efficiencies according to the YFP fluorescence were at 
~50 % for Hi5 (dotted lines) and >90 % for SF21 (straight lines). After 24 h, an increase in the cell diameter was 
observed, indicating viral infection. Concomitantly, cell proliferation was halted at 24 – 48 h post infection. 
SF21 cultures were harvested after 72 hours post infection. Hi5 cultures were cultivated for 24 more hours, 
until the vitality fell below 90 %. The data is listed in Appendix III. 
The respective YFP fluorescence shows that the SF21 and Hi5 cells were infected at efficiencies of 
at least 50 % (Hi5) and >90 % (SF21), which should be sufficient for the expression of the target 
protein at detectable levels. Daily samples were taken from the expression cultures for analysis. 
Both the supernatant and the cells were retained for analysis. Cell extracts were generated of the 
harvested cells (§ 2.8.5). The expression was terminated at 72 hours post infection (SF21) and 
96 hours post infection (Hi5). The total cultures were harvested. To monitor the expression, the 
supernatants as well as the soluble and insoluble cell extract fractions upon centrifugation were 
analyzed by SDS-PAGE and Western blot. However, neither the wildtype nor the mutant form of 
Tmprss2 could be detected, with the exception of a very faint (and hence not reliably strong) signal 
of ~20 kDa in the insoluble lysate fraction (see Appendix III.3). 
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Therefore, the Western blot analysis was repeated with chemiluminescent staining to increase the 
sensitivity (§ 2.9.3). The Western blots were performed with the daily samples of the supernatants 
and the soluble lysate fractions. In addition, the insoluble lysate fractions of the respective final 
samples (72 h and 96 h post infection) were included in the analysis. Moreover, 1 mL supernatant 
samples from the total harvested cultures were concentrated twenty-fold by TCA precipitation 
(§ 2.8.3) to further enhance the detection. The results of the chemiluminescent Western blots are 
depicted in Figure 3.32. The Western blots were developed for an extended exposure time of 900 s 
to ensure the detection of the lowest possible amount of protein. Neither form of Tmprss2 was 
detectable in the supernatant samples, even after TCA precipitation. The aforementioned ~20 kDa 
band was clearly detected in the insoluble fraction. Tmprss2 should be detectable at ~45 kDa and 
~30 kDa under denaturing conditions (§ 3.2.1). Hence, the ~20 kDa band could present the false-
positive detection of a cross-reacting host protein.  
 
Figure 3.32. Analysis of the Tmprss2 expression in SF21 / Hi5 cells by chemiluminescent Western blots. 
The Western blots were developed for an extended time for 900 s. The daily supernatant samples and the 
respective soluble lysate fractions of the cultures were analyzed. The times (0 – 96 h) indicate the hours post 
infection. TCA precipitated supernatant from the harvested culture was included in the analysis. The 
insoluble cell lysate was only loaded for the final sample (72 h or 96 h, respectively). The only observed signal 
was a 20 kDa band in the insoluble fraction (arrow) that was present for both insect cell lines. The Western 
blot was performed with a primary mouse α-Flag mAb and a secondary HRP-conjugated α-mouse pAb. 
Chemiluminescent HRP-staining was done with the Lumi-Light Western Blotting Substrate (Sigma). 
(Processed) Tmprss2-D343N from P. pastoris KM71H/pPICZα-Tmprss2-D343N C116 served as a positive 
control (PC). Mw standard (M): PageRuler Prestained Plus. 
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Alternatively, the signal could be related to Tmprss2. This could indicate that Tmprss2 is present in 
the secretory pathway, as the insoluble fraction includes the ER. However, this was not subjected to 
further analysis for two reasons. First, the 20 kDa signal was only detected on Western blots, which 
were extensively developed with a highly sensitive chemiluminescent staining method. This 
indicates very low levels of the detected protein. So even if the signal would be related to Tmprss2, 
the expression level in the tested insect cell lines would be too low to generate the required 
amounts of the target protein. Secondly, in this case, the ~20 kDa band would most likely result 
from the undesired cleavage of Tmprss2 by host cell proteases.  
In summary, the results show that Tmprss2 is not secreted in insect cells at detectable levels, 
despite sufficiently high efficiencies of the baculoviral infection. Hence, insect cells do not present 
a viable alternative to P. pastoris as an expression host for Tmprss2. Consequently, this approach 
was not further pursued in favor of improving the expression yields of Tmprss2 in P. pastoris. 
 Optimization of the Tmprss2 constructs for the production in 
P. pastoris 
Tmprss2 could not be successfully expressed and secreted in HEK293-6E, SF21 or Hi5 cells 
(§ 3.2.3). A preliminary test expression of Tmprss2 was also conducted in E. coli Rosetta (DE3) 
with a periplasmic signal sequence. However, Tmprss2 was not expressed at detectable levels (data 
not presented). In contrast, P. pastoris offered proper processing and secretion of Tmprss2 into the 
supernatant during the previously described experiments, although only low expression yields were 
obtained (§ 3.2.1 and 2.3). Overall, P. pastoris presented the most feasible alternative among the 
tested expression hosts for the production of Tmprss2. Hence, several optimizations to the target 
gene constructs were assessed to improve the production yields of Tmprss2 in P. pastoris.  
3.2.4.1 Expression of the serine protease domain of mouse Tmprss2 in P. pastoris 
An important aim of this project was to establish a method for the generation of sufficiently high 
amounts of Tmprss2 for co-crystallization with HA H1. The expression of truncated versions of a 
target protein can significantly enhance the expression yields, because of the lower complexity of 
the constructs. It was tested whether the secretory expression of just the serine protease domain 
(SPD) of Tmprss2 would provide a substantial improvement over the expression of the whole 
ectodomain (§ 3.2.1). 
The SPD of Tmprss2 (amino acids 254 – 490 of the full length protein) was cloned into pPICZα-A 
(Thermo Fisher Scientific) from the existing expression vectors pPICZα-Tmprss2-WT and 
pPICZα-Tmprss2-D343N (§ 2.3). Thereby, the C-terminal tags of the recombinant genes were 
included. The vectors were named pPICZα-Tmprss2-SPD-WT and pPICZα-Tmprss2-SPD-D343N. 
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The vectors were respectively linearized and transformed into P. pastoris KM71H (§ 2.6.10). 
Primary selection was performed on YPDS agar plates (100 µg/mL Zeocin). Single clones were 
isolated on YPD agar plates with 100 µg/mL and 1000 µg/mL Zeocin to select for multi copy 
insertions, which had been shown to be favorable for the expression of Tmprss2 in the previous 
experiment (§ 3.2.1). Clone numbers were assigned as described previously for the full ectodomain 
(§ 3.2.1). The prefix “s” was added to distinguish the new clones expressing only the SPD. The 
expression of 142 clones each was tested in high-throughput (§ 2.8.1). An overview of these clones 
is listed in Table 3.5. The current jackpot clones 17 (KM71H/pPICZα-Tmprss2-WT) and 116 
(KM71H/pPICZα-Tmprss2-D343N) were cultivated in parallel as comparative controls to correlate 
the expression from the new clones. Furthermore, untransformed KM71H were cultivated in 
parallel as a negative control. The expression was comparatively tracked by immunostaining of 
supernatant samples on a slot blot (§ 2.9.4).  
Table 3.5. Survival of the analyzed Tmprss2-SPD clones on an increased Zeocin concentration. 
All transformants showed growth at a Zeocin concentration of 100 µg/mL. 
Highest concentration of Zeocin 
survived [µg/mL] 
Tmprss2-SPD-WT Clones Tmprss2-SPD-D343N Clones 
1000 s6, s28, s34, s79, s88, s94, s201, 
s235, s239 
s106, s124, s127, s136, s137, s138, 
s159, s195, s195, s301, s316, s322, 
s323, s335, s336, s339, s341  
 
The results of the slot blot are shown in Figure 3.33. Expressing just the SPD of Tmprss2 did not 
enhance the yields over the jackpot clones 17 and 116, although the SPD is a significantly smaller 
and simpler target protein compared to the whole ectodomain. It is possible that the folding of the 
protein – particularly the SPD – presents the major bottleneck for the expression of Tmprss2 in 
P. pastoris. In this case, the removal of the N-terminal domains would not necessarily result in an 
increased product yield. Even more so, their removal could also be disadvantageous, if they aid in 
the folding or stabilization of the SPD. It should be noted that the active form of Tmprss2 was 
again expressed at significantly lower rates than its mutant counterpart, which was particularly 
evident for the multi insertion clones. This is congruent with the former observations made for the 
whole ectodomain (§ 3.2.1). Consequently, it was concluded that the expression of just the SPD did 
not comprise an improvement over the production of the whole ectodomain of Tmprss2 in 
P. pastoris. Hence, this approach was not further pursued. 
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Figure 3.33. Slot blot of the expression screen of Tmprss2-SPD. 
Clones of KM71H/pPICZα-Tmprss2-SPD-D343N (s100 – s199; s300 – 341) and KM71H/pPICZα-Tmprss2-
SPD-WT (s1 – 99; s200 – s242) were screened in high-throughput for the expression of the respective Tmprss2 
form. The expression was conducted in 500 µL BMMY for 48 hpi. 300 µL of the culture supernatant were 
loaded onto the slot blots. Clones 116 (KM71H/pPICZα-Tmprss2-D343N) and 17 (KM71H/pPICZα-Tmprss2-
WT) were included in the expression screen as comparative controls. The negative control/NC (supernatant 
from untransformed cells) did not show any signal. This indicates no cross interference by natively secreted 
host proteins with the immunostaining. None of the screened clones was stronger than clones 116 and 17 for 
the expression of Tmprss2. The mutant form is expressed at higher rates than the wildtype form. The 
expression levels roughly correlate to multi insertions of the vector, as evident by survival on high 
concentrations of Zeocin. The slot blot was conducted with a primary mouse α-Flag mAb and a secondary 
goat AP-conjugated α-mouse pAb. Colorimetric AP staining was performed with NBT and BCIP. 
3.2.4.2 Expression of codon-optimized Tmprss2 in P. pastoris 
In the next step to improve the expression yields of Tmprss2, gene optimization for P. pastoris was 
performed. A codon optimized Tmprss2-D343N gene was ordered from GenScript (“Tmprss2-
D343Nopt”), including the C-terminal tags used before (“TEV site – 1xFlag tag – 8xHis tag”). The 
wildtype gene Tmprss2-WTopt was generated by fusion PCR to re-introduce the original codon 
“GAC” (aspartic acid, D) in place of “AAC” (asparagine, N). Subsequently, Tmprss2-WTopt and 
Tmprss2-D343Nopt were cloned into pPICZα-A (Thermo Fisher Scientific), as described in detail 
in chapter 2.3. The vector products were designated as pPICZα-A-Tmprss2-WTopt and pPICZα-A-
Tmprss2-D343Nopt.  
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Each vector was linearized and transformed into P. pastoris KM71H (§ 2.8.1). Primary selection 
was conducted on YPDS agar plates with Zeocin (100 µg/mL). For single clone isolation, the 
clones were transferred to YPD agar plates with 100 µg/mL and 1000 µg/mL Zeocin. Clone 
numbers were assigned as described previously for the full ectodomain (§ 3.2.1). The prefix “o” 
was used to denote the clones harboring the optimized genes. The clones that were able to survive 
on the higher Zeocin concentration are denoted in Table 3.6. 
Table 3.6. Survival of the analyzed Tmprss2opt clones on an increased Zeocin concentration. 
All transformants showed growth at a Zeocin concentration of 100 µg/mL. 
Highest concentration of Zeocin 
survived [µg/mL] 
Tmprss2-WTopt Clones Tmprss2-D343Nopt Clones 
1000 o5, o8, o13, o16, o17, o20, o41, o50, 
o72, o84, o201, o202, o224, o225  
o103, o104, o107, o108, o111, o112, 
o115, o116, o119, o123, o139, o155, 
o159, o167, o187, o199, o304 
 
Initially, 120 clones of KM71H/Tmprss2-pPICZα-Tmprss2-D343Nopt were tested for the 
expression of Tmprss2-D343N. The respective jackpot clone with the original CDS 
(KM71H/pPICZα-Tmprss2-D343N 116) was cultivated in parallel for comparison. Untransformed 
KM71H cells were included in the experiment as a negative control. The expression screen was 
performed for 48 hpi in high-throughput (§ 2.8.1). The relative protein amounts were analyzed on 
slot blots (§ 2.9.4). Purified Tmprss2-D343N was used as a positive control for the 
immunostaining. The results are depicted in Figure 3.34. The new clones harboring the optimized 
gene were significantly stronger in respect to the Tmprss2 expression levels than the ones with the 
original CDS of Tmprss2-D343N (§ 3.2.1.2). This is evident by comparing the respective slot blot 
signals to the control clone 116. Clones o107 and o108 showed particularly strong signals and were 
retained for further analysis. The same expression screen was also conducted with 140 clones of 
KM71H/pPICZα-Tmprss2-WTopt. As controls, KM71H/pPICZα-Tmprss2-D343Nopt clone o108, 
KM71H/pPICZα-Tmprss2-D343N clone 116 and KM71H/pPICZα-Tmprss2-WT clone 17 were 
cultivated in parallel. Similar to the expression with the original CDS (§ 3.2.1.2), Tmprss2-WT was 
expressed at considerably lower levels than the mutant form D343N even in the clones harboring 
the optimized gene. This further supports the hypothesis that the enzymatic activity carried out by 
Tmprss2-WT may present the bottleneck for its own expression. Still, improved expression levels 
were observed for multi copy clones, such as clones o5 and o20. Hence, these clones were retained 
for further analysis. 
In the next step, the expression yields of the maximum producer clones were quantified. For this, 
1 L BMMY expression cultures (5 L of preculture) were set up with clones o108 (D343N) and o20 
(WT) (§ 2.8.1). At 0 hpi, the cultures had an OD595 of 53 (D343N) and 58 (WT). The supernatants 
were harvested at 48 hpi and diafiltered for affinity capture of Tmprss2 (§ 2.8.7). Tmprss2 was 
captured using a 1 mL Ni-NTA column (§ 2.8.11). The different fractions of the affinity capture 
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were analyzed by SDS-PAGE and Western blot (Figure 3.35). In contrast to Tmprss2-D343N, the 
purified Tmprss2-WT was only visible in the Western blot, which is consistent to the lower 
observed expression levels during the expression screen (Figure 3.34). The elution fractions 1 to 8 
for clone o108 and 1 to 5 for clone o20 were pooled and dialyzed to remove imidazole. The codon 
optimized clone o20 (Tmprss2-WT) had displayed higher productivity compared to the original 
jackpot clone KM71H/pPICZα-Tmprss2-WT 17 (Figure 3.34). Still, the amounts expressed by 
clone o20 in the 1 L expression culture could not be reliably quantified using a Nanodrop 
spectrometer. In contrast, the mutant form D343N expressed from clone o108 could be quantified 
at ~0.3 mg/L (0.6 mg total). This presents a 100 % increase over the amounts obtained from the 
original jackpot clone KM71H/pPICZα-Tmprss2-D343N 116 (§ 2.3).  
 
Figure 3.34. Slot blot of the expression screen of Tmprss2opt. 
300 µL of culture supernatant from the clones KM71H/pPICZα-Tmprss2-D343Nopt (o100–o199; o300–o320; 
left-hand side) and KM71H/pPICZα-Tmprss2-WTopt (o1 – o99; o200 – 240; right-hand side) were loaded per 
slot to assess the expression levels. The optimized clones provide improved expression levels. Clones o107 
and o108 were identified as the strongest producing clones for Tmprss2-D343N. Clone o20 was identified as 
the strongest producing clone for Tmprss2-WT. Generally, the mutant form is expressed at higher rates than 
the wildtype form. The expression levels roughly correlate to multi insertions of the vector, as evident by 
survival on high concentrations of Zeocin. Arrows indicate the clones delivering the strongest expression 
signals. Controls are denoted in bold-italics. They comprised purified Tmprss2-D343N as a positive control 
(PC) as well as culture supernatant from parallel cultivated clones KM71H/pPICZα-Tmprss2-D343N clone 
116; KM71H/pPICZα-Tmprss2-WT clone 17; KM71H/pPICZα-Tmprss2-D343Nopt clone o108 (for the WT 
screen) and supernatant from untransformed KM71H as a negative control (NC). The blots were stained with 
a primary mouse α-Flag mAb and a secondary goat AP-conjugated α-mouse pAb. 
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Taken together, the results show that the codon optimization was beneficial for the expression of 
Tmprss2. However, Tmprss2-WT is still expressed at significantly lower levels than Tmprss2-
D343N and could consequently not be quantified from a 1 L expression scale. 
 
Figure 3.35. Affinity capture of 2 L Shake flask scale expression of Tmprss2 (optimized) from P. pastoris. 
SDS-PAGE and Western blot are shown with the harvested culture supernatant (S), the flow through of the 
Ni-NTA column (F), the wash fraction (W) and the elution fractions (0-9) of the Ni-NTA affinity capture. 
Tmprss2 was completely captured from the supernatant. For Tmprss2-D343N the elution fractions 1 to 8 were 
pooled for further analysis. For Tmprss2-WT, the protein was only visible on the Western blot. The elution 
fractions 1 to 5 were pooled. Staining of the SDS gel was performed with InstantBlue. The Western blot was 
performed with a primary mouse α-Flag mAb and a secondary goat AP-conjugated α-mouse pAb. 
Colorimetric staining was done with NBT and BCIP. Mw standard (M): PageRuler Prestained Plus. 
3.2.4.3 Evaluation of human serum albumin as a cargo protein for Tmprss2  
The low expression levels of Tmprss2 and its fast degradation in the medium during cultivation 
present major bottlenecks in its production. Human serum albumin (HSA) is expressed at very high 
levels in P. pastoris. Furthermore, it is highly stable in the culture supernatant, which allows for the 
accumulation of high amounts of the protein over an extended period of time. For this reason, it 
was tested whether the fusion of HSA to Tmprss2 presented a viable option to improve the 
expression yields of the latter protein in P. pastoris by two means. First, the strongly secreted HSA 
could aid the secretion of Tmprss2 and serve as a cargo protein. Secondly, the stability of HSA in 
the supernatant might also protect Tmprss2 from degradation. This would allow extending the 
methanol induction phase, i. e. the productive time of a single batch of previously grown cells. For 
this, HSA was fused N-terminally to Tmprss2 separated by a GSGG linker and a PreScission 3C 
protease recognition site. Hence, the secretion of the fusion protein HSA-Tmprss2 is mediated by 
the native HSA secretion signal. 
The vector pPICZ-HSA was generated by replacing the original MF-α ss of pPICZα-A (Thermo 
Fisher Scientific), located upstream of the MCS, with the HSA gene (including the sequences of the 
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GGSG linker and the 3C site). HSA was cloned in frame with the c-myc and His6 tags of  
pPICZα-A, located downstream of the MCS, to enable individual expression of tagged HSA. The 
initial test expression of the HSA-Tmprss2 fusion protein was limited to Tmprss2-D343N, as the 
individual mutant form had previously been expressed at quantifiable levels (in contrast to 
Tmprss2-WT). The gene Tmprss2-D343Nopt was cloned into the MCS of pPICZ-HSA in frame 
with HSA. The resulting vector was named pPICZ-HSA-Tmprss2-D343Nopt. The cloning steps are 
described in detail in chapter 2.3. 
The vectors pPICZ-HSA-Tmprss2-D343Nopt and pPICZ-HSA (“empty”) were respectively 
linearized and transformed into P. pastoris KM71H. The transformed clones were designated by 
the prefixes “h” (KM71H/pPICZ-HSA) and “ht” (KM71H/pPICZ-HSA-Tmprss2-D343N). 
Following primary selection on YPDS Zeocin agar plates and single clone isolation, a high-
throughput expression screen was performed in 500 µL BMMY cultures. The jackpot clone 
KM71H/pPICZα-Tmprss2-D343Nopt o108 was included in the experiment as a comparative 
control. Methanol induction was maintained for 48 hpi. Slot blots were performed with the culture 
supernatants (§ 2.9.4). In a first test round, 24 clones of KM71H/pPICZ-HSA-Tmprss2-D343N 
were tested. The overall expression levels were significantly lower than that of the jackpot clone 
o108. As a consequence, 68 additional clones were analyzed in the same way. Furthermore, 71 
clones of KM71H/pPICZ-HSA were cultivated in parallel for comparison. The strongest clone 
from the initial set (ht11), the jackpot clone o108 and empty KM71H cells were included as 
controls. For the slot blots, the supernatants of the clones expressing HSA were diluted 1:10. The 
supernatants of the clones expressing HSA-Tmprss2-D343N were not diluted prior to the analysis. 
The results of both expression screens are shown in Figure 3.36. The expression of HSA-Tmprss2-
D343N was significantly lower than the expression of the individual proteins (HSA or Tmprss2-
D343N) in all tested clones.  
To evaluate this observation, the total cell lysate and the supernatant of the maximum producer 
clone of HSA-Tmprss2-D343N (ht11) and a weaker producer (ht31) were analyzed by SDS-PAGE 
and Western blot (§ 2.9). The maximum producer clones of the individual constructs (HSA: clone 
h34; Tmprss2-D343N: o108) served as comparative controls. The expression experiment was 
repeated with these clones. The harvested culture supernatants were concentrated twenty-fold by 
TCA precipitation (§ 2.8.6). Cell extracts were generated (§ 2.8.4). The results of the SDS-PAGE 
and the Western blot are shown in Figure 3.37. Unlike the individual proteins (HSA or Tmprss2-
D343N), the HSA-Tmprss2-D343N fusion protein showed a strong smeared signal in the insoluble 
cell extract fraction. One possible explanation could be that the fusion protein cannot be secreted 
properly. Speculatively, HSA-Tmprss2-D343N might get stuck in the ER, where it would be 
subsequently degraded.  
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All in all, the N-terminal fusion of HSA to Tmprss2 did not lead to improved expression yields of 
the target protein. For this reason, this project path was not pursued any further in this PhD thesis. 
Instead, it was tested, whether the expression process could be optimized in order to improve the 
product yields of Tmprss2 with the current jackpot clones. 
 
 
Figure 3.36. Slot blots of the expression screen of HSA and HSA-Tmprss2-D343N. 
In a first test, 24 clones of KM71H/pPICZ-HSA-Tmprss2-D343Nopt (ht1-h24) were analyzed for the 
expression of the fusion protein HSA-Tmprss2-D343N. Subsequently, 68 more clones (ht25-ht92) were 
analyzed. In parallel, 71 clones of KM71H/pPICZ-HSA (h1-h71) were analyzed in comparison. Controls are 
denoted in bold-italics. The controls comprised purified Tmprss2-D343N as a positive control (PC). Moreover, 
culture supernatant the clones KM71H/pPICZα-Tmprss2-D343Nopt clone o108 and untransformed KM71H 
cells (negative control, NC) served as comparative controls. For each sample of KM71H/pPICZ-HSA-
Tmprss2-D343Nopt and for the controls, 150 µL of culture supernatant were directly loaded per slot. For 
KM71H/pPICZ-HSA the supernatant was diluted 1:10 in PBS to a final volume of 150 µL. The slot blots were 
stained with a primary mouse α-His mAb and a secondary goat AP-conjugated α-mouse pAb. Colorimetric 
staining was done with NBT and BCIP. The clones expressing the HSA-Tmprss2 fusion construct performed 
significantly weaker than the clones expressing the two individual proteins. The strongest clone expressing 
HSA-Tmprss2-D343N (ht11) is marked in bold and indicated by the black arrow. 
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Figure 3.37. Analysis of the localization of the HSA-Tmprss2-D343N fusion protein in P. pastoris. 
The culture supernatants and the cell extracts of the HSA expressing clone h34, the Tmprss2-D343N 
expressing clone o108 and the two HSA-Tmprss2-D343N expressing clones ht11 and ht31 were analyzed. The 
SDS-PAGE and Western blot are shown with the TCA precipitated supernatant (SN) (1:20 conc.) as well as the 
soluble and insoluble cell lysate fractions. The dominant signal of the HSA-Tmprss2-D343N fusion protein is 
presented by a strong smear in the insoluble extract fraction, which indicates proteolytic degradation. Staining 
of the SDS gel was performed with InstantBlue. The Western blot was performed with a primary mouse α-His 
mAb and a secondary goat AP-conjugated α-mouse pAb. Colorimetric staining was done with NBT and BCIP. 
Mw standard (M): PageRuler Prestained Plus. 
 Optimization of cultivation and downstream processing for the 
production of Tmprss2 in P. pastoris 
Even after the gene optimization, Tmprss2 was only produced at low levels in P. pastoris from 
jackpot clones identified by extensive expression screens. Hence, it is unlikely that the expression 
yields could be sufficiently improved from the “gene / construct side”. Particularly Tmprss2-WT 
was problematic in this regard, because it was hypothetically diminishing its own maximal 
production rate due to its enzymatic activity. Consequently, it could be impossible to generate 
producer clones with significantly higher expression yields. 
Apart from the productivity of the generated producer clones, the cultivation strategy and the 
downstream processing are major factors that influence the effective space-time yields of the target 
protein. For this reason, it was assessed, whether minimizing the required process time and the loss 
of the target protein during the downstream process could improve the effective product yields of 
Tmprss2 with the current jackpot clones. 
3.2.5.1 Direct capture of Tmprss2 from the culture supernatant using Q-Sepharose  
In the previously described experiments, Tmprss2 was purified from harvested P. pastoris culture 
supernatant in two separate steps. The first step comprised diafiltration and concentration of the 
culture supernatant. The second step consisted of the His tag based affinity capture of the target 
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protein. This could result in a time-consuming process, particularly for large scale productions of 
Tmprss2. The amount of required time could be detrimental for the quality of the target protein. 
Moreover, each separate step during downstream processing is generally associated with a loss of 
the target protein. For this reason, it was analyzed whether the downstream processing could be 
streamlined.  
One possible approach was to initially capture Tmprss2 directly from the culture supernatant using 
ion exchange chromatography to omit the diafiltration step. As a secondary effect, this would also 
result in a “pre-purification” of the target protein prior to further tag based affinity capture steps. 
This “double purification” would beneficially result in lower amounts of possible contaminant 
proteins in the final eluate. In combination with an ÄKTApilot (GE Healthcare), which is 
particularly suited for large sample volumes and high flow rates, this method would result in a 
time-saving process to purify Tmprss2. Furthermore, the ÄKTApilot can be operated with two 
separate columns. Hence, the eluent fraction of the ion exchange column (containing Tmprss2) 
could be directly and automatically loaded onto a second column for His tag based capture in the 
same run. This would minimize the process time and reduce the risk of protein degradation 
occurring over time. 
To initially test the capture of Tmprss2 by ion exchange, Tmprss2-D343N was produced from 
clone o108 (KM71H/pPICZα­Tmprss2-D343N) in a Labfors bioreactor (§ 2.8.1). The culture 
supernatant was diluted 1:5 in in 25 mM Tris buffer, pH 9.0 to adjust the pH. The ion exchange 
capture of Tmprss2-D343N (estimated pI 6.43) from the diluted supernatant was successfully 
performed with a Q-Sepharose FF column (GE Healthcare) (§ 2.8.11). Tmprss2-D343N was eluted 
from the resin at a NaCl concentration of 500 mM (Figure 3.38A). Tmprss2 was subsequently 
captured from the respective ion exchange eluent fraction using a 1 mL HisTALON resin (GE) 
(Figure 3.38B). This shows that Q-Sepharose columns present an adequate method to directly 
capture Tmprss2 from the culture supernatant. Furthermore, Tmprss2 can be further purified by His 
tag based affinity capture from the respective eluent fraction.  
This could provide a time-saving, one-step setup using the ÄKTApilot. The proposed method 
would be particularly beneficial for large culture volumes, which could be essentially required to 
produce sufficient amounts of Tmprss2 for structural analyses. 
An alternative approach to the use of two separate resins would be the direct tag based affinity 
capture of Tmprss2 from the culture supernatant. This method would take a pass on the benefits of 
the “double purification” described above. However, it would enable the fast and direct capture of 
Tmprss2 in one single purification step even without an ÄKTApilot. This would be particularly 
advantageous for smaller culture volumes (e. g. test expressions in shake flasks). 
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Figure 3.38. Direct capture of Tmprss2-D343N from P. pastoris culture supernatant.  
At pH 9.0, Tmprss2-D343N was binding to Q-Sepharose FF up to a NaCl concentration of 500 mM (A). 
Subsequently, the protein could be purified from the eluent fraction (500 mM II, III) on a HisTALON resin (B). 
Indices: S: Supernatant; F: Flowthrough; 100 mM – 1000 mM: NaCl concentrations for Q-Sepharose elution;  
I-III: start, maximum and tail fractions of observed peaks following NaCl concentration increase; W: Wash 
fraction HisTALON; 0 to 10: eluent fractions HisTALON. Staining of the SDS gel was performed with 
InstantBlue. The Western blot was performed with a primary mouse α-Flag mAb and a secondary goat AP-
conjugated α-mouse pAb. Colorimetric staining was done with NBT and BCIP. Mw standard (M): PageRuler 
Prestained Plus. 
Hence, the possibility to perform the direct, tag based capture of Tmprss2 was assessed with the 
resin materials Ni-NTA HisTrap (GE Healthcare) or ANTI-FLAG (Sigma). For this, Tmprss2-
D343N was expressed at 1 L scale in shake flask cultures from clone o108 (§ 2.8.1). The harvested 
culture supernatants were cleared by centrifugation and filtration as described in chapter 2.8.1, but 
not diafiltered. The experiment was performed with 20 mL culture supernatant samples. The 
detailed protocol is provided in chapter 2.8.10. Briefly, the binding to the materials was tested in 
batch. The samples were supplemented with 50 mM of binding buffer to adjust the pH (pH 7.4) for 
proper conditions of the target protein to the respective resin materials.  
The direct capture on Ni-NTA material was tested with or without the addition of 1 mM NiSO4 as a 
protecting supplement against chelating substances. Furthermore, the Ni-NTA samples were 
supplemented with 10 mM imidazole to provide more specific binding of the target protein to the 
resin. The ANTI-FLAG samples were not supplemented with any additional substances. However, 
two different conditions were tested for the elution of Tmprss2-D343N from the ANTI-FLAG 
resin: The elution at low pH (pH 3.5) and the competitive elution (against Flag peptide). Samples 
of the respective supernatants before and after binding (“non-bound”), the wash fractions and the 
eluent fractions were analyzed by SDS-PAGE and Western blot (§ 2.9.3). To evaluate the presence 
of left-over or precipitated target protein on the material, the used resin materials were each boiled 
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in 2x concentrated SDS loading buffer. The results are depicted in Figure 3.39. Ni-NTA binding 
was improved significantly by the addition of 1 mM NiSO4 to the supernatant. The capture by 
ANTI-FLAG material resulted in protein degradation under both applied elution conditions. 
Particularly low pH elution was detrimental for the protein quality. It was concluded that the direct 
capture Tmprss2 from the culture supernatant by Ni-NTA under the addition of 1 mM NiSO4 
presented the most feasible method among the four tested alternatives. Therein, the use of Ni-NTA 
beneficially also comprises the more cost-efficient approach in comparison to ANTI-FLAG 
material. 
 
Figure 3.39. Binding test of Tmprss2 to Ni-NTA or ANTI-FLAG resin from P. pastoris culture supernatant.  
The direct binding of Tmprss2-D343N was tested with Ni-NTA and ANTI-FLAG resin. For Ni-NTA, the 
binding to the material was tested without (His) and with the addition of 1 mM NiSO4 (His+Ni). The elution 
was performed competitively with imidazole. For ANTI-FLAG, the elution was performed either by low pH 
(Flag-pH) or by competition with Flag peptide (Flag-P). The samples comprise the (supplemented) culture 
supernatant before binding, the supernatant fraction after binding (non-bound), the wash fraction, the eluent 
fraction and the beads. Direct capture by Ni-NTA was significantly more efficient in the presence of 1 mM 
NiSO4. Direct binding via ANTI-FLAG resulted in protein degradation. Staining of the SDS gel was performed 
with InstantBlue. The Western blot was performed with a primary mouse α-Flag mAb and a secondary goat 
AP-conjugated α-mouse pAb. Colorimetric staining was done with NBT and BCIP. Mw standard (M): 
PageRuler Prestained Plus. 
Taken together, the results of the two experiments show that the downstream process can be 
streamlined by directly capturing Tmprss2 from the culture supernatant in a time-efficient, one-step 
purification process. On the one hand, the direct His tag based capture of Tmprss2 presents a fast 
and cost-efficient method. On the other hand, the use of an ÄKTApilot would be particularly 
beneficial to handle large culture volumes during scale-up, as two columns could be managed in a 
single run. In this case, the “double purification” of Tmprss2 using the Q-Sepharose ion exchange 
column prior to His tag based capture would present an appropriate approach, as it would 
conceivably reduce the risk of contaminant proteins in the final eluate.  
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3.2.5.2 Iterative methanol induction to optimize the production process of Tmprss2 
The production process with mutS strains like KM71H and the AOX1 promoter usually comprises 
two separate phases: The accumulation of cell mass under glycerol conditions and the methanol-
induced expression phase, in which the cells do not proliferate at high rates anymore. The first 
phase usually takes up about 48 h. This is half of the time of the total production process of 
Tmprss2, as the methanol induction is equally maintained for 48 hpi to ensure the protein quality 
(§ 3.2.1). Consequently, each production process is “void” for half of the time, in which sufficient 
amounts of the producer cells have to be generated. As discussed in chapter 3.2.4.3 for the HSA 
fusion protein, the prolonged expression from one generated batch of cells might present a viable 
option to enhance the space-time yields of Tmprss2. Since the N-terminal fusion of HSA did not 
provide such a way, the iterative induction of the same batch of cells was assessed as an alternative 
approach to reach this goal. The idea was to harvest the supernatant at 48 hpi (as before). However, 
instead of discarding the cells, the pellet would be resuspended in fresh expression medium for a 
second round of expression (again for 48 hpi). Therein, it was of interest whether the iterative 
production phases would result in comparable expression yields of Tmprss2. 
Additionally, the used media in this experiment were supplemented with of the antifoam (AF) 
J673A (Struktol). J673A had been reported to significantly enhance the total yield of GFP 
produced in P. pastoris as well as its secretion to the culture supernatant (Routledge et al. 2011). 
Hence, it was tested whether the addition of J673A was beneficial for the secretory production of 
Tmprss2 and enable higher yields in shake flask cultures. The experiment was initially limited to 
the the codon optimized jackpot clone KM71H/pPICZα-Tmprss2-D343Nopt o108, because only 
Tmprss2-D343N had previously been expressed at quantifiable (and thereby, comparable) levels 
(§ 3.2.4.2). The expression was conducted at 1 L scale in shake flask cultures (§ 2.8.1). The cells 
were grown in 5 L of BMGY medium with 1 % (v/v) J673A (BMGY+AF) for 48 h. The grown 
cells were harvested and resuspended in 1 L BMMY. An OD595 of 80 was measured for the 
expression culture. Directly after the OD595 measurement, 1 % (v/v) J673A was added to the 
culture medium (BMMY+AF) and the production phase was started.  
At 48 hpi, the culture supernatant was separated from the cells by centrifugation at 3.000 x g. The 
harvested cells were resuspended in 1 L of fresh BMMY medium for the second (iterative) 
production phase. An OD595 of 86 was measured, showing that the cells did not proliferate 
significantly since the first methanol induction of the culture. This was anticipated due to KM71H 
being a mutS strain. Thus, the ratio of the nutrients (medium) to the cells in the second production 
phase was comparable to the first production phase. J673A was added again to the medium 
(BMMY+AF) and the cultivation was continued. The expression was again conducted for 48 hpi, 
after which the supernatant was harvested as before.  
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Tmprss2 was directly captured on Ni-NTA from the respectively harvested and cleared culture 
supernatants of the two iterative production phases using the previously developed protocol 
(§ 3.2.5.1). As described in chapter 3.2.5.1, the pH of the supernatants was adjusted to 
pH 7.4 through the addition of an appropriate sodium phosphate buffer. The supernatants were 
supplemented with 10 mM imidazole and 1 mM NiSO4. The supplemented supernatants were then 
respectively loaded onto a 1 mL Ni-NTA column to capture Tmprss2-D343N (§ 2.8.11). The 
fractions of the purification process were analyzed by SDS-PAGE and Western blot (Figure 3.40).  
 
Figure 3.40. Direct Ni-NTA affinity capture of Tmprss2-D343N from 1 L shake flask cultures in P. pastoris. 
The expression of Tmprss2-D343N from clone o108 was analyzed in a 1 L expression culture. The cells were 
used for two subsequent induction phases à 48 hpi after their initial growth. The Ni-NTA affinity capture was 
performed directly from the culture supernatant in the presence of 1 mM NiSO4. SDS-PAGE and Western blot 
are shown with the harvested culture supernatant (S), the flowthrough (F), the wash fraction (W) and the 
elution fractions (0 to 9). Tmprss2 was virtually completely captured from the supernatant in both cases. Both 
induction phases resulted in the expression of similar amounts of Tmprss2-D343N. Staining of the SDS gels 
was performed with InstantBlue. The Western blots were conducted with a primary mouse α-Flag mAb and a 
secondary goat AP-conjugated α-mouse pAb. Colorimetric staining was done with NBT and BCIP. Mw 
standard (M): PageRuler Prestained Plus. 
The elution fractions 2 to 8 (first induction) and 1 to 8 (second induction) were pooled and dialyzed 
(§ 2.8.7). The protein concentration was measured with a Nanodrop (§ 2.6.14). Tmprss2-D343N 
was expressed at similar levels of 0.6 mg/L and 0.7 mg/L during the two production phases. This 
proves that the iterative induction of the cells is possible and results in comparable expression 
yields. Furthermore, the addition of J673A to the culture media resulted in increased expression 
yields of Tmprss2-D343N. The respective yields in both production phases were considerably 
improved in comparison to the previously described experiments with the same codon optimized 
jackpot clone (o108) (§ 3.2.4.2).  
Consequently, it was tested, if the optimized protocol would also improve the expression yield of 
Tmprss2-WT using the optimized jackpot clone KM71H-pPICZα-Tmprss2-WTopt o20. For this, 
the expression was conducted at an identical scale of (1 L of expression culture). The cells were 
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grown in 5 L BMGY+AF medium for 48 h. Two iterative rounds of production (48 hpi each) were 
performed in BMMY+AF medium with the same batch of cells. As described above, the OD595 of 
the expression culture was measured at 0 hpi. Thereby, an OD595 of 71 and an OD595 of 78 were 
measured for the first and the second induction phase, respectively. Tmprss2-WT was captured 
directly from the harvested and cleared culture supernatant on a 1 mL Ni-NTA column. The results 
are depicted in Figure 3.41. The elution fractions were pooled, concentrated to 1 mL with a 
Vivaspin 6 (10 kDa) column and dialyzed (§ 2.8.7, 2.8.8). The protein concentration was measured 
with a Nanodrop (§ 2.6.14). The optimized protocol resulted in the production of quantifiable 
amounts of Tmprss2-WT. The expression was quantified at 70 µg/L (first induction) and 80 µg/L 
(second induction). Thus, it was finally possible to correlate the expression levels of Tmprss2-WT 
and Tmprss2-D343N from the respective jackpot clones o20 (WT) and o108 (D343N). Therein, the 
expression level of Tmprss2-WT is around ten-fold lower in comparison to Tmprss-D343N. 
 
Figure 3.41. Direct Ni-NTA affinity capture of Tmprss2-WT from 1 L shake flask cultures in P. pastoris. 
The expression of Tmprss2-WT from clone o20 was analyzed in a 1 L expression culture. The cells were used 
for two subsequent induction phases à 48 hpi after their initial growth. The Ni-NTA affinity capture was 
performed directly from the culture supernatant in the presence of 1 mM NiSO4. SDS-PAGE and Western blot 
are shown with the harvested culture supernatant (S), the flowthrough (F), the wash fraction (W) and the 
elution fractions (0 to 9). Tmprss2-WT was completely captured from the supernatant in both cases. Tmprss2-
D343N served as a positive control (PC). Both induction steps resulted in similar amounts of Tmprss2-WT. 
Staining of the SDS gels was performed with InstantBlue. The Western blots were performed with a primary 
mouse α-Flag mAb and a secondary goat AP-conjugated α-mouse pAb. Colorimetric staining was done with 
NBT and BCIP. Mw standard (M): PageRuler Prestained Plus. 
In summary, the volumetric expression yields of Tmprss2 were significantly improved by the 
overall optimized expression and purification process. The yield of Tmprss2-D343N was improved 
by a factor of 4x compared to the initially used protocol with the original gene, with which 
0.15 mg/L were obtained from 1 L shake flask expression cultures (§ 3.2.2). Moreover, Tmprss2-
WT was expressed at quantifiable amounts with this enhanced method. The cultivation of the cells 
under the addition of the AF reagent J673A resulted in higher yields of the secreted target protein. 
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Furthermore, the direct capture prevented the loss of the target protein due to additional steps, such 
as diafiltration and concentration. In addition to this, the iterative methanol induction resulted in 
comparable productivity and thus presents a considerably time-saving and work-efficient 
improvement over the original process.  
3.2.5.3 Evaluation of long-term storage possibilities for Tmprss2 
For crystallization, large amounts of highly pure protein are required. Due to its low expression 
levels, Tmprss2 requires the accumulation of the necessary amounts of protein over time in a series 
of production batches. However, Tmprss2 displays only low stability. During cultivation, first signs 
of degradation are evident from 72 hpi onwards (§ 3.2.1.1). During storage at 4 °C, degradation of 
the affinity captured protein was observed after approximately two weeks. This is visibly evident in 
the Western blot positive controls comprising purified Tmprss2-D343N, which were used during 
the test expression in insect cells or the HSA fusion tests (§ 3.2.3.2 and 3.2.4.3). Therefore, several 
storage conditions were investigated in order to identify a condition for long-term storage of 
Tmprss2 with relatively minimal loss of quality. The tested conditions included temperatures of -
20 °C and -80 °C and different concentrations of glycerol (0, 25 or 50 %). The test was conducted 
for 28 days of storage with 15 ng samples of the affinity captured Tmprss2-D343N (§ 3.2.5.2). An 
additional control sample stored at 4 °C. The samples were analyzed by SDS-PAGE and Western 
blot (§ 2.9). The results are shown in Figure 3.42. No visible degradation was observed for all 
samples stored at -20 °C and -80 °C. In contrast, significant degradation was evident for the sample 
stored at 4 °C. Consequently, the storage of Tmprss2 at either -20 °C or -80 °C presents an 
appropriate alternative to storage at 4 °C, regardless of the added amount of glycerol. 
 
Figure 3.42: Long-term storage stability test of Tmprss2-D343N. 
The storage was tested at -20 °C or -80 °C for 28 days with 15 ng samples of Tmprss2-D343N, which were 
supplemented with 0, 25 or 50 % of glycerol. The samples were either frozen slowly in a Mr. Frosty™ Freezing 
Container with isopropanol (Thermo Fisher Scientific) (“slow freezing”) or quickly frozen with liquid nitrogen 
(“shock freezing”). A sample stored at 4 °C served as a control. In contrast to the control, all frozen samples 
show significantly less degradation. Staining of the SDS gels was performed with InstantBlue. The Western 
blots were performed with a primary mouse α-Flag mAb and a secondary goat AP-conjugated α-mouse pAb. 
Colorimetric staining was done with NBT and BCIP. Mw standard (M): PageRuler Prestained Plus. 
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 Functional analysis of recombinant Tmprss2 
A preliminary enzymatic in vitro assay with Tmprss2-WT and Tmprss2-D343N was conducted. 
Therein, the functionality / activity of Tmprss2-WT should be initially evaluated. Moreover, 
proteolytic activity of Tmprss2-WT for the cleavage of hemagglutinin (HA) H1 was compared to 
the activity of the mutant form Tmprss2-D343N. 
Tmprss2 should cleave the unprocessed H1 (HA0) into two split halves (HA1 and HA2). This was 
tested in vitro using the previously produced recombinant Tmprss2-WT and Tmprss2-D343N 
proteins (§ 3.2.5.2). Recombinant hemagglutinin H1 produced in Hi5 cells was used as a substrate 
for the reaction, as described in chapter 2.9.6. Briefly, equal amounts of Tmprss2-D343N and 
Tmprss2-WT were respectively mixed with HA H1 (HA0) and incubated at 37 °C. An according 
mock control was set up without Tmprss2. Samples were taken after 3 h and 16 h of incubation and 
analyzed by Western blot (§ 2.9.3). The results are shown in Figure 3.43. Tmprss2-WT completely 
cleaved H1 after 3 h, while Tmprss2-D343N showed only marginal activity at this time. After 16 h, 
slight cleavage was also observed for the samples with Tmprss2-D343N, albeit less than the 
amount of cleavage caused by Tmprss2-WT after 3 h. For the mock control, no specific cleavage 
was visible after 3 h or 16 h of incubation. Furthermore, protein degradation of H1 was visible after 
the extended incubation at 37 °C for 16 h.  
 
Figure 3.43. Enzymatic cleavage of hemagglutinin H1 by recombinant Tmprss2-WT and Tmprss2-D343N. 
For an initial functional analysis, the ability of Tmprss2-WT (Tmp-WT) and Tmprss2-D343N (Tmp-D343N) to 
enzymatically cleave the viral substrate hemagglutinin H1 (H1) from its unprocessed form (HA0) into the 
subdomains HA1 and HA2 was tested in vitro. For the reaction, 10 µg of H1 were each mixed with 10 ng of 
either Tmprss2 form and incubated at 37 °C. As a mock control, H1 was incubated without Tmprss2. Samples 
were taken after 3 h and 16 h of incubation. Furthermore, Western blot negative controls (NC) were set up 
comprising only Tmprss2-D343N or Tmprss2-WT without H1. The HA1 and HA2 subdomains are indicated 
by the respective arrows. The Western blot was performed with a primary rabbit α-PR8HA (H1) pAb and a 
secondary goat AP-conjugated α-rabbit pAb. Colorimetric staining was done with NBT and BCIP.  
Mw standard (M): PageRuler Prestained Plus. 
The enzymatic cleavage of hemagglutinin H1 by the produced and purified recombinant Tmprss2 
could be shown in this experiment. Tmprss2-WT displays a specific enzymatic activity on its viral 
substrate H1. The activity exerted by Tmprss2-WT is significantly higher than that of the mutant 
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form D343N. This is congruent with the previously observed reduced rate of zymogenic cleavage 
by Tmprss2-D343N, which could be significantly accelerated by the addition of Tmprss2-WT 
(§ 3.2.1 and 2.3). Furthermore, both forms of Tmprss2 could (at different rates) carry out the same 
defined cleavage of H1. This indicates that the mutant form D343N can still specifically bind to 
H1. However, this experiment does not allow distinguishing between the processed and the 
unprocessed protein molecules in the reaction mix. Hence, the presented results could not be used 
to analyze, whether Tmprss2-D343N has to be zymogenically processed in order to efficiently bind 
to the substrate H1.  
All in all, Tmprss2 was identified as a difficult to express target protein in this work. Particularly 
Tmprss2-WT was produced at very low levels compared to the activity knockdown mutant 
Tmprss2-D343N. P. pastoris was shown to be a suitable expression system for the secretory 
production of Tmprss2. An optimized protocol for the expression of Tmprss2 was established using 
codon optimized jackpot clones (o20 and o108). The time-efficiency of the production process was 
substantially improved through iterative methanol induction of a single batch of grown cells. The 
downstream process was streamlined through fast, direct affinity capture of Tmprss2 from the 
harvested culture supernatant after the production phase. By this, the effective product yields were 
also significantly enhanced. Finally, it was proven that the recombinant Tmprss2 can enzymatically 
cleave H1 in vitro. Still, the question remains whether the activity of Tmprss2-D343N is 
sufficiently low for co-crystallization with HA H1. 
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4 Discussion 
4.1 Evaluation of the established RMCE System in P. pastoris 
Common transformation methods in P. pastoris rely on stable transformation by homologous 
recombination. This approach faces some drawbacks such as off-target integration of the 
expression vectors with unpredictable expression results. Moreover, the transformation generally is 
limited to the number of the currently characterized genomic loci for the integration of the GOI. 
Still, even if an expression vector is targeted to an established genomic locus, the resulting 
producer clones display very diverse expression yields. Hence, the generation and screening of 
high producer (“jackpot”) clones usually presents a time-consuming and laborious bottleneck for 
the expression of recombinant target proteins. Minimizing the required effort and time-
consumption for the generation of producer clones with uniform expression patterns is an important 
goal in order to streamline the expression process. Consequently, this work aimed at the 
establishment of a Flp/FRT RMCE system in P. pastoris to enable flexible and highly specific 
insertion of any GOI into a tagged genomic locus.  
FRT F3 impairs protein translation in P. pastoris in a location between promoter and GOI 
The preliminary model system to establish the RMCE in P. pastoris relies on the constitutive GAP 
promoter and the integration of the tagging vectors into its genomic locus by homologous 
recombination. The initially devised RMCE cassette for P. pastoris was designed to be compatible 
to the multi-host expression system mHost-XS and its versatile multi-purpose vector pFlpBtM 
(Meyer et al. 2013). However, the combination “Promoter – F3 – GOI”, required for the RMCE 
cassette of pFlpBtM, impaired the protein expression of the GOI in P. pastoris. The influence was 
identified to occur at the level of translation.  
Assumingly, F3 is transcribed into the 5’-UTR of the mRNA of the GOI, where its secondary 
structure might hamper the initiation of protein translation. This hypothesis is supported by studies 
about the mRNA leader region, which report that both inhibitory and activating regions inside the 
5’-UTR affect the translation efficiency (Dvir et al. 2013). This can either be related to secondary 
structures that influence ribosomal attachment or movement or to trans-acting factors, which bind 
to the 5’-UTR and influence the translation machinery (Mignone et al. 2002, Chatterjee and Pal 
2009). In contrast to P. pastoris, no critical impact of FRT F3 was observed in HEK293-6E, CHO 
LEC 3.2.8.1, SF21 and Hi5 cells so far (Meyer et al. 2013). All of these eukaryotic cell lines are 
significantly different from the methylotrophic yeast. Therefore, it is possible that the secondary 
structure of FRT F3 acts as a critical element only in P. pastoris, for example by cross-interacting 
with an inhibiting 5’UTR trans-acting factor. Still, an in-depth analysis of this phenomenon would 
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have been beyond the scope of this thesis. For this reason, this matter was not further analyzed in 
favor of finding a working alternative to establish the RMCE system in P. pastoris.  
The expression of the fluorescent model GOI is rescued by relocating FRT F3 inside 
P. pastoris RMCE master cell lines 
The expression could be fully rescued by relocating FRT F3 upstream of the GAP promoter inside 
the genomic GAP locus (master cell line V5). Thereby, the initially intended compatibility to the 
mHost-XS was sacrificed. Consequently, the array of screenable expression hosts in the mHost-XS 
cannot be extended to P. pastoris using the RMCE system. Despite that, the identified working 
setup for the RMCE in P. pastoris offers a higher grade of flexibility. Not only the GOI, but also 
the promoter can be exchanged at will in P. pastoris within a single RMCE master cell line. This 
trait is beneficial, as the choice of the promoter can significantly influence the protein yields in 
P. pastoris depending on the target protein. For example, the usually weaker GAP promoter was 
shown to catch up to the expression levels of the AOX1 promoter or to outperform it for some 
target proteins (Macauley-Patrick et al. 2005, Yang et al. 2015). Conceivably, this phenomenon 
may apply to many potential target proteins. The P. pastoris RMCE system hence is advantageous 
on the grounds of testing different promoters, including heterologous and even artificial promoters, 
without the need of generating a completely new RMCE master cell line every time.  
On the other hand, the critical combination of “Promoter – F3 – GOI”, which inhibits the protein 
translation, could be purposefully applied to any gene of P. pastoris to perform a targeted 
expression / translation knockout. This approach could synergize particularly well with the Flp 
recombinase based marker gene regeneration in P. pastoris (Cregg and Madden 1989). This 
method is used to excise a stably integrated selection cassette through the recombination of an 
identical pair of FRT FWT sites in parallel cis orientation (Cregg et al. 1989). Usually, the excision 
of the selection cassette leaves a “scar” (the recombined FRT FWT site) in the respective genomic 
locus. If such a cassette would be inserted between a specifically targeted promoter and the 
downstream gene, the excision of the selection cassette would result in the “Promoter – FRT site – 
GOI” knockout combination. 
The auxotrophic selection trap Δhis4 is an efficient approach for clone selection in P. pastoris 
During the generation of the P. pastoris RMCE master cell lines, a model for a novel kind of 
auxotrophic selection traps (Δhis4) was successfully established. It presents a less stressful, 
stringent and low-cost alternative compared to the costly antibiotic selection traps that are 
commonly applied in cell culture (Verhoeyen et al. 2001, Wilke et al. 2011, Meyer et al. 2013, 
Baser et al. 2016). Apart from the P. pastoris strain GS115 (his4), other strains with different 
amino acid biosynthesis knockouts exist and can be used for selection. For example, the strain 
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JC303 (arg4 ura3 his4) exhibits an arginine, a uracil and a histidine deficiency (Lin-Cereghino et 
al. 2001). These genes would probably be feasible to create further auxotrophic selection traps in 
P. pastoris. This could be used to insert multiple RMCE cassettes, flanked by different pairs of 
FRT sites into the genome, similarly to binary CHO RMCE master cell lines (Baser et al. 2016). It 
should be noted that the principle of an auxotrophic selection trap is not tied to the RMCE system. 
The setup would be equally feasible for the integration of vectors using one FRT site, comparable 
to the Flp-InTM system (Thermo Fisher Scientific) used in mammalian cells. 
Alternatively, auxotrophic selection traps could also be complemented by homologous 
recombination in P. pastoris. Currently applied expression vectors like pPIC9k (Thermo Fisher 
Scientific) rely on the delivery of the full amino acid biosynthesis genes, including their promoters 
and transcriptional terminators. This increases the size of the vector and thereby the length of the 
integrating DNA fragment, which in turn negatively influences the integration efficiency (Näätsaari 
et al. 2012). Even more so, the auxotrophic markers present extended homologous regions. This 
can facilitate undesired off-target integrations of the vector. These undefined integration events are 
often indiscernible from the targeted integration of the vector in regard of the selectivity of the 
transformants. The principle of the selection trap could counter these drawbacks and lead to a 
higher genomic targeting specificity, while also decreasing the size of the expression vectors.  
This proposed approach would particularly benefit from the ability to perform highly precise 
genomic editing, for example through the Crispr/Cas9 system, which was recently established for 
P. pastoris by Weninger et al. (2016). By specifically excising a genomic region - e. g. the 
promoter and the ATG start codon of the wildtype His4 gene - a defined his4 knockout strain could 
be generated. This strain would display the same selective properties as GS115 (which was instead 
generated by random mutation). The prototrophy of the defined knockout strain could be restored 
with an appropriately designed expression vector, which delivers the missing elements (promoter 
and ATG start codon) to complement the knocked-out his4 gene. Hence, the partial or random 
insertion of the vector should not result in prototroph clones anymore. This should minimize the 
amount of false positive clones. 
The generation of producer cell lines by RMCE with comparable expression levels is possible 
using the established P. pastoris RMCE master cell line V5  
A proof of principle for the RMCE was delivered with master cell line V5 in a preliminary 
exchange experiment. Therein, the principal functionality of Flp recombinase in P. pastoris was 
anticipated, as it had already been used for marker gene recycling (Cregg and Madden 1989). In 
comparison, the RMCE system established for P. pastoris in this work is based on the 
recombination of two pairs of heterospecific FRT sites in trans orientation (respectively on the 
vector and in the genomic tagging cassette). Still, it remains to be evaluated, if and how the size of 
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the exchangeable cassette (due to different GOIs) would influence the efficiency of the RMCE 
reaction.  
Interestingly, all exchanged clones produced similar levels of y-eGFP, as evident by their exhibited 
green fluorescence. This shows that producer clones with comparable expression results can be 
expected through the defined RMCE reaction. A similar observation was reported for binary CHO 
RMCE master cell lines by Baser et al., where the expression levels of two tagged loci were shown 
to be cumulative (Baser et al. 2016). This might rely on a notable aspect of the RMCE system in 
comparison to the “classical” system by homologous recombination: The RMCE system is 
principally restricted to harbor only one copy of the GOI. A lower gene copy number can be 
advantageous for some proteins like alkaline phytase (Yang et al. 2012). However, it can be 
frequently observed that higher copy numbers result in higher expression levels (Liu et al. 2014). 
This was also shown for the secretory expression of Tmprss2 in this work.  
A random RMCE tagging approach might help to identify new, suitable genomic loci for 
recombinant protein expression, similar to the generation of CHO RMCE master cell lines (Baser 
et al. 2016). Once a favorable genomic locus is identified, the RMCE system enables the 
subsequent specific insertion of any GOI into it. Concomitantly, the established genomic loci like 
the AOX1 or the GAP locus would be left in their innate state for the possible insertion of further 
GOI by homologous recombination. This dual approach could be used to enhance the gene copy 
numbers or to provide the expression of accessory proteins and chaperones to aid the expression of 
a GOI. Furthermore, a loxP site could be added to the RMCE cassette, as it is present in multi-host 
vector pFlpBtM-III (Steffen Meyer, HZI). This would allow for the subsequent insertion of 
additional vectors into an exchanged RMCE cassette by the cre-lox system (Sauer 1987). 
As the RMCE master cell line harbors only one gene copy in a specifically tagged genomic locus, 
the expression of a GOI by different promoters should be comparable without any locus-dependent 
influences. This presents a promising approach to screen for the optimal promoter to produce a 
specific GOI. Moreover, high-throughput expression screens of gene construct libraries present an 
important task for recombinant protein expression, as truncated versions of a GOI can differ vastly 
in their expression yields and solubility (Bleckmann et al. 2016a). In P. pastoris, the RMCE system 
could provide an advantageous way for the expression screening of construct libraries due to the 
comparability of the different producer cell lines. A library of RMCE donor vectors could be 
transformed to perform an expression screen followed by the identification of the optimally 
produced gene construct by genomic PCR. This method could even enable subsequent 
transformations of the same construct by homologous recombination, if multi copy strains are 
desired. However, to establish a feasible construct library screening method, the efficiency of the 
DISCUSSION 
 
 128  
RMCE reaction needs to be optimized to achieve significantly higher numbers of positively 
exchanged clones. 
All in all, the successfully established pilot RMCE system in P. pastoris delivers a proof of concept 
for the applicability of the system in the yeast and indicates that the generation of producer clones 
with predictable expression results is possible through a cassette exchange. It remains to be 
analyzed in-depth, whether the RMCE system provides a feasible, time-saving alternative to the 
well-established homologous recombination, particularly following random tagging, for the 
generation of suitable high producer clones of different GOI with reliable expression results. 
4.2 Evaluation of the process optimizations for the expression 
of mouse Tmprss2  
Tmprss2 is a highly interesting drug target playing a crucial role for influenza A infectivity. In this 
work, the secretory expression of the ectodomain of mouse Tmprss2 for structural and functional 
analyses was described. P. pastoris was identified as a suitable expression host. A protocol for the 
production of the active (wildtype) form and an activity knockdown mutant (D343N) of Tmprss2 
was established and optimized to improve the expression yields as well as the downstream process. 
P. pastoris is the most suitable expression host for the ectodomain of mouse Tmprss2 
The expression of Tmprss2 was initially tested in P. pastoris, because it is a frequently used 
expression system for the secretory production of other TTSPs like Hepsin, Matriptase and DESC1 
(Friedrich et al. 2002, Somoza et al. 2003, Yuan et al. 2011). Thereby, Tmprss2 was shown to be a 
difficult to express target protein. During the initial test expression, it was observed that higher 
copy numbers of the vector resulted in higher yields of Tmprss2. The maximum producer 
(“jackpot”) clones were selected on a Zeocin concentration of 1 mg/mL. These clones showed 
significantly higher productivity than all other tested clones, yielding 0.15 mg/L for Tmprss2-
D343N, but only unquantifiable (though detectable) amounts of Tmprss2-WT.  
In addition to P. pastoris, the expression was alternatively tested in eukaryotic hosts HEK293-6E, 
SF21 and Hi5. However, the expression was not successful in any of the tested systems. The 
expression could also not be shown in E. coli in a preliminary expression experiment (data was not 
presented). Tmprss2 is a multi-domain glycoprotein which includes many disulfide bonds. Because 
of this, it was not surprising that the expression in E. coli failed. This is supported by the fact that 
until now no other reports mention the expression of the full ectodomain of any TTSP in E. coli. 
Only the truncated serine protease domain of Matriptase-1 was reported to have been expressed in 
this system (Désilets et al. 2006, Beliveau et al. 2009). The observed lack of expression of Tmprss2 
from SF21 or Hi5 insect cells in this work presents a notable difference to the (albeit unrelated) 
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Drosophila S2 cells, which had been used for the secretory expression of the ectodomains of 
Matriptase-2, Hepsin and DESC1 (Beliveau et al. 2009).  
The deviating expression yields of Tmprss2-WT and Tmprss2-D343N in P. pastoris are 
presumably caused by the different proteolytic activities  
Since all alternatively tested hosts did not produce any quantifiable amounts of soluble target 
protein, the production of Tmprss2 was continued in P. pastoris. Therein, several attempts were 
made to improve the expression yields. The codon optimization (GenScript) of the gene increased 
the expression yields by ca. two-fold. Through optimized cultivation conditions and a streamlined 
downstream processing, ~0.8 mg/L were obtained in shake flask cultures from a Tmprss2-D343N 
jackpot clone with the codon optimized gene (o108). This presents a 500 % increase over the 
originally obtained 0.15 mg/L. In contrast, Tmprss2-WT, while finally quantifiable, was produced 
at an order of magnitude less (~80 µg/L) from the respective codon optimized jackpot clone (o20). 
This difference in expression yields might be caused by the active protease Tmprss2-WT cross-
interacting with the host in an unknown way that eventually inhibits its own production.  
Tmprss2-WT and Tmprss2-D343N only differ in a single amino acid mutation. In D343N, the 
aspartic acid of the catalytic triad was replaced by asparagine, which resulted in a diminished 
proteolytic activity of the target protein. For this reason, it is plausible that the lower expression 
levels of Tmprss2-WT are not caused by limitations in protein processing or folding, but instead by 
its significantly higher activity compared to the mutant D343N. This is supported by a similar 
observation made by Zhao et al., who reported the individual expression of the serine protease 
domain of Matriptase-2 in P. pastoris. Therein, the active form, carrying one mutation (N164Q) to 
remove an N-glycosylation site, was expressed ten-fold lower than its inactive counterpart, in 
which the serine of the catalytic triad had been mutated (N164Q/S195A) (Zhao et al. 2013). 
Although the cause of this phenomenon was not identified, the authors speculated that the 
proteolytic activity of the active Matriptase-2 could be toxic to P. pastoris or exert an inhibitory 
effect on its expression (Sauer 1987). This is congruent with the conclusions drawn in this work. 
Comparable deductions were also made for the expression of active proteases in E. coli (Kwon et 
al. 2011). It is conceivable that similar effects can occur in any expression system.  
This hypothesis is further supported by the fact that the individual expression of the serine protease 
domain of Tmprss2 as a truncated, simpler construct did not improve the expression yields 
compared to the whole ectodomain. The higher complexity of the full ectodomain was most likely 
not a deciding factor for the low expression levels, but rather the aforementioned activity of 
Tmprss2-WT. Notably, the expression yields of the individual serine protease domain of 
Matriptase-2 were reported at ~1 mg/L for the active form (N164Q) and ~10 mg/L for the inactive 
mutant (N164Q/S195A) by Zhao et al. (2013). This is a significantly higher level than the one 
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obtained for the Tmprss2 constructs in this work. However, the expression of the serine protease 
domain of Tmprss2 was only tested with the original CDS of the mouse gene. In contrast, the 
reported Matriptase-2 constructs were codon optimized, which might have substantially enhanced 
the expression levels. Moreover, both Matriptase-2 constructs include the mutation N164Q, which 
removes an N-glycosylation site (Yuan et al. 2011). This mutation might also influence the 
expression of the protein considerably. As a consequence, a definitive comparison is not possible. 
In addition to this, none of the currently available publications offer comparable expression yields 
for the full length ectodomain of Matriptase-2 in P. pastoris. In contrast, the secretory expression 
of the full ectodomains of the TTSPs Matriptase-2, Hepsin and DESC1 was reported with yields of 
50-100 µg/L in Drosophila S2 insect cells (Beliveau et al. 2009). These results cannot be directly 
related to the ones obtained in this work due to the experimental differences (including the used 
expression host). However, it is still notable that the yield ranges within the same order of 
magnitude of Tmprss2-WT in this work. In the end, both publications and the results of this work 
consistently show that the secretory expression of TTSPs is generally a challenging task, regardless 
of the expression system.  
The N-terminal fusion of HSA to Tmprss2 did not enhance the expression yields 
A different approach to improve the expression yields of the Tmprss2 constructs was the 
N-terminal fusion of the strongly expressed and secreted human serum albumin (HSA) to Tmprss2 
to act as a stabilizing carrier protein. However, the fusion protein accumulated insolubly inside the 
cells and was degraded. In contrast, a similar approach for an N-terminal HSA-VEGF165b fusion 
protein resulted in successful expression in P. pastoris (Zhu et al. 2012). Still, since Tmprss2 is a 
particularly difficult to express target protein, it is possible that it presented the critical bottleneck 
for the proper secretory expression of the fusion protein. Additionally, it is noteworthy that the 
recently reported HSA fusion proteins produced in P. pastoris frequently rely on the C-terminal 
fusion of HSA to provide stability to the target protein (Dou et al. 2008, Huang et al. 2008, Gou et 
al. 2012, Lei et al. 2012). This constellation was not tested for Tmprss2 yet.  
Tmprss2 cleaves hemagglutinin H1 while the mutant D343N exerts reduced activity levels  
In a first activity test in vitro Tmprss2-WT and Tmprss2-D343N showed defined catalytic cleavage 
of hemagglutinin H1. Thereby, the single mutation in the catalytic triad of Tmprss2-D343N 
resulted in a significant reduction of the activity, but not in a complete knockout. This is in 
accordance to prior reports on the catalytic triad of serine proteases (Craik et al. 1987, Carter and 
Wells 1988). However, it remains to be analyzed whether the rest activity is problematic to perform 
co-crystallization with hemagglutinin H1. If a significantly stronger knockdown would be required, 
this could be achieved by singly mutating the serine of the catalytic triad to alanine (S439A in 
mouse Tmprss2) (Carter and Wells 1988). Apart from a S439A single mutant, a D343N/S439A 
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double mutant of Tmprss2 should also display considerably lower activity levels than Tmprss2-
D343N (Carter and Wells 1988). 
Usually, zymogens undergo conformational rearrangements following proteolytic activation (Khan 
and James 1998). Tmprss2-D343N is undergoing zymogenic maturation at a significantly reduced 
rate compared to the wildtype. The heterogeneous population of processed and unprocessed 
Tmprss2-D343N proteins (or any other activity knockdown mutant) could be a detrimental factor 
for the co-crystallization of Tmprss2-D343N with HA H1. In this work, Tmprss2-WT was shown 
to accelerate the zymogenic activation of Tmprss2-D343N. Hence, Tmprss2-WT could be used to 
cleave Tmprss2-D343N in order to provide the required homogeneously processed population of 
Tmprss2-D343N for structural biology.  
The co-crystallization of the fully processed Tmprss2-D343N with HA H1 would further be of 
advantage for another reason. Tmprss2 was shown to be an essential key player for influenza A 
virus pathogenesis by cleaving hemagglutinin H1 in living mice (Hatesuer et al. 2013). 
Accordingly, Tmprss2(-/-) knockout mice were protected from H1N1 virus infection (Prielhofer et 
al. 2013). Interestingly, other TTSPs did not facilitate the cleavage of H1 in vivo, despite displaying 
several structural similarities (particularly in regard of the serine protease domain). Hence, it is 
conceivable that the N-terminal LDLA and SRCR domains of the Tmprss2 ectodomain might play 
an important role for the interaction of Tmprss2 with the viral substrate H1. Since Tmprss2 is 
usually active (and processed) in vivo, it consequently makes sense to use the equally processed 
form of Tmprss2-D343N for co-crystallization with H1. 
In summary, through several optimizations to the culture process and the downstream processing, a 
protocol for the robust secretory expression of the ectodomain of Tmprss2 was developed in this 
thesis. Moreover, the proteolytic activity of the recombinant proteins Tmprss2-WT and 
Tmprss2-D343N were shown in a preliminary enzymatic test assay.  The assay revealed that the 
wildtype form could cleave both hemagglutinin H1 and Tmprss2-D343N, while the mutant form 
D343N displayed reduced activity levels.  
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5 Conclusions and Outlook 
In this work, the establishment of a Flp/FRT based RMCE system in P. pastoris was demonstrated. 
A model system was established in the genomic GAP locus and different variants were 
comparatively analyzed for the expression of the GOI. The RMCE tagging cassette was designed 
specifically for P. pastoris. In contrast to the present CHO RMCE master cell lines, the cassette 
harbors a Zeocin resistance cassette in addition to a fluorescent marker to provide a stringent 
primary selection of tagged clones. Furthermore, the amino acid biosynthesis based selection trap 
Δhis4 was developed. Δhis4 presents a model for a novel kind of auxotrophic selection traps, which 
comprise a cost-efficient alternative to the antibiotic based counterparts. The selection trap in 
P. pastoris might also be principally applicable to the existing, classical homologous recombination 
system in order to improve the stringency of auxotrophic selection. The use of further amino acid 
biosynthesis genes as selection traps should be possible. This would provide a viable approach for 
the stringent insertion of multiple GOI, for example for the production of multi protein complexes. 
Unlike originally intended, the P. pastoris RMCE system is not compatible to the multi-host 
expression system and its versatile vector pFlpBtM that is frequently used at the Helmholtz PSPF. 
This is due to the critical influence on protein translation by the FRT F3 site in a position between 
promoter and GOI, which resulted in the necessity to change the RMCE cassette by placing FRT F3 
upstream of the promoter. Still, the RMCE system might provide a time-saving approach to 
perform comparative expression screens of construct libraries or for the production of defined 
levels of a GOI in P. pastoris. It remains to be tested, how the RMCE system performs for the 
exchange of different GOI with variable lengths and whether the expression is sufficient for more 
complex proteins than the model GOI used in this work (y-eGFP). However, it should be noted that 
the RMCE system relies on the insertion of a single gene copy of the GOI. This might significantly 
limit the capabilities of this method in an expression host like P. pastoris, which frequently benefits 
from the presence of multiple tandem insertions of an expression vector. To identify novel, suitable 
genomic loci for stable protein expression at high levels, random tagging should be performed. For 
this, the use of newly identified strong P. pastoris promoters like the GCW14 promoter in place of 
the GAP promoter could additionally help to improve the expression yields. 
In the second project presented in this thesis, a method was developed for the secretory expression 
of the full ectodomain of mouse Tmprss2 in both its active wildtype form and a mutant form with 
reduced activity (D343N). Thereby, it was shown that Tmprss2 is a difficult to express protein, 
which could only be successfully produced in P. pastoris among several tested expression hosts. 
Moreover, the expression level of the active wildtype form was shown to be significantly lower 
than that of the mutant form. Through optimizations of the CDS of the gene, the cultivation 
parameters and the downstream processing, the product yields were significant improved.  
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The functional integrity of Tmprss2-WT was proven in a preliminary enzymatic activity test. 
Furthermore, the mutant D343N could be shown to display a reduced proteolytic activity. 
However, it would still be important to assess whether the reduced activity of Tmprss2-D343N is 
sufficient for co-crystallization with hemagglutinin H1. If this is not the case, then a stronger 
knockdown variant should be generated (e. g. S439A) to ensure that the substrate is not 
prematurely cleaved. A complete knockout of the protease activity of Tmprss2 could also provide 
an interesting approach for a comparative crystallization of Tmprss2 in its processed and its 
unprocessed proenzyme form to evaluate the expected conformational change. The necessary 
proteolytic processing of the inactive Tmprss2 mutant could be mediated by Tmprss2-WT in vitro. 
In perspective, it is worthwhile to assess further optimizations of the production process. First, it 
should be tested if the transfer of the optimized protocol to the bioreactor scale significantly 
increases the protein yields. Apart from the reported iterative methanol induction, a perfusion 
reactor process could present a viable alternative to handle greater culture volumes in a continuous 
process. Secondly, in the same context, the C-terminal fusion of HSA to Tmprss2 should be 
evaluated as a method to provide stability to the target protein in the supernatant. This could in turn 
allow for extended expression times. This would simplify the process and enhance the effective 
space-time yields, as a generated batch of producer cells could be productively used for a longer 
period of time.  
Moreover, it would be possible to further genetically engineer the existing P. pastoris “jackpot” 
clones for Tmprss2. In a recent publication, the co-expression of the endoglycosidase EndoT was 
reported to enhance the protein quality of GPCRs for structural biology through direct 
deglycosylation in vivo (Claes et al. 2016). Furthermore, the same publication showed that the 
induction of the unfolded protein response (UPR) system in P. pastoris and the resulting 
production of ER chaperones can also result in higher amounts of correctly folded target protein. 
These optimizations could conceivably be beneficial to the production of Tmprss2 in P. pastoris 
and the subsequent downstream process. 
Lastly, it is also of interest to assess whether the optimized expression protocol for Tmprss2 could 
also be applied for other TTSPs like Tmprss4, which is also an interesting candidate for structural 
biology to add to the research on influenza infection at the HZI.  
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Appendix I: Oligonucleotides 
 
Cloning, vector construction and mutagenesis 
Name Sequence 5’ → 3’ 
880NcoI-dHis4-F TAGAGCCATGGAAGCCACCTTGTGGGATCG 
BamHI-OpIE1-F CAGTAGGATCCGCGAAACACGCACGGC 
BamHI-PGK-F CAGTAGGATCCAATTCCACGGGGTTGGG 
BamHI-TEF1-F GATCAGGATCCCCCACACACCATAGCTTC 
Bsa-Flpwt-F GACGGTCTCGAATTCAAAACGATGCCACAATTTGATATATTATGTAAAAC 
BsaI-MfeI-GAP-F GACTAGGTCTCTAATTGCAATTGGATCTTTTTTGTAGAAATGTCTTGG 
BsaI-TMP(pET22B)-F GAAGCGGTCTCGAATTCGGACAGCAACTGTTCTACGTCTGAG 
BsaI-TMP-F GAAGCGGTCTCGAATTCGGTGACAGCAACTGTTCTACGTCTGAG 
BstBI-HSA-FOR CATAGTTCGAAACGATGAAGTGGGTAACCTTTATTTCC 
BstBI-PGAP-ATG-R CATTCTTCGAACCATATGCCATATAGTTGTTCAATTGATTGAAATAGG 
Cyc1T-NdeI-R GATCGCATATGAGCTTGCAAATTAAAGCCTTCGAG 
dHis4-880NcoI-R CAGTCCCATGGCTCTAAGACCCTTTG 
dHis4T-ScaI-R GCTCAAGTACTTAATGCGGTAGTTTATCACAGTTAAATTGCTAACGC 
EcoRI-GAP-R GTCTAGAATTCATAGTTGTTCAATTCATTGAAATAGG 
EcoRI-mCherry-f GCTACGAATTCAGCATGGTGAGCAAGGGCGAGGAGGATAAC 
EcoRI-Tmprss2-opt-F GAAGCTGAATTCGGTGACTCAAATTGCTC 
EcoRI-yeGFP-F GCAGGAATTCATGTCTAAAGGTGAAGAATTATTCACC 
GAPintF3-F GAAGTTCCTATTCCGAAGTTCCTATTCTTCAAATAGTATAGGAACTTCAGAATATAAAAGGCGAACACCTTTCC 
GAPintF3-R TGAAGTTCCTATACTATTTGAAGAATAGGAACTTCGGAATAGGAACTTCGATTCTGGTGGTTTCCAATAATCTC 
HindIII-dHis4-F GACTGAAGCTTCTGGTTCGGGAACATTTCCCTTGCTACCTGC 
int-TMPopt-mut-F GTAAGACTAAAAACAACGACATCGCTTTGATGAAGCTTCAGAC 
int-TMPopt-mut-R CTTCATCAAAGCGATGTCGTTGTTTTTAGTCTTACTATCGTAG 
kan_r1 GTCGGGCCGCGTCGGACGTGCTGCAGTTAGAAAAACTCATCGAGCATC 
NcoI-kan_f GCAGACCATGGATGCTGATTTATATGGGTATAAATGGGC 
NheI-TMP-F GATAGGCTAGCTGGTGACAGCAACTGTTCTACGTCTGAG 
Not-Flpwt-R CATGCGGCCGCTTAACCCGCGGATATGCGTCTATTTATGTAGGATGAAAG 
NotI-mCh(woTAG)-r GTTATGCGGCCGCCTTGTACAGCTCGTCCATGCCG 
NotI-Rudolph-R CATGAGCGGCCGCAGTTTCCTTAACATCTACTGTGAAGTG 
NotI-TMP-R2 CTACTTGCGGCCGCTCAGTGATGGTGATGGTGATGGTGATGCTTATCATCATCATCCTTGTAATCGC 
NotI-Tmprss2-opt-R CTAGATGCGGCCGCCTAATGGTG 
Not-Spe-F3_R GTATTGCGGCCGCATAGTTCAATACTAGTGAAGTTCCTATACTATTTGAAGAATAG 
PciI-3'AOX-f GCATTACATGTGTCGGCATCACCGGCG 
PciI-3'AOX-r CAATCACATGTTCTTTCCTGCGTTATCCCCTG 
PGK-PstI-R GATCTCTGCAGCCTGGGGAGAGAGGTCG 
PstI-OpIE1-R GATCTCTGCAGGCAAAGGTGCTGCGCG 
SacII-yeGFP-R CTACACCGCGGTTTGTACAAAAGCTCCATACCATGAG 
ScaI-kan_r2 CTCTCAGTACTCGGACCCGTCGGGCCGCGTCGGACGTG 
SpeI-PGAP-F GATACACTAGTAGATCTTTTTTGTAGAAATGTCTTGG 
SpeI-URG-F3-R2 GATCTACTAGTGAAGTTCCTATACTATTTGAAGAATAGGAACTTCGGAATAGGAAC 
TMP-R1 CTTATCATCATCATCCTTGTAATCGCATGCACCTTGAAAGTACAAGTTTTCGCTGTTCGCCCTCATTTGC 
URG-F3-R1 GAATAGGAACTTCGGAATAGGAACTTCCTCGAGTTGTCAAGTGAAAGGGGCAATT 
XbaI-URG-F CACTATCTAGACTGCAGCTGCTACTCTGGTCCCAAGTGAAC 
XhoI-HSA-REV GTATACTCGAGTGCATGCACGTGAATTCTGGACCTTGAAACAAAACTTCCAATAAGCCTAAGGCAGCTTGAC 
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RT-PCR 
Name Sequence 5’ → 3’ 
rt_Rud-F GTGATGGTATTCTCAAAGGCGACGTTAC 
rt_Rud-R GGACATGCTCGATAATGTGATTTGGTGG 
rt_PGK1-F TAAGGAGTTGACATACTTCGCTAAGGCC 
rt_PGK1-R CAATGATGATGGAATCGACCTTGTCCAG 
rt_ACT1-F CACAGTGTTCCCATCGGTCGTAGGTAG 
rt_ACT1-R GATACCGTGCTCGATTGGGTATCTCAAG 
 
Sequencing and genomic control PCR 
Name Sequence 5’ → 3’ 
s_pPICZ-F GACTGGTTCCAATTGACAAGC 
s_pPICZ-R GCAAATGGCATTCTGACATCC 
s_pGAPZ-F GTCCCTATTTCAATCAATTGAA 
s_dHis4F1 ACATTTCCCTTGCTACCTGCATACGC 
s_dHis4F2 GGAGCTGATCGACAACTTGC 
s_dHis4F3 GGAAGCTGATGAACTTGCAGAAGC 
s_dHis4F4 GCTGCTATGGCTTACGGAACAG 
s_dHis4F5 GGTTCGTATGGAGAAACTGGGAC 
s_pTEF_f GCAATCTAATCTAAGGGCGGTG 
s_tCYC1_r GGCGTGAATGTAAGCGTGAC 
s_aMF-FOR GAAGGGGATTTCGATGTTGC 
s_mCher5'-REV CCTCCATGTGCACCTTGAAGC 
s_pBRori-FOR CGTCTTGAGTCCAACCCGGTAAG 
s_AOX1TT-F GCAGCTGATGAATATCTTGTGGTAGG 
s_AmpR-F CTCATGAGCGGATACATATTTGAATG 
s_pUC-F GGATCTCAAGAAGATCCTTTGATC 
s_3'AOX1-F CCAACATGTGTCGGCATCACC 
s_mCher5'-R CCTCCATGTGCACCTTGAAGC 
s_pBRori-REV GCCTATGGAAAAACGCCAGCAAC 
s_pJET-FOR CGACTCACTATAGGGAGAGCGGC 
s_pJET-REV AAGAACATCGATTTTCCATGGCAG 
s_his4_5'-R CAAGGAATTATCAAACTCTGCAACAC 
s_gGAP-F CGACTGTCAATCATTCATCCTTGC 
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Appendix II: Genomic PCR analysis 
 
Overview of the expected band sizes of the genomic PCR analyses 
The analysis of the P. pastoris RMCE master cell lines and the fluorochrome test cell lines was conducted in 
two PCR reactions. The first PCR (PCR1) was conducted to validate the integration of the vector into 
P. pastoris. The second PCR (PCR2) was conducted in parallel to distinguish single copy insertion clones from 
multi copy clones. The table columns indicate the vector stably transformed into P. pastoris by homologous 
recombination, the PCR oligonucleotide primers and the expected product size in base pairs [bp]. 
Transformed vector PCR1   PCR2   
 Primers Product size [bp] Primers Product size [bp] 
pYTA-RudolphRFP s_pGAPZ-F 
s_pPICZ-R 
958 s_AmpR-F 
s_pPICZ-R 
1,503 
pYEXs-yeGFP s_AOX1TT-F 
s_his4_5'-R 
757 s_AmpR-F 
s_pPICZ-R 
1,562 
pYEXsPGK-yeGFP s_AOX1TT-F 
s_his4_5'-R 
783 s_AmpR-F 
s_pPICZ-R 
1,562 
pYEXsOpi-yeGFP s_AOX1TT-F 
s_his4_5'-R 
555 s_AmpR-F 
s_pPICZ-R 
1,562 
pPICZ-mCherry s_pPICZ-F 
s_pPICZ-R 
998 s_pPUC-F 
s_pPICZ-R 
1,941 
pPICZ-yeGFP s_pPICZ-F 
s_pPICZ-R 
1,004 s_pPUC-F 
s_pPICZ-R 
1,947 
pPICZ-RudolphRFP s_pPICZ-F 
s_pPICZ-R 
968 s_pPUC-F 
s_pPICZ-R 
1,911 
pGAPZAΔ8-mCherry s_pGAPZ-F 
s_pPICZ-R 
941 s_AmpR-F 
s_pPICZ-R 
1,488 
pGAPZAΔ8-yeGFP s_pGAPZ-F 
s_pPICZ-R 
947 s_AmpR-F 
s_pPICZ-R 
1,494 
pGAPZAΔ8-RudolphRFP s_pGAPZ-F 
s_pPICZ-R 
914 s_AmpR-F 
s_pPICZ-R 
1,458 
pYTAaox-mCherry s_pPICZ-F 
s_pPICZ-R 
1,015 s_3’AOX1-F 
s_mCher5’-R 
2,077 
pYTAaox-GAP-mCherry 
AOX1 locus insertion 
s_pGAPZ-F 
s_pPICZ-R 
941 s_3’AOX1-F 
s_mCher5’-R 
2,570 
pYTAaox-GAP-mCherry 
GAP locus insertion 
s_pGAPZ-F 
s_pPICZ-R 
941 s_AmpR-F 
s_pPICZ-R 
2,478 
pYTA-RudolphRFP (V1) 
(Repeated analysis) 
s_gGAP-F 
s_pPICZ-R 
2,063 s_AmpR-F 
s_pPICZ-R 
1,497 
pYTAΔF3-RudolphRFP (V2) s_gGAP-F 
s_pPICZ-R 
2,014 s_AmpR-F 
s_pPICZ-R 
1,448 
pYTAF3PR-RudolphRFP (V3) s_gGAP-F 
s_pPICZ-R 
2,063 s_AmpR-F 
s_pPICZ-R 
1,497 
pYTAatgF3-RudolphRFP (V4) s_gGAP-F 
s_pPICZ-R 
2,074 s_AmpR-F 
s_pPICZ-R 
1,508 
pYTAUR-RudolphRFP (V5) s_gGAP-F 
s_pPICZ-R 
2,074 s_AmpR-F 
s_pPICZ-R 
2,022 
pGAPZAΔ8-RudolphRFP (PC) 
(Repeated analysis) 
s_gGAP-F 
s_pPICZ-R 
2,014 s_AmpR-F 
s_pPICZ-R 
1,448 
pYTA (empty) (NC) s_gGAP-F 
s_pPICZ-R 
1,440 s_AmpR-F 
s_pPICZ-R 
874 
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Appendix III: Cell culture data (Tmprss2) 
1. Growth parameters of HEK293-6E cells following transfection to express Tmprss2 
   HEK293-6E    
hpt GFP gated [%]  Vitality [%]  Cells (x 106)  
 WT D343N WT D343N WT D343N 
0 0,02 0,02 96,8 96,8 1,6 1,6 
24 - - - - 2,1 2,12 
48 60,73 65,82 94,1 93,7 14,6 14,8 
72 78,15 81,27 92,2 90,9 15,1 15,7 
96 91,22 92,65 81,5 89,7 15,1 15,3 
 
2. Growth parameters of SF21/Hi5 cells following the infection to express Tmprss2 
   SF21    
Hours post 
infection 
YFP gated [%]  Mean 
Diameter [µm] 
 Peak Diameter 
[µm] 
 
 WT D343N WT D343N WT D343N 
0 0,41 0,41 18,24 18,24 17,19 17,19 
24 88,28 69,73 20,34 20,24 19,74 19,71 
48 98,28 93,18 21,22 21,41 20,82 21,02 
72 97,66 89,42 21,52 21,91 21,02 21,51 
Hours post 
infection 
Cell Count  
(x 106/mL) 
 Vitality [%]    
 WT D343N WT D343N   
0 0,91 0,91 97 97   
24 1,3 1,2 97,1 96,8   
48 1,3 1,3 96,4 95,6   
72 1,33 1,35 96,1 94,3   
   Hi5    
Hours post 
infection 
YFP gated [%]  Mean 
Diameter [µm] 
 Peak Diameter 
[µm] 
 
 WT D343N WT D343N WT D343N 
0 0,75 0,8 24,98 24,98 24 24 
24 41,69 37,44 26,45 26,41 25,44 25,54 
48 61,97 51,92 27,43 27,11 26,01 26,72 
72 61,97 51,92 27,81 27,67 26,46 26,97 
96 44,6 43,7 27,98 27,87 26,62 27,01 
Hours post 
infection 
Cell Count  
(x 106/mL) 
 Vitality [%]    
 WT D343N WT D343N   
0 1,1 1,1 97 97   
24 1,3 1,4 96,7 97   
48 1,4 1,45 96,7 96,5   
72 1,42 1,46 95,5 95,3   
96 1,49 1,47 81,5 89,7 15,1 15,3 
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3. SDS-PAGE and Western blot of the Tmprss2 expression test in SF21 cells 
 
The unconcentrated and the TCA-precipitated supernatant samples as well as the soluble and insoluble cell 
lysate fractions were analyzed for the presence of Tmprss2 by SDS-PAGE and Western blot. 0 – 72 h indicate 
probing times in hours post infection. Neither Tmprss2-D343N nor Tmprss2-WT could be detected. Staining 
of the SDS gels was performed with InstantBlue. The Western blots were performed with a primary mouse 
α­Flag mAb and a secondary goat AP-conjugated α-mouse pAb. Recombnant Tmprss2-D343N from P. pastoris 
KM71H/pPICZα-Tmprss2-D343N clone 116 (processed) served as a positive control (PC). Mw standard (M): 
PageRuler Prestained Plus. 
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4. SDS-PAGE and Western blot of the Tmprss2 expression test in Hi5 cells 
 
The unconcentrated and the TCA-precipitated supernatant samples as well as the soluble and insoluble cell 
lysate fractions were analyzed for the presence of Tmprss2 by SDS-PAGE and Western blot. 0 –96 h indicate 
probing times in hours post infection. Neither Tmprss2-D343N nor Tmprss2-WT could be detected. Staining 
of the SDS gels was performed with InstantBlue. The Western blots were performed with a primary mouse 
α­Flag mAb and a secondary goat AP-conjugated α-mouse pAb. Recombnant Tmprss2-D343N from P. pastoris 
KM71H/pPICZα-Tmprss2-D343N clone 116 (processed) served as a positive control (PC). Mw standard (M): 
PageRuler Prestained Plus. 
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Appendix IV: Maps of the RMCE vectors 
 
1. pYEXs vectors (§ 3.1.3) 
 
The RMCE “exchange simulation” vector pYEXs-yeGFP harbors the TEF1/EM7 promoter for the 
complementing expression of Δhis4 (d(his4)). In pYEXsPGK-yeGFP and pYEXsOpI-yeGFP, the TEF1/EM7 
promoter was replaced by the human PGK1 (hPGK1) promoter or the OpIE1 promoter, respectively. The 
detailed cloning strategy is described in chapter 2.3. 
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2. Fluorescence test vectors (§ 3.1.4.1) 
 
In the top row, the AOX1 RMCE tagging vector pYTAaox-mCherry is shown. Below, the respective test 
vectors are depicted based on pPICZ and pGAPZAΔ8. The initial tagging vector pYTA-RudolphRFP is shown 
for comparison. The vector maps were generated with the software Vector NTI Suite 8 (Thermo Fisher 
Scientific). The “d” in the figures stands for Δ. The cloning strategy is described in chapter 2.3.  
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3. pYTAaox-GAP-mCherry (§ 3.1.4.2) 
 
The RMCE tagging vector pYTAaox-GAP-mCherry harbors the GAP promoter downstream of the AOX1 
promoter and FRT F3. The vector map was generated with Vector NTI Suite 8 (Thermo Fisher Scientific). The 
“d” in the figures stands for Δ. The detailed cloning strategy is described in chapter 2.3. 
 
4. RMCE tagging vector variants for the expression analysis (§ 3.1.4.3) 
 
The additional RMCE tagging vector variants V2 to V5 are shown: V2: pYTAΔF3-RudolphRFP; V3: 
pYTAF3PR-RudolphRFP; V4: pYTAatgF3-RudolphRFP; V5: pYTAUR-RudolphRFP. The “empty” pYTA was 
used as the negative control vector. The vector maps were generated with Vector NTI Suite 8 (Thermo Fisher 
Scientific). The “d” in the figures stands for Δ. The detailed cloning strategy is described in chapter 2.3.  
pYTAaox-GAP-mCherry
10291 bp
d(his4)
c myc
6xHis
AmpR
Zeo(R)
mCherry
FRT F3
AOX1 promoter
TEF1 promoter
GAP promoter
AmpR-Prom
EM7 promoter
PBR322 ori
AOX1 TT
His4 TT
CYC1 TT (partial)
CYC1 TT
3'AOX1
FRT Fwt
BamHI (2627)
Eco RI (1478)
Pst I (1842)
Avr II (1184)
Not I (2208)
Sac I (208)
Sac II (2198)
Spe I (10286)
Sph I (7228)
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5. pYEXsUR-yeGFP (§ 3.1.5) 
 
The RMCE “exchange simulation”vector pYEXsUR-yeGFP harbors the TEF1/EM7 promoter for the 
complementing expression of Δhis4 (d(his4)) and the URG (upstream region of GAP) for the insertion of the 
vector into the genomic GAP locus of P. pastoris by homologous recombination. The vector map was generated 
with Vector NTI Suite 8 (Thermo Fisher Scientific). The “d” in the figures stands for Δ. The detailed cloning 
strategy is described in chapter 2.3. 
  
pYEXsUR-yeGFP
7793 bp
c myc
6xHis
y-eGFP
AmpR
d(his4)
ATG start codon
URG
FRT F3
TEF1 promoter
GAP promoter
EM7 promoter
AmpR-Prom
PBR322 ori
AOX1 TT
His4 TT
CYC1 TT (partial)
FRT Fwt
BamHI (2220)
Eco RI (1062)
HindIII (2788)
Nco I (3679)
Avr II (765)
Bgl II (576)
Bst BI (1060)
Not I (1801)
Sac II (1791)
Spe I (570)
Sph I (139)
Xho I (516)
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